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GENERAL INTRODUCTION 
Statement of the Problem 
The association between food and water quaiity and the public health of a society has 
been well established. To date, however, totally safe food and water supplies do not exist. Food 
and water supplies require continual monitoring to ensure that they are safe because many are 
contaminated with potentially pathogenic microorganisms and/or toxic chemicals. On the basis of 
sheer numbers, microbiological diseases are by far the most prominent food and waterborne 
threat. The cost in terms of medical expenses, lost productivity, and fatalities is enormous. 
Because testing all foods and water supplies for the presence of all the potentially pathogenic 
microorganisms is impractical, indicator organisms are used to monitor sanitary quality. Although 
there is debate about which organism provides the best indicator of sanitary quaiity, most 
laboratories conduct tests for the presence of total conforms, fecal conforms, and/or Escherichia 
coli. Typically, analyzing samples for the presence of these indicators is time consuming, 
expensive, and oftentimes lacks sensitivity and specificity. Tests for fecal coliforms and £ coli 
often require confirmation of initially presumptive reactions which takes additional assay time and 
labor. Furthermore, nonreactive species (e.g., anaerogenic strains of £. coli and E. coli that will 
not grow under the selective conditions imposed) often are not detected. Evans et al. (5) used a 
procedure to detect false-negative reactions (interference) in the standard most-probable-number 
(MPN) technique for coiiform enumeration of untreated surface water and potable water supplies. 
Coliforms were not detected in over 80% of the samples that were MPN-negative but were verified 
as coliform-positive by using their verification procedure. Nevertheless, the MPN technique was 
superior to the standard membrane filtration (MF) technique. Jacobs et al. (9) assayed 1,483 
drinking water samples collected in Vermont and New Hampshire by using MPN, MF, and 
presence-absence (PA) techniques. Of 336 coliform-positive samples, only 82, 64, and 88%, 
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respectively, were detected with the MPN, IVIF, and PA techniques. Thus, false-negative tests were 
obtained in 12 to 36% of the collform-positive samples, depending on the assay procedure that 
was used. Chang et al. (2) and Clark (3) used a new 4-methylumbelliferyl-B-D-glucuronide (MUG) 
test for E. coli that is widely used in the food industry and was recently approved by the 
Environmental Protection Agency for potable water testing. In the study by Chang et al. (2), a 
mean of 34% of E. coH isolated from human fecal samples yielded negative reactions wiien the 
MUG test was used. Finally, Clark et al. (3) reported that there was no significant differences in 
E. coli detected when the MF and MUG tests were used to detect E. coli in untreated water 
samples, but the MUG test was significantly inferior when used to detect E. coli in treated water 
samples. As these examples show, the techniques commonly used to test water and foods for 
conforms, fecal coliforms, or E. coli are in need of improvement or should be supplemented with 
additional verification techniques. 
This study was undertaken to develop rapid latex agglutination immunoassays based on 
the detection of enzymes specific to E. coli and to determine if the latex agglutination 
immunoassays could be used to complement traditional tests and improve the detection of E. coli 
In foods and water. It was envisioned that this assay could be used as a rapid confirmatory 
method for the detection of E. coli from presumptive-positive cultures without the need for 
additional labor and time intensive cultural confirmation. The original goal was to develop rapid 
latex agglutination assays that could be used as a one-step, 10-minute assay to confirm the 
presence of E. coll from any primary culture, enrichment broth or colony on a petri plate. In 
addition, the latex agglutination assays might be used to rapidly identify E. coli that are either 
glucuronidase negative with chromogenic substrates (such as those belonging to the 0157:H7 
serotype) or are anaerogenic, but are present in the food and water samples. 
The original assay concept employed a novel method of detecting multivalent antigens by 
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using three separate latex particles, each of a unique color, that undergo color separation upon 
immunologic reactions (4, 7, 12). With the multivalent nature of the assay and the rare probability 
of the selected enzymes being present In species other than E. coli, the assay should be uniquely 
specific for the determination of the presence of E. coli, even In the presence of other organisms. 
Dissertation Format 
This dissertation is presented as five parts. The first part is a general literature review. The 
other four parts are presented as separate papers that may be submitted for publication in a 
revised form. Included at the end of each part are separate literature cited sections. An overall 
summary and conclusions follow the fourth part. References cited in General Introduction and 
General Summary and Conclusions follow the General Summary and Conclusions. 
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PART 1. LITERATURE REVIEW 
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INTRODUCTION 
The Food Problem 
One can only imagine the problems that primitive man had with food preservation and 
providing safe and wholesome food to his family. Around 1837, with the beginning of bacteriology 
as a science and the work of Louis Pasteur, studies of food spoilage and illnesses were begun and 
methods to reduce or eliminate them attempted (147). 
The incidence of foodborne illness in the United States is high. For a five year period 
(1983-1987), Centers for Disease Control (Atlanta, GA) reported over 90,000 confirmed cases of 
foodborne diseases (29). These cases did not represent the entire incidence of foodborne disease 
(146). Excluded from this information are sporadic cases of Salmonella infection or outbreaks 
involving less common pathogens such as Bacillus cereus and E coli (29). It is estimated that 
only 10% of foodborne illness cases are reported (328). Estimates for the true annual incidence of 
food and waterborne illnesses range from 1.5 to 275 million cases (10, 11, 328). Bacterial 
pathogens contribute to over 60% of the foodborne illnesses confirmed in the United States 
annually (27, 29). New or "emerging pathogens" are receiving more attention in the literature (11, 
79, 222, 328). Pathogens, such as Listeria monocytogenes, Campylobacter jejuni, Vibrio spp., and 
E. coli 0157:H7 are now being implicated in foodborne diseases worldwide. Furthermore, the 
introduction of new types of food products and processing methods continually creates a variety 
of microbiological concerns (79, 146, 328). 
Indicator Organisms 
To ensure safe food and water supplies, pathogenic or potentially hazardous 
microorganisms must be either absent or at "safe" levels. In this consideration, examination of 
every food or food product for hazardous organisms is not feasible (147). As a result, 
determination of the potential for a food to harbor hazardous microorganisms is evaluated through 
indicator or index organisms (213). 
Criteria for indicator or irxJex organisms 
Suitable indicator or index organisms must comply with several criteria (127, 147)y. First, 
the organism must be associated with the source of the pathogen. Second, the organism should 
be present in greater numbers than the pathogen. Third, the organism should not proliferate in the 
environment. Fourth, the indicator organism should be as resistant as, or more resistant than, 
pathogens to environmental stresses. Finally, the indicator organism should be readily recovered 
and identified. There are no indicator organisms that presently satisfy all these criteria. 
Indicator organisms 
Currently, several organisms are commonly recognized as indicators. These organisms 
form two major groups: the coliforms and the enterococci (113). In certain situations, other 
organisms are specifically recommended as indicators (26, 127) but these will not be discussed 
here. 
Coliforms include several genera that are morphologically similar. Coliforms are defined as 
aerobic or facultative anaerobic, nonsporeforming, gram-negative rods that ferment lactose to acid 
and gas within 48 h at 35''C (26, 113, 133). This ambiguous definition includes predominantly 
E. CO//, Enterobacter aerogenes, Klebsiella spp. and Citrobacter spp. Some of these are widely 
distributed throughout the environment, and as such have little association with public health 
hazards (76). Distinguishing fecal from non-fecal coliforms by the ability of fecal coliforms to 
produce gas from glucose when incubated at 45°C increases the usefulness of coliforms to detect 
the possible presence of intestinal pathogens. Currently, coliforms, fecal coliforms, and E. coll are 
used as marker organisms (113, 133). 
Enterococci formerly were members of the genus Streptococcus. They are gram-positive 
cocci tiiat form pairs or chains, depending on the strain and cultural conditions, in general, they 
are catalase-positive, grow at 10° and 45°C, in 6.5% NaCI, and at pH 9.6 (126,147). Typically, 
Enterococcus spp. are abundant in fecal material regardless of the source (244). There is some 
host/species association, however, absolute host specificity cannot be considered unequivocal 
(113,126). A discussion of the usefulness of conforms versus enterococci as pollution Indicators is 
presented by Jay (147). A complete review on enterococci as Indicator organisms for food and 
water has recently been published (155). 
The choice of indicator or Index organism used, however, is controversial (290). 
Depending on the type of food product or source of water, coliforms, fecal coliforms, E. coli, and 
enterococci each have supporters for their use (14, 44, 107, 134,160, 275, 285). 
Rapid Methods 
The adjective "rapid" means very fast. Rapid Is an arbitrary term that lacl<s conceptual 
precision. It can mean different things under different circumstances to different people. In 
laboratory testing, rapid can take on two important meanings (158). Rapid methods can either be 
methods that are traditional procedures performed with more speed, or those methods that 
exchange or avoid steps that are time-consuming. Further demarcations of rapid methods are 
those with an elapsed time within the range of 4 to 12 h, and very rapid methods are those that 
provide results In less than an hour (106, 144, 329). 
Reasons for rapid methods 
Rapid methods are essential elements of food and water microbiology. In most 
laboratories, samples and analysis parameters are increasing and time, labor, and material 
resources for testing are decreasing. An additional benefit Is that results are obtained sooner, 
reducing warehousing costs for perishable foods and providing earlier recognition that a water 
supply might be contaminated. Overall, requirements for rapid methods are that they reduce the 
time required, mal<e an analysis easier, are less expensive (labor and materials), are better 
standardized, and/or may be automated (144,145). Although a major reason for development of 
rapid methods is cost considerations, a primary consideration must involve specificity, sensitivity, 
precision, and accuracy (106). In one forecast, there was unanimous consensus that traditional 
methods for the enumeration of microorganisms will be replaced by automated and mechanized 
procedures, that rapid immunological methods will become commonplace, and that identification 
methods will rely more heavily on miniaturized biochemical tests or specific substrates (143). 
Although we are halfway through the period of this forecast, adoption of improved methods by 
regulating agencies and the food industry indicate that the prognostication Is being met. 
Types of microbiologic^ rapid methods 
Many methods have been published that meet some or ail the criteria outlined in the 
previous paragraph. Some methods, including hydrophobic grid membrane filters, spiral platers, 
and Petrifiim "plates", are improvements on traditional methods in that accuracy is improved, a 
procedure is automated, or a method is made more convenient. Other methods are truly defined 
as rapid methods. These include methods based on bioluminescence, the direct epifluorescence 
filter technique (DEFT), the use of impedance and conductance, microcalorimetry, radiometry and 
infrared spectrophotometry, the Limulus iysate assay, gas chromatography, immunoassays, and 
DNA hybridization. It is beyond the scope of this literature review to discuss each method 
individually. Several excellent reviews are already available (2, 77, 91, 109, 138, 147). 
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IMMUNOASSAYS 
History 
Immunoassays, defined as an analytical technique based on the reaction of an antibody 
and antigen, were originally developed for studies of the human immune system in a medical 
environment (281). As the potentials of immunoassays were realized, other applications of the 
technique were found. 
The original implementation of immunoassay technology outside studying immunology Is 
credited to the work of Yalow and Berson in 1959 (324). Their work focused on development of 
an assay for insulin and in which a radiolabelled form of the hormone was used. The need for 
alternative methods to detect Immunoassay reactions soon led to non-radioactive methods, 
including enzyme immunoassays (EIA) or enzyme-linked immunosorbent assays (ELISA). The use 
of enzyme labels for an immunoassay technique is normally attributed to Engvall and Perlmann 
(82) and Van Weeman and Schuurs in 1968 (307). Coons, Creech, and Jones, however, should 
receive more credit than they have for linking a non radioactive label (fluorescein) to antibodies in 
1941 (15). Engvall and Perlmann used the term ELISA, which alludes to one of the reactants being 
bound to a solid-phase (test tube, microtitration plate, etc.). For the remainder of this dissertation, 
the term EIA will refer to any immunoassay in which an enzyme is used to detect the presence of 
an antibody-antigen reaction. 
Basic Concepts and Principies of Immunoassays 
To understand the potential for immunoassays in the role of a detector system, an 
understanding of basic concepts and principles of immunoassay is useful. Even though 
immunoassays are a reaction between an antibody and an antigen, many other variables exist to 
be exploited, or to interfere, with assay design. 
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Antibodies 
Two types of antibody preparations are available, polyclonal and monoclonal. Polyclonal 
antibodies are mixtures of antibodies against epitopes on an antigen. The antibody molecules will 
have different affinities and specificities for different epitopes. Polyclonal antibodies are relatively 
easy to prepare. Monoclonal antibodies are a single antibody type that results from the fusion of a 
plasma cell and an immortal tumor cell. Each monoclonal antibody is specific for the epitope on 
the antigen that the plasma cell was sensitized to produce antibody against. Preparation of 
monoclonal antibodies was originally described by Kohler and Mllstein in 1975 (159) and has since 
become one of the most significant innovations in immunoassay technology. 
Antigens 
Antigens are defined as substances that will react with a specific antibody (46). A variety 
of biochemical compounds, including carbohydrates, lipids, proteins, and nucleic acids, are 
antigenic. Smaller molecules do not normally elicit an immune reaction and production of 
antibodies. They can, however, act as haptens, and after linldng with an immunogenic carrier 
molecule, can induce an antibody response (264). Throughout the remainder of this paper, the 
term ligand is used to represent either antibodies or antigens. 
Types of Serological Reactions 
Serological reactions are those reactions that involve an antibody and antigen interaction 
in vitro. There are several useful reactions available for studying serological interactions. These 
reactions differ in their conditions, requirements, and sensitivities. 
Precipitation 
Precipitation is a class of immunological reaction in which an antibody (precipitin)-antigen 
forms an insoluble macromolecular aggregate. If the reaction occurs in a supporting medium such 
as agar gel, the precipitin reaction is readily visualized and evaluated. Precipitation is the basis for 
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Ouchteriony and single radial (IVIancini reaction) Immunodiffusion reactions (48, 105,137,150). 
Agglutination 
Agglutination is a class of Immunological reactions based on the aggregation of cells or 
other particulate material by antibodies. Agglutination reactions are generally more sensitive than 
precipitation reactions because the surface area of cells or particles is much larger than those of 
antigens detected in precipitin reactions (256). The agglutination reaction Is the basis for many 
assays including hemagglutination, coagglutination, and latex agglutination. 
Radioimmunoassay 
Radioimmunoassay (RIA), as previously mentioned, heralded the inception of 
immunoassay technology into diagnostic worl< (54, 59, 189, 211, 237, 289). RIAs involve a variety 
of techniques In which Isotope labelled reagents are used to detect either antibody or antigen. 
Assays are usually competitive in that radiolabelled antigen and native antigen in the sample 
compete for binding to an antibody (46, 289) vyith the amount of signal inversely generated 
proportional to the amount of native antigen present. 
Enzyme immunoassay 
ElAs are similar to RIAs, except that enzyme labels replace radlolabeis on reagents used in 
ElAs. In heterogeneous EIA, activity of the label is not affected by the binding of antibody to 
antigen (80, 256, 289) and separation of antibody-antigen from free antibody is required. 
Homogeneous ElAs regulate activity of the enzyme label through binding of antigens. When 
antibody and antigen interact, the enzyme label is sterically activated. With no antibody-antigen 
interaction, the enzyme remains sterically inhibited from substrate reactions (80, 256, 289). Many 
variations of EIA have been developed, including direct competitive, indirect competitive, and 
double antibody sandwich. These different variations of EIA accommodate various analytical 
requirements (256, 289). Information available on EIA has grown enormously over the past 
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decade. Several authors have published comprehensive reviews (52, 58, 80, 256, 289). 
Affinity ciiromatography 
Only one author (46) has listed affinity chromatography as a separate type of 
immunoassay technique. This is unfortunate because affinity chromatography represents another 
totally different use of antibodies for analytical work. Although the basic idea of binding 
heterogenous molecules was originally described in 1910 (196), the technique has gained common 
use only within the last two decades. 
Affinity chromatography involves irreversibly binding one of the components of the 
antibody-antigen interaction to a solid support such as agarose. The solid support with attached 
reactant is loaded into a column. A solution with a second reactant Is passed over the column. 
Antibody-antigen interactions result in the retention of the reactants in the column while 
contaminating materials are washed away. Collection of the second reactant Is effected by gently 
disassociating the antibody from the antigen and allowing the second reactant to pass through the 
column. Purification, and often concentration of the second reactant are thus achieved. Affinity 
chromatography has been used to detect aflatoxin from peanuts and maize (46) and is the basis 
for antibody purification used in this research. 
Application to Food and Water 
It was mentioned previously that in a forecast concerning the future of food microbiology, 
immunological methods will become commonplace (143). To meet demands of rapid and 
sensitive detection of microorganisms and toxins, increased use of immunoassays in food 
microbiology is one method available. The complex matrix of food requires a method to 
discriminate between hazardous substances, including microbiological organisms and chemical 
compounds, from the non-hazardous food components. Advantage is taken of the specific 
selectivity of antibodies for these hazardous compounds. Applications of immunoassay 
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technology have been successfully applied to a wide variety of analytical problems (2, 5, 212, 223, 
264, 289). There are several very good reviews on the use of immunoassays in food microbiology 
(5, 46, 54, 132, 223, 264, 289). 
Obstacles In Using Immunoassays 
Development of any immunoassay requires specific and sensitive antibodies (4, 132) 
without which assay development Is hampered from its inception. Initially developed for clinical 
diagnostics, immunoassays performed well in the examination of body fluids. But food samples 
are often a complex mixture of animal or vegetable tissues. Components of some foods often 
contain substances such as phenols and surfactants, that could interfere with immunoassays (4, 6, 
132). In addition, the rigors imposed during food processing may have converted target antigen 
from the native form that was used to develop antibodies into another form not easily detected 
with those antibodies (4, 132). These obstacles, although presenting some very real challenges to 
development of immunoassays for food products, can, for the most part, be overcome. 
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LATEX TESTS 
Latex agglutination tests were originated by Singer and Piotz in 1956 (279). in 
hemaggiutination assays, red blood cells were thie agglutination reaction indicator being used. 
Hemagglutination reactions date from 1922 (279) and are still used in blood transfusion work and 
diagnosis of many infectious diseases (220) even tliough thiey have some major disadvantages. 
Hemagglutination assay reagents iiave a stability of only a few weeks, are not well defined (they 
have their own surface proteins), and are not worked with easily (279). 
The discovery of latex particles occurred by accident. A worker at Dow Chemical 
Company (Midland, Michigan) sent a sample of latex paint out for electron microscopy. Results 
revealed a surprising uniformity of polymeric spheres. Although it took five years to refine the 
process by which uniform polymeric particles were made, the particles have become very 
important in immunoassay technology (17). These uniform polymeric particles have become 
known by the generic term "latex". This is because a suspension of particles looks milky, similar to 
the viscous plant sap. 
Fabrication of Latex 
Although uniform latex particles were not developed at Dow Chemical Company until very 
recently, the history of latex is centuries old, and the synthesis of polystyrene has been traced 
back to 1839 (128). The manufacture of styrene and other polymer resins developed because of 
the need for synthetic rubber during World War II (128). 
The process of preparing latex is based on the polymerization of an emulsion. Two types 
of polymerized particles exist: homopolymers and copolymers. Homopolymers are made by 
polymerizing a single monomer whereas copolymers are polymerized by using more than one type 
of monomer. Polystyrene and polyvinyl toluene are examples of the former whereas styrene-
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divinylcarboxylic acid, styrene-divinylbenzene, styrene-butadiene, and vinyltoiuene-f-butylstyrene 
are examples of the latter (17,128). 
Polymerization of an emulsion to form latex requires four compounds: surfactants (e.g., 
lauryl sulfate or sodium dodecyl sulfate), emulsifying agent (e.g., potassium laurate), initiating 
agent (eg., potassium persuifate), and water. The initial process involves establishment of 
surfactant micelles in water. Surfactant hydrophobic-hydrocarbon tail groups aggregate at the 
center of the micelle and hydrophilic groups at the aqueous interface. Polymer monomers are 
added that migrate into the micelle's hydrophobic region. The emulsion is heated with initiating 
reagent which releases free radicals. The free radicals start particle nucleus formation and 
polymerization within the micelle. Depending on conditions of polymerization, reactants used, and 
amount(s) of monomers, negative surface groups are created on the polymer surface that help to 
stabilize the particle (18, 75, 300). Polymerization can be repeated to increase size of the particle 
or particles can undergo ion-exchange treatment to remove surfactant (17, 128). 
By controlling polymerization reagents, the number, size, and surface characteristics of 
particles are changed, resulting in a extensive variety of particle sizes and types. There are four 
manufacturers of latex particles: Interfaciai Dynamics Corporation (Portland, OR), Seradyn Inc. 
(Indianapolis, IN), Polysciences (Warrington, PA), and Rhône-Poulenc (Paris, France). Each 
manufacturer produces a broad range of particle sizes that contain a wide variety of surface 
groups. 
Preparation of Latex Agglutination Assay Reagents 
The preparation of latex sensitized with antibodies is a multistep process similar to 
development of other immunoassays. While the basic procedures are similar for most 
immunoassays, adequate sensitization of latex is more complex than development of an EIA or RIA 
assay. Unlike EIA or RIA, the solid-phase becomes part of the assay, imparting a unique set of 
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conditions on the assay. For this reason, there are special considerations in reagent preparation. 
Cleaning lat&( 
It is well known that detergents decrease or inhibit the binding of proteins to polymeric 
surfaces (69, 103, 271, 306, 323). With current polymerization processes used by many latex 
manufacturers, removal of the emulsifier is necessary to obtain a well-characterized surface for 
protein binding. There are four adequate methods for cleaning latex particles before use: washing, 
dialysis, ion-exchange, and pressure cell filtration. 
Washing in a buffer is the easiest method to remove emulsifiers and extraneous reactants 
from latex surfaces (18, 23, 271). A suspension of latex is diluted in an appropriate buffer, the 
latex is sedimented by centrifugation, the buffer is removed, and fresh buffer is added. The 
procedure is usually repeated several times. Washing is generally quick, but complete removal of 
all traces of emulsifier and polymerization reagents is probably not accomplished. Furthermore, 
complete suspension of individual particles after centrifugation often requires ultrasonication to 
break up clumps of particles (271). 
Like washing, dialysis removes readily desorbed emulsifiers and polymerization reagents 
(18, 23, 68, 271). Dialysis, however, is slow and limits the molecular size of substances removed. 
Ion-exchange resin cleaning of latex is reputed to be very effective in removing emulsifiers 
and polymerization reagents (18, 23, 271, 303). Latex is put into contact with both cationic and 
anionic resins, either separately or as mixed resins. The suspension is then agitated for one to two 
hours before being separated by filtration on a Buchner funnel. A liability in using ion-exchange 
resins to clean latex is the possibility of resin contamination with impurities that will adulterate the 
latex (271, 303). 
Pressure-cell filtration, diafiltration, or serum replacement is similar to dialysis but is 
claimed to be much more effective than the aforementioned methods in removing emulsifiers and 
polymerization reagents (3,18, 23, 163). A filtration cell (sometimes called a stirred cell) is fitted 
with a porous membrane having a pore size of three-quarters to one-half the size of latex being 
cleaned. Ultra high purity water is fed from a reservoir into the cell under slight pressure (about 2 
psi). The latex suspension is stirred for two to three days until the conductance of the filtrate 
attains the same level as the feed supply. Pressure-cell filtration, however, is not suitable for 
cleaning small research quantities of latex. 
Binding of ligand 
Attachment or sensitization of latex with ligands can be a simple process or can become 
quite involved, depending on the requirements of the assay. There are two methods for sensitizing 
latex particles with ligands; adsorption or chemical attachment. Each method has certain 
advantages and disadvantages. 
Adsorption Adsorption is the simplest method of coating a ligand on latex. A suitable 
ligand is dissolved in a buffer solution and a suspension of latex is added and allowed to react for 
times ranging from a few minutes to more than a day. Latexes are generally hydrophobic and 
negatively charged, and they will strongly and almost irreversibly adsorb proteins by way of the 
hydrophobic areas in the proteins. At this point, the latex coating process may be complete and 
ready for use in latex agglutination assays, or additional preparation, such as blocking unreacted 
sites, can be further accomplished. 
The diameter of a latex particle determines total surface area available for adsorbing 
ligands (23, 47, 69, 231, 271, 272). The amount of any proteinaceous ligand adsorbed is 
proportional to the diameter of the latex. The actual amount of protein adsorbed, however, is not 
conclusively known. Bangs calculated that approximately 2.5 fig of immunoglobulin will bind per 
square meter of surface area (23). A report from another commercial latex distributor, however, 
states that the range of binding is 4.4 to 5.8 ng of immunoglobulin per square meter (272). This 
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two-fold discrepancy is most likely due to the source of information that Bangs used for his 
calculations. The work of Cantarero et al. (47) that Bangs cited consisted of an investigation of 
protein adsorption to polystyrene tubes rather than particles. Thus, the data are probably not as 
precise as data acquired specifically from protein binding studies on latex. In addition, as 
previously mentioned, differences in composition and cleaning of latex influences the adsorption of 
proteins (231) and could affect the estimate that is obtained. 
Very rarely should the entire surface of latex be covered with ligand, especially 
proteinaceous antigens. Because of a prozone effect (the phenomenon exhibited by some 
reactions in which agglutination fails to occur because of either an antibody or antigen excess; a 
zone outside of optimal proportions for reaction; 105), maximum sensitivity of a latex assay 
requires less than saturation coverage (271). 
Adsorption of proteins to latex is an incompletely understood phenomenon. Current 
theory is that the proteins adsorb to the latex through a combination of van der Waal's forces and 
hydrophobic bonds (47,140, 306, 323). Adsorption of proteins is very rapid, taking less than an 
hour to reach equilibrium (231, 278). 
The structure of the ligand will also influence adsorption to latex. Ligands that contain 
unusual chemical groups or that are highly hydrophilic are difficult to adsorb (271). Antibodies, in 
general, are a relatively homogenous group of proteins and adsorb readily to the surface of 
polystyrene particles (231). Antigens, on the other hand, are sometimes (but not always) very 
heterogeneous, consisting of a variety of compounds: carbohydrates, proteins, lipids, and nucleic 
acids, if an antigen is to be adsorbed, the chemical structure should be evaluated for presence of 
hydrophobic groups, without which adsorption is difficult. Covalent coupling methods may be 
necessary for hydrophilic antigens (271). 
Different proteins have different maximal adsorption to latex (69). Whereas adsorption of 
human immunoglobulin to latex was independent of pH influences, binding of human albumin and 
rabbit hemoglobin is dependent on pH (306). When the concentration of immunoglobulin being 
adsorbed was large, adsorption temperature affected binding, but for lesser concentrations of 
immunoglobulins or other proteins, adsorption was independent of temperature (306). 
Immunoglobulins seem to be adsorbed on latex primarily by way of their hydrophobic Fc 
region (231, 304) whereas no specific orientation is known for other types of proteins. 
Conformational changes also are likely to occur as proteins are adsorbed to latex (69,157, 231); 
these affect both the orientation of the proteins and the quantities bound. Desorption of adsorbed 
protein is generally minimized if the solution used during adsorption is not changed significantly 
during any subsequent manipulations of the latex (69, 231). 
Latex surface structure greatly influences the amount of protein adsorbed. Sulfate-
surfaced latex has a greater hydrophobicity and lower surface charge than does latex with a 
carboxyl surface structure. Latex with a sulfate surface therefore can adsorb more protein than 
latex with a carboxyl surface structure (231). 
Adsorption initially increases rapidly, then plateaus following a typical bimodal adsorption 
isotherm (85, 231, 278). In the bimodal isotherm model, with the addition of small amounts of 
protein, a protein monolayer forms, latex surface charges are neutralized, and particles tend to 
flocculate spontaneously. A second phase occurs if more protein is added, and stability is 
imparted on the latex suspensions (128). The second phase adsorption has been proposed as 
protein-to-protein association (47, 234, 278). 
Maximum adsorption of protein occurs at the isoelectric point of the protein (when its net 
charge is zero). This results in the protein having the most compact shape and lowest solubility 
(231). In addition, sensitivity of the agglutination reaction also is at its maximum at the isoelectric 
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point (68), although some investigators suggest that the assay pH should not be at the isoelectric 
point (271). 
Protein adsorption to latex also is strongly influenced by ionic strength of the adsorption 
solution. As ionic strength of the adsorption solution is raised, adsorption theoretically increases. 
This is most lil<ely because of reduction of electrostatic repulsion charges between protein and 
latex (231). Nonspecific agglutination reactions also are eliminated by increasing the ionic strength 
to 0.5 or higher (68). 
Covalent coupling Covalent coupling of proteins to latex is used when simple 
adsorption is ineffective or the treated latex does not function well in an immunoassay system. 
Other reasons for covalent coupling include achieving a greater stability of the protein-latex binding 
over time and to provide specific orientation of the protein on the latex (18, 23, 60). 
Several covalent coupling methods are available for attaching proteins to latex. A few 
common methods being used will be briefly mentioned. 
Latex, modified during manufacturing to have carboxylic acid groups on the surface 
(carboxylate modified iatex, CI\/IL), were the first useful particles used for covalent coupling (18). 
Generally, one can couple proteins directly to the carboxylate latex particle. As an alternative, a 
short hydrocarbon chain is used as a spacer between the latex and the protein being bound (18). 
The latter method provides a flexible linkage that allows the protein greater movement and 
reactivity. Direct coupling of proteins, however, is faster and easier. 
Carbodiimides are groups of coupling agents that react with a protein's free amine groups 
and the latex's carboxylate groups. Two carbodiimides frequently used are 1-cyclohexyl-3-(2-
morpholinoethyl) carbodiimde metho-p-toluene sulfonate and 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (18). Coupling is either a direct reaction between protein and latex 
(219, 288) or through an active ester intermediate formed with the latex carboxylate groups (71, 
21 
238). The structure of the carbodiimide used, however, affects the degree of immobilization of 
proteins (292). 
Using a spacer molecule, coupled to carboxylate latex by way of carbodiimides, reduces 
problems caused by steric hinderance (18, 271). Diamino all<anes, such as 1,6-diaminohexame or 
1,7-diaminoheptane, added to CML particles with carbodiimides, provide an amine surface for 
further carbodiimide or glutaraldehyde coupling (192, 248, 250). 
An investigator does not have to go through several steps to obtain reactive amine or 
amide group, because several manufacturers sell amino or amide modified latex. Amide groups 
are further reacted with hydrazine to form hydrazide-modified latex. Ligands are then coupled to 
the latex with a bifunctional compound, such as glutaraldehyde (18, 293). 
Several other methods for covalent coupling of proteins to latex are available. Cyanogen 
bromide, tosyl chloride, and carbonyl imidazole are used to activate hydroxide groups (37,149, 
221, 284). Vinylbenzyl chloride and aldehyde modified particles readily react with ligand amino 
groups to bind ligands (271). 
Optimization 
Optimum assay conditions for latex agglutination tests are very critical for the success of 
the assays. Optimum conditions involve, as a minimum: the particle type, coating and blocidng 
agents, pH, electrolyte, and presence of stabilizers (271, 318). Particle types and the effects of 
ligand have been previously discussed. Other considerations for achieving a suitable latex based 
assay will be briefly mentioned later. 
Theoretical sensitivities of latex agglutination tests have been calculated (21). On the basis 
of a 1 /zm-diameter particle, a sensitivity of 10 pg can be theoretically obtained. In actual assays, 
however, sensitivities have varied greatly (20). In most reports, actual sensitivities are on the 
magnitude of nanograms (129, 197) and only occasionally reach the theoretical limit. 
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Binding ligands to polymer surfaces for use in latex or other Immunoassays often requires 
blocking of unreacted sites with molecules that have no effect on the assay (23, 81, 83, 271). 
Various molecules have been suggested as blocking agents (23, 240), however, bovine serum 
albumin and certain Tweens, such as Tween 20, are most commonly used (52,110, 162, 204, 310). 
Other compounds used to optimize agglutination reactions include high-molecular weight 
polymers, chaotropic agents, and halogen substituted carboxylic acids. Polyethylene glycol is 
probably the most commonly used polymer for increasing the degree or speed of the agglutination 
reaction (60, 65, 111, 130,131, 136, 165, 193, 200, 245, 267). Polyethylene glycol is classified as 
an enhancing agent; a substance that increases the precipitation reaction. Through steric 
exclusion of water, the solubility of the antibody/antigen complex is lowered (114). Chaotropic 
agents (e.g., guanidinium hydrochloride, sodium thiocyanate, urea) have been used successfully in 
reducing nonspecific agglutination reactions (64, 67). Chaotropic agents break or weaken non-
covaient bonds such as those between antibody and antigen. Nonspecific agglutinations also 
have been reduced by the addition of sodium trichloroacetate, a halogen-substituted carboxylic 
acid (283). 
Uses of Latex Particles 
Improvements in methodology and continual development of new applications have 
ensued for latex immunoassays over the years. Initial development of latex agglutination assays, 
and subsequent development of methods based on latex particles, have heralded the development 
of many rapid methods. These rapid methods have allowed laboratories to process more samples 
faster, at less cost, and often with increased sensitivity than has previously been possible. 
Changes in performance 
Since 1956, when Singer and Plotz applied latex particles to the diagnosis of 
rheumatoid arthritis (279), the latex immunoassay has steadily evolved. Well over 140 analytical 
tests based on latex agglutination are commercially available (19, 21). Many ciianges in latex 
immunoassays have been refinements in the performance of the assay. Some manufacturers of 
commercial latex agglutination tests have refined the assay by simply changing the format of the 
test. By using capillary mixing (21, 22) instead of hand rocking, manufacturers have decreased the 
tedium involved in the performance of latex agglutination tests. The simple step of using dyed 
particles has enhanced the objective assessment of latex agglutination tests. By linking different 
antibodies to different colored particles, multianalyte tests are performed in one step (117, 118, 
242, 257). Borrowing from their predecessors, hemagglutination and hemagglutination inhibition, 
latex immunoassays also have been adapted to performance in microtitration plates (21, 24, 56, 
57, 128). 
Automated agglutination assays 
Development of automated instrumentation has allowed development of convenient, 
quantitative, and sensitive latex immunoassays. For large volume applications, such as those 
performed in clinical laboratories, automated methods are more desirable. Automated latex 
immunoassays can detect lower concentrations of reactants than are possible with manual 
reactions (305). 
By modifying instruments originally designed for counting blood ceils (33, 34, 45, 119, 175, 
193) or continuous flow chemistries (35,195), automated measurement of agglutinated particles is 
possible. Instruments can detect and count individual and aggregated clumps separately (318), or 
determine the number of nonagglutinated particles remaining after the agglutination reaction (34, 
35, 45, 119, 193,195). Several assays for clinically relevant analyses have been described (34, 35, 
45, 119, 193, 195). Advantages of full automation and short reaction times do not, however, 
compensate for low overall sensitivity of these assays when compared with other methods, such 
as EIA (305). 
Measurement in iight absorption cliange by a latex suspension, either as transmitted light 
or as scattered light, can also be used to quantitate latex immunoassays (267). Simple 
spectrophotometers have been used to measure decreased absorbance in a solution of 
agglutinated latex particles (33, 34, 36,172). To take advantage of newer clinical laboratory 
instruments that can measure changes in absorbance, several investigators have devised 
innovative methods for latex agglutination assays. Termed particle enhanced turbidimetric 
immunoassays or PETIA, these assays have been applied to a variety of clinical measurements 
(65, 200, 206, 245, 301). A specially designed instrument that can measure light scattered from a 
suspension is called a nephelometer (20,111, 271). Nephelometric measurements are more 
sensitive than simple spectrophotometric methods (optical density determinations) due to 
decreased background light measurements (271). Like PETIA, several clinical analyses take 
advantage of the speed and sensitivity of nephelometry (55, 104, 170, 206, 207). Other more 
advanced measurements of light scatter include quasi-elastic light scatter and angular dissymmetry 
(20, 21, 271, 311). Both methods simultaneously measure light scattered at more than one angle 
and increase the specificity of measurement of agglutination reactions (271, 311). Neither of the 
last methods, however, are in common use for routine latex immunoassays. 
Filter based particle assays 
There are two distinctly different approaches to using latex in combination with phase 
separation by filtration. Commercial applications of both are available, although the success of 
microparticle enzyme linked assays has overshadowed particle capture. 
The principle that agglutinated particles cannot pass through a filter that nonagglutinated 
particles can pass through is the basis of particle capture latex immunoassay (20, 21, 22, 271). By 
using colored latex particles, development of a colored area on a membrane surface reveals that 
an agglutination reaction has occurred. 
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Although particle capture Is not a prevalent method for detecting latex Immunoassays, a 
derivative, micropartlcle enzyme linked assays (MEIA) (20, 21, 22,164, 271) have captured a large 
market in clinical laboratories. Similar to particle capture assays, MEIA starts with antigen or 
antibody bound latex particles and a filtering device. Unlike particle capture assays, MEIA uses an 
enzyme/substrate method to detect agglutination. Unlike membrane dot blots, the use of latex 
particles increases the surface area of the reaction. That, in turn, increases the ease of use and 
reduces assay time (8, 39, 190,191, 302, 317). 
Latex chmmatography 
Within the past few years, another novel use of latex particles has been successfully 
commercialized. Based on the migration of dyed latex along a filter strip, this method employs a 
sandwich antibody capture to form a detectable signal (21, 22, 38). Antibody coated particles are 
spotted on a nitrocellulose strip. When the strip is dipped into a solution, the particles migrate with 
the solution up the strip by capillary action. If the solution contains an appropriate antigen, the 
particles will become bound by a second immobilized antibody. The antigen becomes the link that 
holds the labeled antibody to the immobilized antibody. If the solution does not contain the 
appropriate antigen, the particles continue to migrate past the second capture antibody and no 
spot will develop. 
Magnetic particles 
Magnetic particles have become widely used for immunoassays because of their ability to 
be readily removed from reactions and washed free of interfering agents. Although the particles 
are termed "magnetic", the particles are not themselves magnetic but respond to a magnetic field 
(21). Antibody coated magnetic particles have been used to "capture" a host of substances, 
including human cells and proteins (262), bacteria (96, 176, 178, 229, 298, 309), viruses (121, 201, 
226), and parasite proteins (115). After capture, antigens are detected with enzyme immunoassay 
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(115, 176, 262) or other methods. When capturing bacteria, polymerase chain reaction (PGR) 
analysis (214, 316) or growth in selective media (96,178, 229, 309) can be used to identify the 
captured organisms. Lim et al. (171,173,174) used a second latex particle coated with antibody 
as the indicator system. Antigen, if present, becomes sandwiched between the magnetic particle 
and the indicator particle, allowing removal of the magnetic and indicator particles from the 
preparation. If no antigen is present, removal of the magnetic particles from the preparation leaves 
the indicator particles in the preparation. 
Radioimmunoassay 
To reduce incubation times and Improve bound/unbound separation, latex particles are 
used in radioimmunoassays (21, 261). Commercial applications of magnetic particles in 
radioimmunoassays are available (22). 
Nucleic acid assays 
With the use of nucleic acid techniques increasing, application of particles to nucleic acid 
hybridizations and amplifications are natural extensions of immunoassays (21). Nucleic acids are 
directly attached to particles (321) or are captured through intermediates such as biotin (21, 214). 
Latex particles also have been used to capture PCR-amplified products (308). 
High d&isily particles 
High density latex particles (approximately 1.5 g/cm^) have been used in both a reversed 
passive latex agglutination test and a sandwich assay. Using high density particles in a reversed 
passive latex agglutination test decreased the assay time from 16 h to 3 h (99). A high density 
particle can be combined with an indicator particle in a sandwich assay, similar to two-particle 
magnetic immunoassays. This allows detection of analyte after centrifugation of the high density 
particle; no further processing steps are needed (167). 
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Fluorescent micropartides 
Latex particles, Into which fluorescent dyes have been incorporated, have a multitude of 
novel uses. Fluorescent particles are being used to label cell surface antigens for microscopic 
work (41, 205, 251), determine antibodies or cell types in flow cytometry (75, 198, 199, 291), 
undergo phagocytosis for virus research (41), trace neuron pathways (41), and signal different 
R^EiA applications (41,164, 236). 
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THE ENZYMES 
Glucuronidase 
Properties 
Glucuronidase is an acid hydrolase that hydrolyses B-D-glucuronides (testosterone, 
oestriol, pregnanediol, and others) to D-glucuronic acid (92, 168, 169). It is a tetrameric 
glycoprotein present in tissue lysosomes, endoplasmic reticulum (169, 235, 239) and bacteria (42). 
The enzyme contains a high concentration of polar amino acids and the sugars include galactose, 
mannose, glucose, and hexosamine (235). 
Mouse glucuronidase Is described as having a subunit molecular weight of 69,000 to 
82,000 and whole unit molecular weight of 280,000 to 300,000 (102, 235). In comparison, bacterial 
glucuronidase from £ coli has a monomeric molecular weight of 68,200 (148). The genes 
encoding bacterial enzyme activity were isolated and characterized in 1986 by Jefferson et al. 
(148). The operon maps at minute 36 on the E. coli chromosome and consists of four separate 
genes (225). Regulatory functions are controlled by a 600 bp gene, uidB. Enzyme activity Is 
encoded by a 1806 bp gene, aid A. A glucuronide-specific permease is encoded by a 1371 bp 
gene, uidB. A fourth gene of 1125 bp, uldC, has an unknown function. Within some groups the 
genotypic designation of the operon has been changed from uid to gus (319). The change of the 
operon designation is based on glucuronidase worl< done in the mouse model and subsequent 
revision of mouse genetic nomenclature (cited in 235) 
Glucuronidase is inducible by glucuronide and fructuronic acid substrates (224) but the 
efficiency of induction varies among bacterial strains (125). A regulatory gene encodes an operon 
HO COOH ENZ HO 
• 
COOHr 
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repressor and loss of the regulatory gene leads to constitutive glucuronidase activity (319). 
Besides repressor activity, the glucuronidase operon appears to have a CAP binding site that 
prevents transcription in the presence of carbohydrates (265, 319). Another source of 
glucuronidase repression Is under the control of another operon's regulatory gene. Repression of 
the uxu operon (that encodes for further metabolism of glucuronic acid) represses glucuronidase 
transcription (225). 
The pH optimum of the glucuronidase enzyme from £ coli is between 5.0 and 7.5 (148); 
however, the pH optimum may vary, depending on the substrate (125). Glucuronidase resists 
thermal inactivation at 50°C (148). Heavy metals (13, 72, 169) and ascorbic, citric, and some other 
organic acids (239) inhibit glucuronidase activity. Chelating agents can Increase or Inhibit 
glucuronidase activity (13, 125). 
Methods of detection 
Several fluorometric and nonfluorometric substrates are available to detect glucuronidase 
activity (218, 297). Most of the substrates contain D-glycopyranoslduronic acid attached by way of 
a glycosidic linkage to a hydroxyl group of a detectable molecule (218). Hydrolysis of the 
hydroxy I group results In cleavage of the glycosidic bond and release of the detector molecule. 
The glucuronidase from E. coli has a specificity for B-conjugated glucuronldes and will not cleave 
other glycosides (218). 
There are several methods for detecting glucuronidase activity on the basis of 
histochemical demonstration of the enzyme. These involve hydrolysis of 8-hydroxyqulnollne 
glucuronide in the presence of acid-ferrocyanide reagent, 1- or 2-naphthyl glucuronide or naphthol 
AS 6-D-glucuronlde with post coupling to a diazonlum salt, or indoxyi glucuronldes (218, 239). 
5-bromo-4-chloro-3-indolyi B-D-glucuronide (BCIG), although expensive, Is probably the best 
substitute for coiorimetric assays and is the recommended histochemical method (218). The 
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colorless substrate is first hydrolyzed releasing an indoxyl group. The indoxyl group is then 
dimerized and oxidized to a water-insoluble indigo dye. BCIG has been used to identify 
glucuronidase-positive bacteria. Watkins et ai. (313) added BCIG to both lauryl tryptose broth and 
mTEC agar as a direct indicator of glucuronidase activity. Frampton et al. (95) and Restaino et al. 
(252) incorporated BCIG into peptone-tergitoi agar for direct glucuronidase detection. All three 
media were successfully used to identify E. coll from food sources. 
Another colorlmetric substrate is p-nitrophenyl fi-D-giucuronide (PNPGIu) (218). Cleavage 
of the bond between the phenol group and glucuronic acid liberates 4-N-nitrophenol that is 
measured spectrophotometrlcaliy at 402-410 nm. 4-nitrophenol is water soluble and less sensitive 
than other substrates, limiting its usefulness for some purposes. Adams et al. (1) used this 
substrate in a tryptone broth to study environmental water samples. They found that using a 
threshold optical density cutoff, detection time was inversely linear to the concentration of E. coli 
present. 
The most widely used substrate for detection of glucuronidase activity is 
4-methylumbeliiferyl B-D-glucuronic acid (MUG). Hydrolytic cleavage yields a fluorescent 
7-hydroxy-4-methyl coumarin that when excited at 363 nm, fluoresces at 447 nm. This substrate is 
two to thirty times more sensitive than PNPGIu and certain other substrates (218). 
7-hydroxy-4-methyl coumarin exists in both a phenolic and phenoxide form, depending on the pH 
(50). At a higher pH (greater than pH 8.2), the more fluorogenic phenoxide form exists, whereas 
at a lower pH (less than pH 8.2), the non-fluorogenic phenolic form exists. The excitement of 
iVIUG can readily be achieved with long-wavelength ultraviolet light (365 nm) with visual detection 
of the blue fluorescence. 
Other fluorogenic substrates for glucuronidase are resorufin 6-D-glucronic acid and 
4-trifluoromethylumbelliferyl 6-D-glucuronic acid (TFMUG) (218). Cleavage of the substrate yields 
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resorufin wliich emits a fluorescence at 584 nm when excited at 571 nm. Resorufin, unlil<e MUG, 
has maximal fluorescence at neutral pH and is stable except in the presence of reducing agents. 
Like resorufin B-D-glucronic acid, TFMUG (pK^ 7.3) has increased fluorescence at the more neutral 
pH values. TFMUG has an excitement wavelength of 393 nm with an emission of 502 nm. Further 
information on glucuronidase substrates is found in reviews by Feng (88) and Manafi et al. (184). 
Several Investigators have applied nucleic acid-based methods to detect the presence of 
the genes encoding for glucuronidase activity. Cleuziat and Robert-Baudouy (53) used three 
different gene probes based on uldB or uidA gene fragments and polymerase chain reaction (PGR) 
DNA amplification to test the usefulness for detecting E coli from collection strains. They found 
that 78% of Escherichia and Shigella strains hybridized with probes. Of those strains, 43% were 
phenotypically negative. Two strains of non-Escherichia/Shigella spp. were phenotypically 
glucuronidase-positive but gene probe-negative. 
Bej and co-workers (30, 31, 32) used PGR and DNA probes to extensively study E. coli 
and conforms in water. Although their original assays did not target glucuronidase genes, they 
later started using glucuronidase genes as targets. Their original assays used PGR amplification of 
gene fragments from lacZ and lamB (32). Their detection limits were one to five viable E. coli cells 
per 100 ml of water; however, the lacZ and lamB gene fragments were not specific for E. coli. 
When they switched to lacZ, uidR and uidA gene targets, the assay became specific for E. coli 
and Shigella species, including four MUG-negative E. coli strains (30). Estimated sensitivity was 
calculated to be one to two bacterial cells when the uidR gene was used. In a comparison 
between MUG-containing media and PGR detection using uidA gene probes, there was, or nearly 
was, a statistically significant difference in the detection when used to monitor water quality (31). 
Green et al. (112) used a gene probe based on an E. coli K-12 glucuronidase gene to 
detect fecal contamination of water. A 10 h non-selective enrichment period after filter membrane 
isolation was optimum. Only 90% of E. coll strains Isolated from environmental sources were 
phenotyplcally glucuronidase-positive, but all were gene probe-positive. Other than E. coli, only 
Shigella spp. were phenotyplcally and gene probe-positive for glucuronidase. Feng et al. (90) 
studied phenotyplcally glucuronidase-negatlve E. coll with a synthetic gene probe for part of the 
glucuronidase gene. Ninety-seven percent of E. coll were gene probe-positive, despite the 
phenotypical expression. Of particular importance in this study was the inclusion of E. coli 
0157:H7 that are typically glucuronidase-negatlve with MUG (74) but are 100% positive by gene 
probe for the glucuronidase gene. 
Bacterial identification 
In 1949 Buehler et al. (42) demonstrated that certain strains of E. coll and two species of 
Corynebacterium produced G-glucuronidase. Since that time, glucuronidase activity has been 
used to detect E. coll as an indicator organism in many food and water methods. Glucuronidase 
activity is a characteristic limited primarily (among the gram-negative bacteria) to E. coli and about 
half the Shigella strains (108, 122,153, 243, 273, 299, 319). In Killan and Billow's original report 
(153) on using glucuronidase for identification of E. coll, they reported that 97% of Escherichia 
strains, in which they included Shigella spp., possessed glucuronidase activity. Chang et al. (49), 
however, reported that 34% of their E. coll isolates were giucuronidase-negative. Suggestions 
about the differences in results obtained by Chang et al. (49) and those of other investigators were 
presented, but no evidence to support any of them was given. A further study was undertalcen in 
which the E. coll reference collection (ECOR) was used (177). The standardized collection 
contains a representative population of E. coli strains and is available from the American Type 
Culture Collection (Rockvllle, MD) as well as other sources. Results of this study demonstrated 
that many more fecal E. coli are giucuronidase-negative than E. coll from other sources, and the 
results were consistent with their previous report (49). In contrast, urinary isolates of E. coll were 
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100% positive for glucuronidase activity (177). In a later study (254), involving human, bovine, and 
equine fecal £ coli, 96% of the isolates were glucuronidase-positive. These studies suggested that 
the exact percentage of E. coli that have glucuronidase activity is dependent on the source and 
test methodology. 
A unique serotype of E. coll, 0157:H7, is described as most often negative for 
glucuronidase activity (73, 74,161, 249, 270). This strain is the causative agent of hemolytic 
uremic syndrome and hemorrhagic colitis, and it is a significant public health threat. The genus 
Escherichia also includes E. adecarboxyiata, E. blattae, E. fergusonii, E. hermannii, and E. vulnerls] 
these are generally negative for glucuronidase activity (253). One strain of E. vulneris, however, 
has been described as being positive (53). 
Other than E. coll and Shigella spp., the overall occurrence of glucuronidase producing 
organisms within the family Enterobacteriaceae is low (125). Some investigators have described 
strains of Hafnia aivel that are glucuronidase-positive (62, 274) although others have not found any 
glucuronidase positive Hafnia spp. (153, 255). Le Minor et al. (166) characterized 30% of the more 
than 4000 strains of Salmonella that they studied as having glucuronidase activity. Sharpe et al. 
(274) reported that 20% of 566 Salmonella strains tested were positive for glucuronidase activity. 
Kampfer et al. (151) described five of nine S. arizonae that were glucuronidase-positive but none of 
S. typhi (14 strains) or S. enteritidis (6 strains) tested were positive. Feng and Hartman (89) and 
Trepeta and Ed berg (299) stated that 17 and 15% of the Salmonella strains that they examined 
were glucuronidase-positive. But, Kilian and Bulow (153) reported that none of their ten strains of 
Salmonella were positive. The last four studies, however, did not involve as many strains as were 
studied by Le Minor et al. (166) or Sharpe et al. (274). As pointed out by Feng and Hartman (89) 
and Damaré et al. (62), although glucuronidase-positive Salmonella limit specificity of using 
glucuronidase solely for identification of E. coli, it does not hinder the intended public health 
intention of MUG use for rapid identification of potential contamination. In some reports, some 
strains of CItrobacter and Enterobacter have been described as producing glucuronidase (125, 
313), but the overall occurrence of these organisms producing glucuronidase is less than 10% of 
those studied. In one report an Enterobacter cloacae was phenotypically, but not genotypically, 
glucuronidase-positive (53). In this report the authors question the phenotype, hence the identity, 
of the organism. Yersinia kristensenii also has been described as having strains that are 
glucuronidase-positive (four of nine strains) (151). A complete review of the distribution of 
glucuronidase in selected genera and species has been published (125) as well as a survey of 
glucuronidase activity within the family Enterobacteriaceae (151) and for use in food, water, and 
clinical samples (94). 
Other gram-negative non-coliform bacteria have been reported to have glucuronidase 
activity. Petzel and Hartman (243) reported some strains of Fiavobacterium spp. produced 
glucuronidase. This problem was seen in cultures from frozen foods that were allowed to grow on 
a medium selective for gram-negative bacteria when the plates were incubated for over 20 h. 
Aeromonas spp., a common waterbome organism, has demonstrated a few glucuronidase-positive 
strains (125, 266). 
Some strains of Staphyiococcus, Micrococcus and Streptococcus have glucuronidase 
activity. Robinson and Moberg (202, 258) isolated glucuronidase-positive staphylococci and 
streptococci from lauryl sulfate tryptose broth supplemented with MUG. In another study, 
staphylococci and a Micrococcus sp. isolated from peptone tergitol glucuronide agar produced 
glucuronidase (62). In addition, a single species of Bifidobacterium is described as having 
glucuronidase activity (260). Other gram-positive organisms described as having glucuronidase 
activity include Clostridium spp. (263) and Corynebacterium spp. (61). To avoid problems with 
using glucuronidase activity for identification of £. coll, the presence of gram-positive organisms 
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can readily be discriminated by selective culture (202). 
Other non-coliform glucuronidase producing bacteria include a gliding bacterium (thought 
to be Myxobacteria), an organism similar to either a Micrococcus or Clavibacter, an unidentified 
bacterium (similar to either staphylococci or brevibacteria), and a Curtobacteria spp. (296, 319). 
The significance of these reactions has not been addressed in using glucuronidase activity outside 
of plant genetics, the source of this information. Further assessment of these organisms and the 
lil<elihood of their presence in non-contaminated food and water needs addressing. 
Glucuronidase substrates have been used in a variety of media, under a variety of 
conditions, and for a variety of samples. Liquid media such as lauryl tryptose broth (9, 49, 89,177, 
202, 241, 255, 258, 280, 313), lactose broth (7), m-Endo broth (7, 89, 98), m-FC broth (98), EC 
broth (9, 156, 255, 273), MacConkey broth (63), MacConkey-purple broth (16), brilliant green 2% 
bile broth (63), and B-glucuronidase-tryptone broth (1) have all been described as having certain 
advantages and disadvantages, depending on the application. Solid media such as violet red bile 
agar (7, 89, 315), MacConkey (299, 315), peptone tergitol agar (62, 95, 98, 227, 252), LES Endo 
agar (194), tryptone bile agar (268, 274), lactose-monensin-MUG agar (98), tergitol-monensin-MUG 
agar (98), MUG-7 agar (265), buffered MUG agar (84), m-LGA (266), EMX ID-agar (185), and m-FC 
(98, 194) were used with similar results as the broth media. 
Lauryl tryptose broth and buffered MUG agar have been adopted by the Association of Official 
Analytical Chemists for official use in testing (84, 203). Two commercially available rapid methods 
for detecting conforms and E. coli are available and are subject to controversy (78, 232). In the 
study by Clark et al. (51), these commercial media had respective failure rates of only 12% and 
19% for untreated water but a failure rate of 61% and 81% for treated water (when compared to 
membrane filtration for detection of E. coli). When compared to standard membrane filtration for 
total conforms, commercial methods fared better with greater than 94.8% agreement (233). Further 
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information on tlie use of glucuronidase activity in differentiating E coli in foods and water was 
reviewed by Hartman (125). 
Glutamate Decarboxylase 
Althougfi previous investigators described the production of amino acids, Including 
Y-aminobutyric acid from glutamate by bacteria, Gale (100), in 1940, was the first to describe 
strains of Bacterium coli (E. coli) that have glutamate decarboxylase. In further studies (101), he 
proposed that decarboxylase activity is used by bacteria to maintain physiological pH under acidic 
conditions. 
Prqoerties 
Glutamate decarboxylase is a pyridoxal-phosphate containing enzyme. The enzyme is a 
hexameric molecule with a total molecular weight of approximately 310,000 and a subunit 
molecular weight of approximately 52,000 (282, 286). The subunits are composed of nearly 
identical proteins (286). The optimal pH for enzyme activity is 3.8 (276, 286). Glutamate 
decarboxylase is responsible for the decarboxylation of glutamic acid; carbon dioxide and 
Y-amlnobutyrate are produced (93). The enzyme is inducible and is produced in large amounts by 
NH2 
I u+ 
HOOC-CH-CH2-CH2-COOH —HN2-CH2-CH2-CH2-COOH + C02 
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E. coli when grown in a medium containing L-glutamate (93). Glutamate decarboxylase is specific 
for L-glutamate and will not decarboxylate D-glutamate (101). Uniquely, glutamate decarboxylase 
is less stable at low temperatures than at room temperature when in neutral preparations (277). A 
study using electron microscopy (294) contributed to the knowledge that the enzyme has a 
hexameric structure consistent with its subunit composition, and the study confirmed that low 
temperature instability was structurally related. 
Lupo and Halpern (179, 181) used immunological methods to study glutamate 
decarboxylase. They concluded that there were no Immunological differences among glutamate 
decarboxylases from different strains of E coll with different enzyme activities. Their later work, 
with anti-glutamate decarboxylase and mating experiments, lead to the conclusion that glutamate 
decarboxylase Is under control of a regulatory gene that is responsible for differences In activity 
among bacterial strains (180). 
Smith et ai. (282) recently recounted that glutamate decarboxylase activity is under the 
control of two distinct genes. The two genes, gItA and gItB, both code for very similar, but not 
identical, proteins. This information contradicts the resuits of eariier works (180,187, 188) on the 
location of gadS and a regulatory gene, gadR, determined by genetic analysis. The amino acid 
sequence of E. coll glutamate decarboxylase has been determined (186) and has some similarity 
to those of mammalian glutamate decarboxylases. Divalent metal cations. Including Zn^\ Hg^\ 
and Cu^\ are Inhibitors of enzyme activity (326). In addition, conformational analogues, such as 
4,5-dlhydroxyisophthallc acid, chelidonic acid, and 4-bromoisophthaiic acid are potent inhibitors 
(326). 
Methods of detection 
Paper chromatography was one of the original methods employed to detect glutamate 
decarboxylase. King and Fletcher (154) and Proom and Woiwod (246, 247) used paper 
chromatography to detect the presence of an end product, y-aminobutyric acid, In culture fluids. 
The two research groups used different solvent systems, however, both used ninhydrin as the 
developing agent. Proom and Woiwod (247) later studied the production of glutamate 
decarboxylase by members of the family Enterobacteriaceae and genus Aerobacter as a method 
to classify species. 
Moiler (215) used manometric measurements of carbon dioxide evolution to study 
Enterobacteriaceae decarboxylases, including glutamate decarboxylase. Moran and Witter (209) 
developed an automated test for detecting glutamate decarboxylase activity. Using a Technicon 
AutoAnalyzer, they were able to liberate carbon dioxide into a phenolphthalein indicator solution 
and measure the decrease of absorbance as indicator of the presence of E. coli in the original 
sample. The detection level was determined to be 50,000 cells/ml of sample and was described 
as being useful in milk (209, 320) and water samples (208). IVIeasurement using a carbon dioxide 
sensitive electrode also has been used (327) but suffers from slow response time to the liberated 
carbon dioxide. 
Meiler (217) later developed a liquid medium in which decarboxylase activity from 
microorganisms could be detected. This method, based on decarboxylation of amino acids, 
results in an alkaline pH shift of the medium. This method, and its modifications (86), are the 
primary method for detecting the decarboxylation of lysine and ornithine. The detection of 
glutamate decarboxylase activity, however, requires careful and exact manipulation of the pH of 
detection media and the method is too exacting for routine use. A rapid resting-cell method of 
detecting glutamate decarboxylase activity has been developed (314), but is not in widespread 
use. In this method, a heavy suspension of toluene-treated bacteria in 0.1% sodium glutamate 
with brom cresol green as an indicator is used. This method normally required only three to four 
hours of incubation at 37°C before results were interpretable, but overnight incubation was 
necessary for some organisms. Schubert et ai. (269) later used a similar method in their study of 
glutamate decarboxylase activity. Instead of using a glutamic acid solution, they impregnated filter 
paper disks with glutamic acid. Toluene-treated cells were sedimented by centrifugation and 
suspended in an acid-water solution. After 20 min, brom-cresol green indicator solution was 
added and results were recorded the further incubation. 
Many other methods to study glutamate decarboxylase have been used. Radiolabelled 
glutamate has been used to study enzyme activity (124). Using an acid-base indicator, Rosenberg 
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et al. (259) developed a spectrophotometric method. Although their method was more rapid and 
convenient than manometric methods, it was less sensitive. None of these glutamate 
decarboxylase procedures are in common use for routine bacterial classification. 
Several agar-based methods for detecting decarboxylase activity have been described in 
the literature. Burman and Ostensson (43) described a medium composed of decarboxylase broth 
base with added agar to detect lysine, ornithine, and arglnine decarboxylases. Maccani (182) 
developed a decarboxylase test agar for the determination of lysine and ornithine decarboxylation 
without anaerobic incubation. Yamani and Untermann (325) described a decarboxylation medium 
that has been used for histidine, lysine, ornithine, and arginine decarboxylation determinations. 
Reacting amines from decarboxylation reactions with nitrosallcylaldehydes formed colored nickel 
complexes in another method (142). The latter method has been used for lysine and ornithine 
decarboxylase determinations. No reference, however, was made to using any of these methods 
for glutamate decarboxylase. 
A method for finding glutamate decarboxylase from brain tissue is based on the detection 
of NADPH (228). The reaction is based on the fact that glutamate decarboxylase produces 
Y-aminobutyric acid which then combines with ketoglutarate and continues through two steps to 
succinate and NADPH. Although no bacterial application has been described, it is doubtful that 
this method would be practical for bacterial classification. 
Bacterial identification 
Proom and Woiwod (247) originally observed that glutamate decarboxylase production 
was limited to Bacterium coli (reclassified as E. coli) and Shigella spp. among the 
Enterobacteriaceae. In later studies by Moller (217), 99% of E. coli, 83 to 89% of Shigella spp., 
69% to 100% of Proteus spp., 100% of Providencia, and only a few Hafnia spp. were described as 
having glutamate decarboxylase activity. Other Enterobacteriaceae were negative. Although, in an 
earlier report (216) a few rare Enterobacter and Klebsiella spp. were described as positive for 
glutamate decarboxylase activity, the method used was paper chromatography rather then a 
metabolic method. Using the rapid method of Wauters and Cornells (314), Freier et al. (97) 
established that 96% of £ coli, 71% of Proteus spp. (P. vulgaris -100% negative), 100% of 
Shigella spp., and 18% of Provldencia spp. (P. alcalifaciens -100% positive) were positive for 
glutamate decarboxylase activity whereas other Enterobacteriaceae species were negative. In 
addition, several species of anaerobic bacteria, including strains of Bacteroides spp., Clostridium 
spp., Fusobacterium spp., Eubacterium llmosum, Propionibacterium acnes, and 
Peptostreptococcus sp., also had glutamate decarboxylase activity (25, 97). When testing for 
enteric contamination, these latter organisms are seiectiveiy excluded in glutamate decarboxylase 
testing. Glutamate decarboxylase also is produced by some strains of Listeria monocytogenes 
and Mycobacterium leprae (cited in 28), but this should not limit the usefulness of glutamate 
decarboxylase for E. coli identification. 
Tryptophanase 
Distinguishing between two organisms within the Enterobacteriaceae by using indole 
production was originally described by Kitasato in 1889 (cited in 141). Indole production is now 
one of the most commonly used tests to differentiate Enterobacteriaceae and is used in most 
commercial identification systems. 
Properties of the enzyme 
E. coli tryptophanase also is a pyridoxal-phosphate containing enzyme (210, 322). The 
apoenzyme is a tetrameric molecule with a total molecular weight of approximately 209,000 to 
220,000 and a subunit molecular weight of approximately 55,000 (210). Each tryptophanase 
subunit contains a combining site for pyridoxal-phosphate (210). Tryptophanase catalyses a 
reversible deamination of the L-tryptophane side chain resulting in the formation of indole, 
pyruvate, and ammonia (123, 322). The reaction requires water, the coenzyme pyridoxal 
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phosphate, and monovalent cations such as and NH/ for activity (152, 210). In addition to 
B-elimination, tryptophanase can catalyze ^-elimination, B-replacement, and é-hydrogen exchange 
reactions with amino acids (152). The optimal pH for tryptophanase activity Is 7.5 (116). 
Tryptophanase is inducible by tryptophan and its analogs (66), and peptones used in 
media to detect indole must contain enough tryptophan to induce enzyme production (295). 
Tryptophanase synthesis is repressed by growth in the presence of carbohydrates such as 
glucose, lactose, xylose, or maltose (40). 
Methods of detection 
Detection of indole production, although a good means of differentiating among bacteria, 
does have some inherent problems (141). Two different reagents are in common use to determine 
indole production; Ehrlich's reagent and Kovac's reagent. Both reagents consist, in part, of 
p-dimethylaminobenzaldehyde. Indole formed from the deamination of L-tryptophan combines 
with the aldehyde in a multistep reaction to form a red colored quinoidal compound (183). In 
routine use, these reagents are either added to broth cultures or broth cultures or colonies are 
applied to filter paper impregnated with the reagents. A more recent reagent that has been 
applied to testing indole production is p-dimethylaminocinnamaldehyde (124). The latter reagent 
gives more intensely colored reactions, increasing test sensitivity by a factor of ten. Inasmuch as 
use of this reagent detects cultures that produce small quantities of indole, some cultures formerly 
deemed indole-negative when other reagents were used, would be considered indole-positive 
when the new, more sensitive reagent is used. 
In what can arguably be called the origin of rapid, miniaturized biochemical tests for 
bacteria, Arnold and Weaver investigated a microtechnique for indole detection (12). Using 1 ml 
quantities of media, a heavy inoculum, and incubation at 37°C for up to six hours, Arnold and 
Weaver (12) found that results were identical to four-day methods. Their results later lead to 
development of rapid, miniaturized fermentation tests for bacterial identification (120). In an 
attempt to achieve even more rapid test for indole production, Vracko and Sherris (312) 
investigated using p-dimethylaminobenzaldehyde as an indicator for a rapid spot test. By applying 
bacteria to filter paper prewet with the reagent, results were comparable to the results of the more 
venerable Kovac's test and were available within seconds. 
Other methods for determining tryptophanase activity also are available. Tryptophanase 
activity is determined by monitoring the reduction of NADH as lactate dehydrogenase converts an 
end product, pyruvate, to lactic acid (210, 287). Radiolabelled tryptophan has been used as a 
substrate for tryptophanase activity in a method used to determine the content of pyridoxal 
phosphate (230). A direct spectrophotometric assay of tryptophanase on the basis of a 
chromogenic substrate, S-o-nitrophenyl-L-cysteine, also has been described (287). In this method, 
tryptophanase causes an é,B-elimination, forming o-nitrothiophenolate; the reaction is monitored at 
370 nm. This method is not as sensitive as the lactate method nor as easy to perform as the 
p-dimethylaminobenzaldehyde or p-dimethylaminocinnamaldehyde reagent methods. 
Bacterial identification 
Tryptophanase activity has been described in many fecally associated bacteria (66). These 
include E. coli, Citrobacter spp., Edwardsiella spp., Klebsiella spp., Kluyvera spp., Leclercla 
adecarboxylata, Morganella spp., Provldencla spp., Bacillus (Hafnla) alvel, Proteus vulgaris, 
Aeromonas liquefaclens, Bacteroides spp., Corynebacterlum acnes, Micrococcus aerogenes, 
Photobacterlum harveyl, Pasteurella multoclda, and some Yersinia spp. and Serratia odorlfera 
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spp. (66, 87, 135). Although tryptophanase activity is not limited to E. coli, the incorporation of 
indole detection has evolved as a useful adjunct test to identify £ coli in samples of shellfish, 
urine, and water (70,139, 268). 
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PRODUCTION AND CHARACTERIZATION OF POLYCLONAL ANTIBODIES TO 
SELECTED E coli ENZYMES 
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INTRODUCTION 
The development of a diagnostic assay based on immunological reagents requires the 
availability of specific and sensitive antibody preparations. Kaspar (31) and Holt (21) used 
commercial Escherichia coll enzyme preparations to produce polyclonal anti-enzyme antibodies, 
some of which seemed to have the specificities and sensitivities needed for coagglutination and 
enzyme-capture tests. Therefore, to obtain antisera for use in developing rapid latex-agglutination 
assays, rabbits were immunized by using the purest commercial enzyme preparations available of 
£ coll glucuronidase, glutamate decarboxylase, and tryptophanase. The results of initial latex 
agglutination tests using these antibody preparations suggested, however, that characterization of 
the antibody preparations was necessary because cross-reaction were observed. Studies on 
antibody purity, cross-reactivity, and functionality were determined by using polyacrylamide gel 
electrophoresis, Ouchteriony immunodiffusion, and enzyme immunoassay techniques. Later, 
because Ouchteriony immunodiffusion assays yielded ambiguous results, Western blots were 
made to study cross-reactivities of the antibody preparations. 
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MATERIALS AND METHODS 
Antibody Production 
Antibodies were generated using six female New Zealand White rabbits. Each rabbit 
weighed approximately seven pounds on receipt and they were allowed to acclimatize to their 
holding area for 26 days before being used for antibody production. Two rabbits were used for 
each type of antibody. Antibodies were generated against three £ coli enzymes: G-glucuronidase 
(Sigma Chemical Co., St. Louis, MO, product number G7896), glutamate decarboxylase (Sigma, 
product number G3757), and tryptophanase (Sigma, product number A6007). One ml of 
phosphate buffer (0.01 M NaHgPO '^HgO, pH 7.2) containing 100 fxg of an enzyme preparation was 
emulsified with 3 ml of complete Freund's adjuvant (Difco Laboratories, Detroit Ml, product number 
0638-60-7). The immunogen/adjuvant mixture was injected intradermally along the shaved back of 
the rabbit (19, 24, 49); each rabbit received approximately thirty to forty 0.025-ml injections. Thirty 
days later, fresh enzyme preparations were administered to boost specific anti-enzyme antibody 
levels. The second and subsequent immunogens consisted of 100 /xg of appropriate enzyme 
suspended in 1 ml of 0.01 M phosphate buffer (pH 7.2) emulsified in 3 ml of incomplete Freund's 
adjuvant (Difco Laboratories, Detroit Ml, product number 0639-59). The second and subsequent 
immunogens were used for approximately thirty to forty intradermal injections per rabbit. 
Two weeks after the booster injections, whole blood was collected for purification of 
specific anti-enzyme antibodies. Blood was collected from anaesthetized rabbits by cardiac 
puncture and vacuum collection (Vacutainer System, Becton-Dickenson, Rutherford, NJ). The 
rabbits were anaesthetized to a surgical level with 1 ml of 1 ;3 acepromizine and ketamine. 
Approximately 30 mis of blood were collected and allowed to clot at room temperature for 
approximately 2 h. Cellular components were removed from the antisera by centrifugation of the 
clotted blood at approximately 1000 x g for 15 min (Sorval Instruments, DuPont Co., Newton CT, 
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model RT6000B) at 10°C. The antisera were transferred to labeled polypropylene centrifuge tubes 
(Corning product number 25319 or similar) and stored between -35 to -90°C until use. 
The rabbits were subsequently given a booster dose of antigen approximately every 
month. Collection of whole blood followed two weeks after boosting, as described previously, for 
one year after which the rabbits were euthanized. 
After six months, one rabbit, being used for anti-glucuronidase antibody production, 
expired. A male New Zealand White rabbit was acquired and another immunization series was 
started. Owing to previous problems in preparing homogenous emulsions with enzyme 
preparations and the difficulty In accurately performing inoculations caused by 
immunogen/adjuvant viscosity, an alternate adjuvant was used. One ml of Ribi adjuvant (Ribi 
Immunochemical Research, Hamilton MT, product number R730) was mixed with 0.78 mg of 
B-glucuronidase according to Ribi recommendations. Briefly, the adjuvant was warmed to 45°C, 
2 mis of B-glucuronidase in 0.01 M phosphate buffer (pH 7.2) were injected into the vial and the 
vial was agitated on a vortex mixer for 3 min. The rabbit was immunized with 0.3 ml intradermally 
(0.05 ml at six sites along the back), 0.4 ml intramuscularly (0.2 ml in each hind leg), 0.1 ml 
subcutaneously (in the neck region), and 0.2 ml intraperitoneally. A booster inoculation was 
administered 21 days later using 1.02 mg of B-glucuronidase in Ribi adjuvant as previously 
described. The rabbit was bled 26 days later and then established on the monthly boost/bleed 
cycle with the remaining five rabbits. 
Antibody Purification 
Antibodies against three £ coli enzymes were purified from stored antisera. The 
immunoglobulin G (IgG) fraction of each serum was separated from other serum proteins by one 
of three methods; protein A chromatography, antigen-specific affinity chromatography, or 
diethylaminoethyl (DEAE) column chromatography. 
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Pmfe/n A antibody purification 
For purification by using protein A, the serum was diiuted 1:1 with 1 M Tris buffer (pH 8.0) 
and clarified by passage through a 0.22- or 0.45-/im cellulose acetate syringe filter. The clarified 
serum (5 to 20 ml per application) was passed through a protein A-Sepharose (Sigma, product 
number P2545; binding capacity of approximately 100 mg of IgG) 8 cm x 1.25 cm column 
equilibrated with 100 mM Tris buffer (pH 8.0). The eluate was monitored at 280 nm with an Isco 
model UA-2 spectrophotometer (Instrumentation Specialties Co., Inc., Lincoln, NE) equipped with a 
flow cell. Passage of unwanted serum proteins was seen as a rise then fall of absorbance values 
with continuous flow of 100 mM buffer through the column (approximately 15 to 20 ml of buffer 
after serum application). After the absorbance returned to the base line, the wash was continued 
for another 10 to 15 ml followed by approximately 20 ml of 10 mM Tris buffer (pH 8.0). IgG was 
eluted from the column with 0.1 M glycine (pH 2.8). When the absorbance started to Increase, the 
fraction containing IgG was collected in a polypropylene centrifuge tube containing approximately 
2 ml of 1 M Tris buffer (pH 8.0) until the absorbance returned to the base line (approximately 
15 ml). The pH was adjusted to 7-8 with 1 M Tris (pH 8.0). Alternatively, IgG was eluted from the 
column with a sodium acetate solution (2.5 ml glacial acetic acid, 4.5 g NaCI, 0.2 g NaNg, quantity 
sufficient to mal<e 500 ml with dHjO, pH 2.8). 
ImmunoPure® gentie antibody eluti'on from protein A 
As an alternative to standard protein A purification, ImmunoPure® gentle antibody elution 
(Pierce, Rocl<ford, II, product number 21014) was used. This procedure is termed the "gentle 
method" for the remainder of this dissertation. Antibodies were purified according to instructions 
from the manufacturer. Briefly, this entailed diluting rabbit serum 1:1 with binding buffer (buffers 
were supplied with the l<it). Diluted serum was applied to an equilibrated 1-ml protein A column 
and allowed to flow completely Into the gel. The column was washed with approximately 15 ml of 
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binding buffer. IgG was dissociated from the protein A and eiuted with 5 ml of ImmunoPure® 
gentle Ag/Ab elution buffer. The antibody fraction was extensively dialyzed before further use. 
Antigen-spedfic aKnity chromatography antibody purification 
Antigen-specific affinity chromatography columns (Pierce, product number 44890) were 
prepared according to the manufacturer's Instructions. Briefly, activated Sepharose 4B In 
polypropylene chromatography columns was mixed with 5 to 10 mg of enzyme in coupling buffer 
(0.1 M phosphate, pH 7). A reducing solution (0.2 ml; sodium cyanoborohydride) was added. The 
columns were mixed by gentle rocking on a Thermolyne Speci-Mix (model M26125) for 2 h 
followed by 4 h stationary. The columns were blocked with 2 ml of quenching buffer (Tris-HCI, 
pH 7.4) and 0.2 ml of reducing solution for 30 min before washing and use. Initially, the columns 
were prepared by using the same commercial enzymes used for antibody production. Later, 
preparations of tryptophanase and glutamate decarboxylase, believed to be of better purifty, were 
used. (They were gifts from Dr. David Metzler, Department of Biochemistry and Biophysics, Iowa 
State University.) 
For antigen-specific affinity chromatographic purification, the serum was first diluted 1:1 
with 1 M Tris buffer (pH 8.0) and clarified by filtration through a 0.22- or 0.45-/im syringe filter. 
Serum (1 to 2 ml) was added to an antigen-specific affinity chromatography column that had been 
equilibrated with 100 mM Tris buffer (pH 8.0). When the sample had completely entered the gel 
bed, 0.2 ml of buffer was added and allowed to enter the gel bed, at which time the bottom cap 
was placed on the column. One ml of buffer was added to the column and the column was 
incubated at room temperature. After one hour (occasionally longer), the column was washed with 
approximately 16 ml of 100 mM Tris buffer (pH 8.0). Affinity specific immunoglobulins were eiuted 
from the column with 0.1 M glycine (pH 2.8). Either individual 1-ml fractions, or fractions 2 through 
6 in bulk, were collected and neutralized with 1 M Tris buffer. 
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DEAE AfR-Gel® Blue antibody purification 
DEAE Affi-Gel® Blue columns (Blo-Rad, Richmond, CA, product 732-3037) were used as 
recommended by the manufacturer. Briefly, samples were first desalted by using the Econo-Pak 
10DG columns and the application buffer (for rabbit immunoglobulins) supplied with the kit. The 
eluate from the desalting column was applied to an equilibrated DEAE Affi-Gel® Blue column 
followed by 20 ml of application buffer. Fractions were collected and those containing IgG, as 
determined by absorbance at A^go (6,19), were combined. Antibodies purified by this method are 
called as DEAE antibodies for the remainder of this dissertation. 
Dialysis and storage 
The immunoglobulins were dialyzed against 0.03 M Tris/azide buffer (0.03 M Tris, 0.05% 
sodium azide, pH 7.8), unless othen/vise noted. Quantities of immunoglobulins recovered were 
estimated by using A20O values and an extinction coefficient of 1.4 (6, 19). As necessary, the 
immunoglobulins were concentrated by using either a 15- or 2-ml capacity Centraprep 30 unit 
(Amicon Division, W.R. Grace and Co., Beverly, MA, product numbers 4306 and 4208, 
respectively). Working stocks of immunoglobulins were stored at 4°C until used. Immunoglobulins 
more than the immediate need were stored at -30 to -95°C. 
Characterization of Antibodies 
Polyacrylamide gel electrophoresis 
A nondenatured polyacrylamide gel electrophoresis (PAGE) and a denatured PAGE was 
prepared for each of four types of immunoglobulin preparations. PAGE procedures were 
conducted according to the instruction Manual (89-0451 789 dated 1989) for the Blo-Rad Protean 
llxi Slab Cell electrophoresis unit (Blo-Rad Laboratories, Richmond, CA). The gels were 
discontinuous gels on the basis of the method of l_aemmli (2,19). Briefly, two 16-cm glass plates 
were spaced 1 mm apart in sandwich clamps, aligned and placed in the casting stand. Activated, 
degassed 12% acrylamide/bis monomer solution was allowed to fill the space in the glass 
sandwich to a point 1.5 cm below the bottom of the comb assembly wells. The gel was overlaid 
with dHgO and allowed to polymerize for 45 to 60 min or overnight. After polymerization, the top 
of the gel was rinsed and dried before casting the stacking gel. An activated, degassed 4% 
stacking gel was poured to the top of the glass sandwich with the comb assembly in place and 
allowed to polymerize for 30 to 40 min. The comb assembly was removed, and the wells were 
rinsed free of unpolymerized reagents and dried. The glass sandwich with gel and a buffer dam 
was mounted in the cooling core and the unit was placed in the tank assembly with buffers. 
Approximately 10 jul of sample in sample buffer (6 ml of 20% aqueous sodium dodecyl sulfate, 3 ml 
of glycerol, 2.4 ml of 1 M Tris-HCI (pH 6.8), 15.6 mis of dHgO, and a few grains of bromophenol 
blue) were underlayed in each well. The lid was put in place and the unit connected to an Isco 
electrophoresis power supply (Isco, Lincoln, NB, model 494). A constant 16 mA was applied to 
the gel until samples entered the separating gel; Then the current was increased to 24 mA and 
held constant. The samples were allowed to migrate through the gel until the leading edge was 
within 1 to 2 cm of the bottom edge of the gel. On completion of electrophoresis, the gel was 
removed from the unit and fixed in an aqueous solution of 40% methanol and 10% acetic acid until 
further use. 
Ouchteriony immunodiffusion analysis 
Ouchterlony immunodiffusion (8, 9, 23, 29) slides were prepared on 7 mil 10 x 3.75 mm 
electrophoresis film (Sigma product number E 1380) with a 0.5" header on one end. Six ml of 
immunodiffusion agar (Bio-Rad Laboratories, product number 170-3002) were added to each slide 
with a pipette. After hardening, 4-mm diameter wells were cut by using a Grafar Auto-Gel punch 
assembly (Grafar Corp., Detroit, Ml). The wells were spaced 6 mm, edge to edge, from the center 
well. Either antibody or antigen (20 /il) was added to each well. The slides were incubated in 
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humidified pétri dishes for 24 to 48 h. After incubation, the slides were soaked in 0.3 M NaCI 
overnight and then were stained with Coomasie blue stain (Bio-Rad Laboratories, product number 
500-0001) for 20 min. The slides were destained with two changes of dH20 until the bacl<ground 
was clear. Precipitant bands stained as blue bands between wells. 
West^  blot analysis 
Reactivity of each of the antigen affinity purified antibody preparations (anti-tryptophanase, 
anti-glutamate decarboxylase, and anti-glucuronidase) toward the electrophoretically separated 
commercial enzymes was determined by Western blot analysis. A nondenatured PAGE was made 
essentially as previously described. The three commercial enzymes and suitable controls 
(B-galactosidase, Sigma product number G5635, L-glutamate decarboxylase from Clostridium 
perfringens, sigma product number G2376, and 6-glucuronidase from Helix pomatia [snail], Sigma 
product number G1512) were used as samples. The first seven and second seven wells of the gel 
were loaded in such a manner as to provide a duplicate pattern for each gel run. After completion 
of electrophoretic separation of the enzymes and controls, the gel was cut in half; one-half was 
used for general protein staining and the other half for Western blotting. 
Western blotting was performed essentially as described by Gershoni and Pelade (15) and 
instructions supplied with an Immun-blot kit (Bio-Rad Laboratories, product number 170-6450). 
Briefly, the gel was sandwiched between an approximately 6x13 cm sheet of nitrocellulose and 
filter paper (2) and placed in the electroblotting unit (Transphor Power-Lid, model TE50, Hoefer 
Scientific Instruments, San Francisco, CA). Ten amps at a constant 14 volts were applied. After 
approximately 18 h, the nitrocellulose sheet was transferred to a heat-sealable bag for the 
remaining procedures. The nitrocellulose sheet was blocked for one hour with 3% gelatin in Tris 
buffer. The nitrocellulose sheet was then washed and incubated for 18 h with a 1:1000 dilution of 
primary antibody (approximately 2.8 ng for anti-glutamate decarboxylase, 1 ng for 
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anti-tryptophanase, and 1 lig for anti-glucuronidase). After incubation, the primary antibody was 
removed, the membrane washed, and the secondary antibody (goat anti-rabbit with conjugated 
aikaiine phosphatase) added. The secondary antibody was incubated with the nitrocellulose sheet 
for approximately 2 to 3 h before being removed. The substrates 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP) and nitroblue tetrazolium (NBT) were added and allowed to react until band 
development appeared to be complete (15 to 30 min). The reaction was stopped by removing the 
nitrocellulose sheet from the bag and washing the membrane in dH^O. 
Besides the four Western blots of the commercial enzymes, a gel was run by using all 
three enzymes separated by a sample containing bovine serum albumin (BSA; Sigma product 
number A-7030). After PAGE and electroblotting, the blot was cut vertically so that each blot strip 
contained two of the blotted gel lanes; one lane contained an enzyme and a second lane 
contained a BSA sample. Each blot section was incubated with primary antibody against the 
enzyme and processed as described previously. 
EIA analysis 
Preparation of conjugated enzymes 
Alkaline phosphatase-antibody conjugates were prepared essentially as described by 
Voeller et al. (50). Approximately 1.4 mg of antibody in 1 ml of PBS (0.05 M, pH 7.4) was added 
to 5 mg of alkaline phosphatase (type Vll-T, Sigma product number P6774). Two microliters of 
25% glutaraldehyde (Sigma, product number G-5882) were added and the preparation was 
incubated at room temperature for 2 h. The preparation was dialyzed overnight at 4°C against 
PBS (0.05 M, pH 7.4). The buffer was changed to 0.05 M Tris buffer (pH 8.0, containing 1 mM of 
MgCl) and the conjugated antibodies were again dialyzed overnight at 4°C. After dialysis, BSA and 
sodium azide, enough to yield 1.0 and 0.2% solutions respectively, were added to the conjugated 
antibodies. The preparations were stored at 4°C. 
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Preparation of dot enzyme-linked immunosorbent assays 
An 8 X 12 cm membrane sheet (UltraBind™ US-450, Gelman Sciences, Ann Arbor, Ml, 
product number S80245) was prewet with PBS (0.05 M, pH 7.2) and placed in a vacuum dot-blot 
apparatus (Bio-Dot™, Bio-Rad Laboratories, product number 170-6545). Commercial enzymes 
(2 mg/ml glutamate decarboxylase, Sigma, product number G3757 and 0.1 mg/ml 
B-glucuronidase, Sigma, product number G7896), were reconstituted with 0.05 M PBS. To each 
well In columns two through twelve, 50 fû of 0.05 M PBS was added. To each well in column one, 
100 /il of an enzyme was added. Serial dilutions of enzymes were completed for columns two 
through twelve (except column three was skipped to serve as a control) by taking 50 (J\ from one 
column and mixing it with the buffer in the next column. To column three, 50 /J of 1% BSA (in 
0.05 M PBS) was added. The solutions were allowed to react with the membrane for 2 min before 
a gentle vacuum was applied to the membrane through the apparatus. Approximately 0.05 ml of 
1% nonfat dried milk (Sigma, product number M-7409) was added to each well and the vacuum 
was reapplied. The membrane was washed three times with 0.05 ml of PBS containing 0.01% 
Tween 20. Alkaline phosphatase conjugated antibodies were diluted and added to the wells 
according to the schemes shown in Figures 1 and 2. The conjugated antibodies were allowed to 
react for approximately 5 min before being gently removed by vacuum. Unreacted antibodies 
were removed with three 0.1-ml applications of wash solution (0.05 M PBS, 0.01% Tween 20). The 
membrane was removed from the apparatus, placed in a pouch that was sealed by heat for each 
of the following steps. The membrane was washed for 15 min in TTBS (20 mM Tris, 500 mM NaCI, 
0.05% Tween 20, pH 7.5) with 0.12% nonfat dried milk added. The first wash solution was 
removed and the membrane was washed three times with 15 ml of TTBS. After the final TTBS 
wash, the membrane was washed in TBS (20 mM Tris, 500 mM NaCI, pH 7.5). The TBS solution 
was removed and 15 ml of substrate (BCIP/NBT, Bio-Rad laboratories, component of product 
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number 170-6450) were added. After approximately 5 min, the membrane was removed and 
washed in dHjO. 
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RESULTS AND DISCUSSION 
Antibody Production and Purification 
Kaspar (31) developed enzyme capture and coaggiutination methods to test cell lysates for 
the presence of specific enzymes. Although the methods were described as sensitive and specific, 
they have not been adopted for routine use, most lil<ely because they are inconvenient to carry 
out. in the original work, Kaspar (31) produced antibodies to four £ coli enzymes: 
B-glucuronidase, G-galactosidase, glutamate decarboxylase, and tryptophanase. The antibodies 
were produced in rabbits using commercial enzyme preparations in Freund's adjuvants. Anti-
enzyme serum titers were not determined. All the antibody preparations, except 
anti-tryptophanase, performed satisfactorily in Kaspar's assays (31). The anti-tryptophanase 
assays were unable to detect tryptophanase in E. coli cell lysates. Kaspar concluded that this 
could be the result of either of two possibilities. The first was that the anti-tryptophanase titers 
were to small because the tryptophanase used for antibody production was not as pure as the 
other enzyme preparations. The second possibility was that tryptophanase production was 
repressed in the enzyme induction broth being used for growing the cell lysates. 
To avoid problems that Kaspar encountered In his worl<, some minor changes were made 
in the production of the antibodies. Rabbits were immunized using a different protocol that should 
have produced better antibody preparations. The change to several smaller intradermal injections 
has been described as making higher affinity antibodies (10, 49). To improve on the 
antl-tryptophanase production, a tryptophanase was selected as the Immunogen that was thought 
purer than the enzyme preparation Kaspar had used. 
Initial efforts to develop latex agglutination tests resulted in extensive false-positive 
reactions, with both cell iysates and commercial enzyme preparations, including negative controls. 
Because antibody preparations functioned well in Kaspar's systems (31), similar preparations 
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should function satisfactorily in latex agglutination tests. Because one major difference between 
latex agglutination and coagglutination of enzyme capture methods is adsorption of antibodies on 
the latex, initial studies were performed on adsorption of antibodies to latex particles (described In 
part 2 of the dissertation) and the effects of blocldng agents on assay sensitivity and specificity 
(described In part 3). Another likely cause of the false-positive reactions (which we now believe 
was the major problem, so it is reported first) is the antibody preparations themselves. Enzyme 
induction, cell lysis, and Interpretation of the results were not considered problem areas. 
Electrophoretic analysis of antibody proteins 
One major variable was the method of antibody preparation; antigen-specific affinity 
chromatography purified antibody preparations were used in this project whereas Kaspar had used 
protein A purified antibody preparations (31). Antigen-specific affinity chromatography purified 
antibodies were used because they should contain a greater fraction of specific antibodies than 
protein A purified antibodies. It is known, however, that isolation methods induce changes in 
antibodies (34) and by changing the isolation method, a change in assay results could occur. 
Furthermore, Limet et al. (33) theorized that rabbit rheumatoid factors present in IgG preparations 
caused spontaneous agglutination. Antibodies purified by antigen affinity chromatography, as 
used In this study, should have been free of contaminating rheumatoid antibodies, and were not 
considered part of the problem. When there were no changes in efficacy of the latex agglutination 
assays when antigen-specific affinity purified antibody preparations were replaced with protein A 
purified antibodies, other methods of isolation were tried. Even with the other purification 
methods, there was no difference in false-positive reactions, now being called nonspecific 
agglutination, because of different antibody purification methods (data presented in part 2). 
The different immunoglobulin preparations were evaluated by polyacrylamide gel 
electrophoresis (PAGE) to determine the presence of extraneous nonimmunoglobulin proteins. 
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(Not all bands discussed in the following sections can be observed on the prints made of the 
photographs of the gels.) 
Nondenaturing conditions 
Antibodies to tryptophanase purified by all methods exhibited a major band at 
approximately 147 kDa and a minor band at approximately 54-kDa (Figure 3). The 54-kDa bands 
were more discernible by observing the gel then they are on the photographic prints of the gels. 
All except the gentle method had an additional band at approximately 67 kDa. The DEAE purified 
antibodies he;d three additional bands corresponding to 75, 66 and 52 kDa. 
Antibodies to glucuronidase purified by all methods exhibited a major band at 
approximately 147 kDa and a minor band (is very faint on the photographic print) at approximately 
54 kDa (Figure 3). DEAE and antigen-specific affinity chromatography purified antibodies had four 
additional bands corresponding to 75, 67, 66 and 52 kDa, similar to anti-tryptophanase. 
The major band in gels of anti-giutamate decarboxylase was calculated to have a 
molecular mass of 143 kDa, slightly less than anti-tryptophanase and anti-glucuronidase, but within 
experimental error (Figure 4). Similar to anti-tryptophanase and anti-glucuronidase, a minor band 
at approximately 68-kDa was detected in all antibody preparations. Other bands observed 
included a 54-kDa band in protein A (lane B), the gentle method (lane D), and Kaspar's protein A 
preparations (lane F), 82- and 44-kDa bands in antigen-specific affinity chromatography purified 
preparations. Two additional bands appeared at 75, and 67 kDa in the DEAE-purified preparations. 
In general, all PAGE preparations revealed a significant band at approximately 146 kDa 
that probably represents the intact rabbit IgG molecule. The minor band at approximately 54 kDa 
is most likely the result of some denaturation of the IgG molecule into fragments; the heavy chain 
would be at 54 kDa. Light chain fragments most likely failed to be separated at the low molecular 
weight front. Other bands represent either contaminating proteins not removed by the antibody 
purification processes or otiier Isotypes of immunoglobulins Including fragments of IgM. This Is 
possible especially for antigen-specific affinity chromatography purification because it Is not 
specific for IgG but rather for any immunoglobulin class present that will bind antigen. Except in 
the DEAE-purified antibodies, the concentrations of non-IgG proteins were considerably less than 
those of IgG and were not considered significant. Gels of DEAE-purified antibodies revealed as 
many as four additional bands, some of which contained substantial quantities of protein and 
might be considered significant contamination. 
Denaturing conditions 
Because the nondenatured PAGE assays revealed the presence of more protein bands 
than should be present in homogeneous antibody preparations, fully denatured antibody 
preparations were subjected to PAGE. As expected, no major bands were observed at 
approximately 147 i<Da and the major band, for all preparations, was at approximately 59 to 
61 kDa (Figures 5, 6, and 7). 
Protein A preferentially binds immunoglobulins, especially those of class IgG (17, 40). 
Antibodies purified with protein A and the gentle method displayed a homogeneity consistent with 
a single subclass of immunoglobulin (Figures 5, 6, and 7). 
Antigen-specific affinity chromatography purification Is not as specific toward a single class 
of Immunoglobulin as is the protein A method. Any class of Immunoglobulin that will bind to the 
antigen will later be eluted off the solid support. This is demonstrated in the denatured PAGE of 
anti-glucuronidase (Figures 5, 6, and 7). Antigen-specific affinity chromatography purification of 
anti-glucuronidase revealed three additional bands that probably correspond to denatured chains 
of other immunoglobulin classes, such as lgl\1 or IgD. 
Denatured PAGE gels of DEAE-purified antibodies (Figures 5, 6, and 7) revealed five to 
eight distinct bands. The bands obtained did not correspond with albumin, the major serum 
85 
protein. DEAE purification is intended to bind the aibumin fraction and other negatively charged 
proteins, aiiowing the neutral or positively charged immunoglobulin fraction to pass through (24). 
Other serum proteins also pass through DEAE columns. The manufacturer of the columns stated 
that residual contamination of IgG with transferrin is normal (5). Transferrin, an iron transporting 
protein, has a molecular mass of 76.5 kDa (43) that is consistent with a band obtained on the 
PAGE of the DEAE-purified antibodies examined here. In addition to transferrin, other proteins 
such as complement proteins (CI, molecular mass of 86 kDa; 43), plasminogen (molecular mass 
87 kDa; 43), or hexokinase (molecular mass 97 kDa; 47) might account for other protein bands 
that appeared in the PAGE gels. 
The major bands at 59 to 61 kDa are consistent with the molecular mass attributed to IgG 
heavy chain fragments (11, 18). IgG light chain fragments were not resolved from the protein front 
in these gels. Antibodies purified by the DEAE method had at least four bands; besides the heavy 
chain fragments, bands appeared at approximately 93, 82, and 76 kDa. These fragments, although 
the calculated molecular masses differed slightly, are probably the same proteins present in the 
nondenatured PAGE, suggesting that the proteins are not immunoglobulin fragments. 
This paragraph is presented to describe important bands that would be observed on the 
denatured PAGE. Some analogies with the human immunoglobulins are included because rabbit 
immunoglobulin primary structures bear many similarities. Normal human immunoglobulin is 
composed of nine known different types or subclasses of immunoglobulins; IgG^, IgGj, IgG^, IgG^, 
IgM, IgAi, IgAg, IgD, and IgE (18, 19). Molecular masses of whole molecule immunoglobulins 
range from 970 kDa for IgM to 146 kDa for IgG^ 2,4- The immunoglobulins are composed of four 
subunits that can be denatured into components with molecular masses ranging from 72 to 51 kDa 
for IgE and IgGi 2,4 heavy chains, respectively, and from 32 to 21.5 kDa for IgM and IgE light 
chains, respectively (18, 19). Rabbit immunoglobulins, however, are made up of only four 
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subclasses; IgG, IgM, IgA, and IgE (38). Unlike human immunoglobulins, rabbit IgG exists as a 
single subclass, however, considerable heterogeneity, with respect to overall charge, exists (16, 
38). Although IgG composes over 90% of the total Immunoglobulin in rabbit serum (38), the 
immunoglobulin fraction constitute only 4.3 to 11.8% of the total serum proteins (20, 35, 47). In 
other animals, such as sheep or goats, a much greater percentage (15 to 26% and 13 to 31%, 
respectively) of their serum proteins consists of Immunoglobulins (20, 35, 47). Unlike human IgG, 
the two chains of rabbit IgG are held together by only a single disulfide bond (38). The molecular 
mass of rabbit IgG has been reported to range from 145 to 188 kDa (42, 44). Results of this study 
are more consistent with the smaller molecular mass of 145 kDa. Overall, rabbit immunoglobulin 
molecular masses are considered similar to human immunoglobulin. 
In summary, the results of denaturing PAGE assays indicated that all four antibody 
purification methods should result in the preparation of suitable antibody preparations for use in 
latex agglutination tests. 
Ouchterlony 
The initial development of the latex agglutination assay included false-positive reactions 
when commercial enzymes, other than those used to elicit antibody production, were used as 
negative controls. To evaluate if the immunoglobulin preparations contained antibodies cross-
reacting with the enzymes used as negative controls, sixty Ouchterlony immunodiffusion tests were 
run with combinations of antibodies and antigens (Table 1). The antibodies were purified by using 
the four different methods described in Materials and Methods, and the antigens were commercial 
enzyme preparations. Reactions and cross-reactions of antibodies and antigens were seen as one 
or more visible bands or lines between the two reactants. 
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Tryptophanase 
Using commercial tryptophanase preparations at an estimated concentration of 1 mg/mi, 
levels of endpoint titration to antibody concentrations were higher than those obtained with anti-
glucuronidase. Protein A-purified antibodies again had a range of end points, from 1 to 0.5 mg/mi 
in repeatable tests (Table 1 and Figure 8). Antibodies from the gentle method had an endpoint of 
0.5 mg/ml (Table 1). With antigen-specific affinity chromatography anti-tryptophanase, an 
endpoint of 0.25 mg/ml was obsen/ed. DEAE-purified antibodies did not form a precipitate with 
any concentration of antibody or antigen tested. When the antibody level was held constant at 
1 mg/ml and the concentration of commercial enzyme was varied, protein A and antigen-specific 
affinity chromatography purified antibody both had endpoints of 0.125 mg/ml. Antibodies gently 
eluted had an endpoint titration of 0.0625 mg/ml. When testing anti-tryptophanase against the 
other commercial enzymes, antibodies purified by protein A had precipitation reactions against 
both glucuronidase and glutamate decarboxylase. 
Glucuronidase 
Using commercial glucuronidase enzyme at an estimated concentration of 1 mg/ml, 
protein A-purified antibodies developed a precipitation band when endpoint concentrations of 0.5 
to 0.0625 mg/mi of antibody were used (Table 1 and Figure 9). When gentle methods and DEAE 
purification were used, an endpoint titration of 0.5 mg/ml of antibody was observed. If antigen-
specific affinity chromatography purified antibodies were used, an endpoint titration of 
0.0625 mg/ml was observed. Holding the antibody constant at 1 mg/ml and varying the 
concentration of commercial enzymes, protein A-purified antibody had endpoint titrations of 0.0625 
to 0.03125 mg/mi. DEAE and antigen-specific affinity chromatography purified antibodies had 
endpoint titrations of less than 0.03125 mg/mi. The gentle method of antibody eiution resulted in 
an endpoint titration of 0.0625 mg/ml. In no tests of anti-glucuronidase antibodies against either 
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commercial tryptophanase or glutamate decarboxylase at any concentration tested, did a visible 
precipitin band form. 
Glutamate decartxx^ ase 
Antibodies to glutamate decarboxylase from tlie four different purification methods as well 
as a previously purified antibody by another investigator (32) were also tested. When a 
commercial glutamic acid decarboxylase at an estimated concentration of 1 mg/ml was used, the 
levels of endpoint titration for protein A purified and gently eluted antibodies were 0.25 mg/ml 
(Table 1 and Figure 10). Both antigen-specific affinity chromatography and previously purified 
antibodies had endpoint titrations of 0.5 mg/ml. Antibodies isolated with the DEAE method 
resulted in an endpoint of only 1 mg/ml. Holding the antibody constant at 1 mg/ml and varying 
the concentration of commercial enzyme preparation resulted in a titration endpoint for all the 
antibodies of less than 0.0625 mg/ml. When testing antibodies to glutamate decarboxylase for 
reactions to other commercial enzymes, all the antibodies except those gently eluted, reacted with 
tryptophanase but not glucuronidase. 
Ouchterlony immunodiffusion has been used for many years to detect Immunological 
reactions. Although it is not highly sensitive, it is relatively simple to do and could provide the 
types of information necessary to evaluate the antibody preparations used in this project. 
Although the tests did prove that the antibody preparations were functional at relatively low titers, 
the Ouchterlony method was neither as precise as needed nor readily reproducible. When using 
protein A-purifled antibodies and their respective enzymes, results of titration end points often 
varied up to five two-fold dilutions. Furthermore, in reactions designed to indicate cross-reactions 
with the nontarget enzymes, the results often were contradictory. Also, there should have been no 
significant differences in the cross-reactivities of antibodies purified with protein A and those from 
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the gentle method. This was not so, however, and another approach to detecting cross-reactivity 
was determined necessary. 
Western Blotting 
Because of the difficulty in interpreting and drawing conclusions from the Ouchterlony 
immunodiffusion work, another method of detecting cross-reactivities was needed. Western 
blotting, normally a technique using antibodies for the analysis of other proteins, was performed in 
a reversed format to evaluate antibodies and not other types of proteins. The Western blot 
analyses revealed that the enzyme preparations were not as homogeneous as previously thought. 
A denatured PAGE of the commercial enzymes is shown in Figure 11 to serve as a basis for 
comparisons to the Western blots. 
Anîi-tryj}tophanase primary antibody 
When anti-tryptophanase antibody was used as the primary antibody, a blot was obtained 
that had over 40 distinguishable bands in the lane containing commercial tryptophanase (Figure 
12, lane C). The most intense bands were at approximately 55 kOa. This would closely 
approximate the monomeric size of tryptophanase (46 to 55 kDa; 36). Other bands within the 
tryptophanase lane probably represent contaminating proteins and possibly enzyme fragments. 
Since the commercial enzyme preparation used for the Western blot also was used to produce 
antibodies, detection of these proteins is expected. 
Reactivity with proteins In the commercial preparation of E coli glutamate decarboxylase 
resulted in fifteen distinguishable bands (Figure 12, lane A). The most intensely reactive of these 
bands were at molecular masses of approximately 54 and 26 kDa. The former band likely 
represents contaminating tryptophanase in the glutamate decarboxylase preparation whereas the 
latter probably represent protein fragments and other small molecular mass proteins not removed 
from the commercial preparation during purification. In the molecular mass range of monomeric 
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glutamate decarboxylase (46.5 to 50 kDa; 46, 48), two bands were present that could represent 
cross-reactivity of the anti-tryptophanase with glutamate decarboxylase enzyme. Remaining 
reactive bands most likely represents other cross-reactive impurities in the glutamate 
decarboxylase enzyme preparation. 
Reactivity with the proteins in the commercial preparation of glucuronidase (Figure 12, lane 
B) resulted in eight distinguishable bands. Of these, three were very strongly reactive and one was 
broad and diffuse. Both the diffuse band and one of the strongly reactive bands were between 75 
and 84 kDa. The other strongly reactive band within the glucuronidase lane was at a molecular 
mass of approximately 36.6 kDa. E. coli has well over 100 different proteins, ranging from 30 to 
80 kDa (41). Differentiation of the reactive protein bands was beyond the scope of this study. 
Reactivity with the control proteins resulted in ten slightly reactive bands with the 
galactosidase (Figure 12, lane D) and nine slightly reactive and two very reactive bands in the 
C. perfringens glutamate decarboxylase lane (Figure 12, lane E). The broad and diffusely reactive 
band at 116 kDa with galactosidase corresponds to the molecular mass of monomeric 
galactosidase (19). The identities of the other reactive bands are not known nor could they be 
readily determined. 
For the most part, the cross-reactions of anti-tryptophanase were mainly within the enzyme 
preparations used for immunizations and did not extend as strongly to other enzyme preparations 
used as controls. The reactions revealed very little reactivity with the E. coli B-gaiactosidase 
preparation used as a control. Considering the extensive heterologous nature of the 
B-galactosidase preparation from the commercial source (Figure 11), equivalent cross-reactions 
from the anti-tryptophanase should be more evident. If the fi-gaiactosidase control had shown 
more reactivity with the antibody preparations, the antibody preparations would have probably 
been considered more seriously impaired and probably would have been redone. Consequently, 
the cross-reactivity of the antibody preparations was viewed as not as significant as it probably 
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was. In retrospect, the results of the Western blotting should have suggested that better enzyme 
preparations were required and new antibody preparations, using more specific antigens, should 
have been made. 
Anti-glutamatB decartxxc^ ase primary antibocty 
When anti-glutamate decarboxylase antibody was used as the primary antibody, a blot was 
obtained that had over 23 distinguishable bands reactive with glutamate decarboxylase (Figure 13, 
lane A). The most intense bands were at approximately 78, 55, 35, 27, and 26 kDa. The 
monomeric mass of E. coll glutamate decarboxylase is approximately 52 kDa (46, 48). Bands, 
other than the 55-kOa band, within the glutamate decarboxylase lane probably represent 
contaminating proteins. Because the commercial enzyme preparation was used to produce 
antibodies, reactivity with these proteins would be expected. 
Reactivity with proteins in the commercial preparation of glucuronidase (Figure 13, lane B) 
resulted in eleven distinguishable bands. Two of the most reactive bands were at approximately 
81 and 72 kDa, the molecular mass of glucuronidase. Reactivity with proteins in the commercial 
preparation of tryptophanase (Figure 13, lane C) resulted in four distinguishable bands. The most 
reactive band was at approximately 36.8 kDa and could be one of several E coli proteins. There 
was no significant cross-reactivity with the galactosidase (Figure 13, lane D) control but the 
C. perfringens glutamate decarboxylase control (Figure 13, lane E) did have a reactive band at 
approximately 76 kDa. Although the reactive band within the C. perfringens glutamate 
decarboxylase lane was at the same approximate molecular mass as similar reactive bands in all 
three commercial enzyme preparations, it was significantly heavier than the molecular masses of 
E. coli or C. perfringens glutamate decarboxylase (13). 
Similar to the Interpretation of the anti-tryptophanase Western blot results, the anti-
glutamate decarboxylase preparation was more strongly cross-reactive with the enzymes used for 
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immunizations than with the control enzyme preparations. The lack of significant reactivity with the 
control enzyme preparations lead to the belief that the cross reactivities of the antibody 
preparation was not as consequential as it was later discovered. 
And-glucumnk/ase fm'maiy antibody 
Use of anti-glucuronidase antibody as the primary antibody yielded a blot that had over 29 
separately distinguishable bands In the lane containing commercial E. coli glucuronidase (Figure 
14, lane B). The most intense band was at approximately 76 kDa. This would closely approximate 
the monomeric size of 68 to 82 kDa of glucuronidase reported by others (12,14, 22, 39). Other 
bands within the glucuronidase lane most likely represent contaminating proteins. Because the 
commercial enzyme preparation was also used to produce antibodies, reactivity of these proteins 
Is expected on a Western blot. 
Reactivity with proteins in the commercial preparation of glutamate decarboxylase (Figure 
14, lane A) resulted in sixteen distinguishable bands. The three most intensely reactive bands were 
at a molecular mass of approximately 76, 52, and 26 kDa. The 76-kDa band likely represents 
contaminating glucuronidase in the glutamate decarboxylase preparation. The 52-kDa isand could 
be cross-reactivity with either tryptophanase, glutamate decarboxylase, or another £. coli protein of 
that molecular mass. The 26-kDa band probably represents protein fragments and other small 
molecular mass proteins not removed from the commercial preparation during purification. 
Reactivity with the proteins in the commercial preparation of tryptophanase (Figure 14, 
lane C) resulted in four distinguishable bands. The first band was at approximately 91 kDa. This 
could represent a cross-reactive dimeric form of tryptophanase that was not fully denatured or it 
could be a contaminating protein that was present in both the glucuronidase preparation used for 
the immunizations and the tryptophanase enzyme preparation. Bands at 52 and 26 kDa are similar 
to those obtained in the reaction with glutamate decarboxylase and probably represent similar 
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contaminating proteins. 
Reactivity with the control proteins (Figure 14, lanes D and E) resulted in two very slightly 
reactive bands with galactosidase and no detectably reactive bands with Helix pomatia (snail) 
glucuronidase (bands may not be visible on the photograph). The broad and diffusely reactive 
band at 116 kDa with galactosidase corresponds to the molecular mass of monomeric 
galactosidase (19); thus it is likely that the glucuronidase preparation used for immunization 
contained a trace of B-galactosidase. Lack of reactions with H. pomatia glucuronidase revealed 
that E. coli and H. pomatia glucuronidase did not share common immunologic epitopes. 
Again, like the results from the anti-tryptophanase and anti-glutamate decarboxylase 
Western blot results, the cross-reactions with the anti-glucuronidase were confined predominately 
to the enzymes used for immunizations and they did not significantly extend to the control enzyme 
preparations. These results are consistent with, and support the supposition available at this time, 
that the cross-reactions were not seriously compromising the character of the antibody 
preparations. The antibody preparation's cross-reactivity within the enzymes used for 
immunizations, however, was significant and ideas on how to best deal with them were 
considered. 
Absorbed anti-glutamate decartxxcylase primaiy antitxxfy 
After observing the results of the first three Western blots, this Western blot was done to 
determine if cross-absorption of an antibody preparation with the other enzyme preparations could 
significantly reduce the cross-reactivity of the antibody preparation. When absorbed anti-glutamate 
decarboxylase antibody was used as the primary antibody, a blot that had over 19 separately 
distinguishable bands with commercial glutamate decarboxylase was obtained (Figure 15, lane A). 
This was a reduction of only four bands from the nonabsorbed anti-glutamate decarboxylase 
(Figure 15, lane A). The most intense bands (Figure 15, lane A) were at approximately 79, 58, 44, 
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and 22 kDa; this was similar to the results of the reactions with nonabsorbed anti-glutamate 
decarboxylase, indicating that adsorption did not result in significant loss of anti-glutamate 
decarboxylase activity. 
Reactivity with proteins in the commercial preparation of glucuronidase (Figure 15, lane B) 
resulted in two distinguishable bands. In comparing this blot to the blot with the nonabsorbed 
antibody (Figure 13, lane B), this blot revealed a loss of several bands and significant loss of 
intensity in the band at 95.6 kDa. Reaction with the proteins in the commercial preparation of 
tryptophanase (Figure 15, lane C) resulted in eleven distinguishable bands. In comparing this blot 
to the blot with the nonabsorbed antibody (Figure 13, lane C), this blot revealed a significant gain 
of a band at approximately 28 kDa. Although absorbed anti-glutamate decarboxylase contained 
fewer cross-reacting antibodies than the unabsorbed antiserum, the absorbed preparation retained 
so many cross-reactivities that there was no difference of practical significance between the 
absorbed and nonabsorbed preparations. 
Anti-BSA cross-reactMty 
Because of the heterogenous mixture of proteins contained in the commercial enzyme 
preparations and the extent of the false-positive reactions, detection of any anti-BSA contamination 
in the antibody preparations was evaluated. BSA was being used to block any unreacted sites on 
the latex after immunoglobulin adsorption. Any anti-BSA in the antibody preparations would 
seriously compromise the antibody preparations when BSA was being used to block the latex. 
A PAGE was run with ail three enzymes separated by a sample containing 1 mg/ml BSA. 
BSA was used to block any unsaturated spots on the latex during sensitization of the latex with 
antibodies. This Western blot determination was made to insure that no anti-BSA cross-reactivity 
existed in the antibody preparations. 
Each lane containing the commercial enzyme preparations had reactions consistent with 
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the Western blot results discussed previously (Figure 16). No lane containing BSA had any 
significant reaction with the primary antibodies. Therefore, cross-reactions within the latex system 
were not caused by a reaction of the antibodies with the BSA that was used in blocking the latex. 
In general summary, the Western blots showed that besides extensive cross-reactions with 
the commercial enzyme preparations, the reactions within the immunizing enzyme preparation 
were often considerable, consisting of up to forty different antigenic proteins. Feng and Lampel 
(12), however, used both protein A and antigen-specific affinity chromatography purified anti-
alucuronidase from this project in Western blots to probe for uidA (glucuronidase) gene 
expression. Although the protein A purified antibody that was supplied did not work, the antigen-
specific affinity chromatography purified antibody worked well (personal communication) and gave 
clean blots without background cross-reactions with other E. coll proteins. Their success, 
combined with the results of the Western blot analyses, led to the belief that, although the antibody 
preparations seemed heterogeneous (were cross-reactive) in this project, antibody specificity was 
not a major problem. The reason(s) for these discrepancies between data obtained by using 
similar methodologies in two different laboratories cannot be explained. In retrospect, more weight 
on the cross-reaction data should have caused realization that the antibody preparations were not 
sufficient and should have been redone. 
EIA analysis 
Although the Western blot analyses proved that the antibody preparations were functional, 
a more substantial examination was performed. The intent of the EIA analyses was to determine if 
the antibody preparations were functional after solid-phase adsorption. If the antibody 
preparations could withstand conjugation conditions, the antibody preparations should be robust 
enough to be adsorbed to the latex and retain immunological activity. 
The conjugated antibodies functioned well in the EIA tests (Figures 17 and 18). The 
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conjugated anti-glutamate decarboxylase antibodies exhibited reactivity at a 1:10,000 dilution with 
approximately 0.4 /xg glutamate decarboxylase (Figure 17). The conjugated anti glucuronidase 
antibody, however, exhibited reactivity only at a dilution of 1:100 or less with approximately 6.25 fig 
of glucuronidase (Figure 18). In this EIA, a 1:1000 dilution of conjugated anti-glutamate 
decarboxylase antibody cross-reacted with approximately 50 jug of glucuronidase enzyme. A 
sandwich EIA also was made with anti-glutamate decarboxylase antibody to capture glutamate 
decarboxylase that was subsequently detected by conjugated anti-glutamate decarboxylase 
antibody (data not shown). Results of the EIA analysis implied that the antibodies were functional 
after purification and conjugation, and should be functional after solid-phase adsorption. 
EIA results reinforced the perception that the antibody preparations were active and 
suitable for solid-phase adsorption. Although the use of antigen-specific affinity chromatography 
should have eliminated the need for the establishment of antibody titers as a standardization 
method, further EIA work on the antibody preparations could also have been used to titer the 
antibody preparations and insure that they were equally reactive. This would have eliminated any 
antibody preparation bias that might be caused by using separate serum samples. 
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SUMMARY AND CONCLUSIONS 
The antibody preparations used in this study were on the basis of the methods of Kaspar 
(31) and Holt (21). Because their work had yielded antibody preparations that seemed to have 
adequate sensitivities and specificities, only minor modifications to their protocols were made. In 
retrospect, preparation of the antibodies should have included several more changes from the 
methods used by Kaspar. Foremost among the changes is the need for higher purity antigens, 
although this might not solve the problems encountered. The commercial enzymes, used for 
antibody production, probably were not as homogeneous as is needed for the production of 
antibodies suitable for latex agglutination tests. It is possible that antibody preparations used to 
sensitize latex for latex agglutination tests must be more specific than those used for other 
immunological tests, such as coagglutination and EIA. Whether this is true or not was not 
resolved in the present studies, although the results suggest the need for more specific antibody 
preparations for latex sensitization. 
A potentially significant source of error in the preparation of the antibodies was the lack of 
pooling of the various antisera. Each rabbit bleed was, for the most part, stored and purified 
separately during the course of this project. It was believed that the use of antigen-specific affinity 
chromatography would compensate for differences in the purified antibodies. Pooling of each 
antisera, however, would have eliminated differences in antibody performance that could be 
attributed to variations in antibody titers that arose during the antibody production phase. 
Methods, such as bulk gel electrophoresis, could be used to obtain better antigens. 
Although proteins are denatured during gel electrophoresis, antibody responses are not usually 
reduced and adequate antibody preparations are normally obtainable (19). In addition, an 
immunization protocol using either selective in vitro or in vivo depletion (1) could be used to 
produce a more specific antibody preparation. A more consistent source of good quality 
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antibodies mighit have made a significant difference in this project. 
Antigen-specific affinity chromatography purification also could be used to refine antibody 
preparations if a relatively pure antigen composed the affinity ligand. Commercial enzyme 
sources, other than Sigma, were sought for their use In antigen-specific affinity chromatography 
purification, but none were found. Near the end of the project it was discovered that Or. David 
Metzler (Department of Biochemistry and Biophysics, Iowa State University) was working on two of 
the enzymes: glutamate decarboxylase and tryptophanase. Although samples of the enzymes 
were obtained, there was not enough time to evaluate them for use as antigens. The enzymes 
were used for the preparation of antigen-specific affinity chromatography columns for purification 
of antibody preparations (used in part 3 of this dissertation). 
The use of monoclonal antibodies should be considered in future attempts. Although 
monoclonal antibodies were considered initially, they have disadvantages that preclude their 
development and use. Monoclonal antibodies have a poor inherent ability to form the cross 
linkages necessary for agglutination assays. Although a pool of several monoclonal antibody 
preparations might alleviate the problem with formation of cross linking, monoclonal antibodies 
also are difficult to adsorb to latex (3, 4, 28, 45) and often require covalent or other chemical 
coupling to the latex particles. Monoclonal antibodies also require excessive time and effort for 
screening and production compared to the production of polyclonal antibodies. Only one 
monoclonal antibody to an E. coli enzyme has been reported (25, 26, 27, 30) but attempts to 
obtain the antibody were unsuccessful. Because of the successful use of polyclonal antibodies by 
Kaspar (31) and Holt (21), polyclonal antibodies should have been sufficient for latex agglutination 
tests. Even with an assay designed around monoclonal antibodies, initial antibody development 
probably would require purer antigens than were used in this project. 
Although the antibody preparations were not prepared from homogeneous antigens and 
antigen-specific affinity chromatography was not able to compensate for the lack of purity, the 
antibodies were considered good enough for further latex agglutination assay development. This 
idea was on the basis of three pieces of information. Foremost was that during the 
characterization of the antibodies, other experimental evidence was found that suggested that the 
entire problem with nonspecific agglutination was not the fault of the antibody preparations (see 
Part 2). In addition, because of the results of the Ouchterlony tests, Western blot controls, and EIA 
analyses, the reactivities of the antibody preparations were thought limited to the enzyme 
preparations and did not necessarily extend to other proteins. Finally, the successes by Kaspar 
(31) and Holt (21), and later by Feng and Lampel (personal communication), indicated that 
polyclonal antibodies should have sufficed. 
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TABLE 1. Summary of Ouchteriony immunodiffusion results 
Antibody 
Antibody 
purification 
method 
Antibody titer 
(antigen constant) 
(mg/ml) 
Antigen titer 
(antibody constant) 
(mg/ml) 
Cross-reactivity 
Anti-glucuronidase Protein A 0.0625 - 0.03125 0.5 - 0.0625 none 
DEAE <0.03125 0.5 none 
Gentle method 0.0625 0.5 none 
AgSAC® <0.03125 0.0625 none 
Anti-tryptophanase Protein A 0.125 1 -0.5 glucuronidase 
glutamate 
decarboxylase 
DEAE not detected not detected none 
Gentle method 0.0625 0.5 none 
AgSAC 0.125 0.25 none 
Anti-glutamate 
decarboxylase 
Protein A 
DEAE 
<0.0625 
<0.0625 
0.25 
1.0 
tryptophanase 
tryptophanase 
Gentle method <0.0625 0.25 none 
AgSAC <0.0625 0.5 tryptophanase 
Kaspar's 
antibody 
<0.0625 0.5 tryptophanase 
®AgSAC - antigen-specific affinity chromatography 
Figure 1. EIA scheme for anti-glutamate decarboxylase assay. Except column 3, columns 1 through 12 contain doubling dilutions 
of glutamate decarboxylase starting with 0.1 mg/ml in column 1 through 0.0000977 mg/ml in column 12. Column 3 
contains BSA a negative control. Rows A and H are blank. Rows B (1:10,000). C (1:5,000), D (1:1.000), E (1:500), F 
(1:100), and G (1:10) contain dilutions of alkaline phosphatase conjugated anti-glutamate decarboxylase. 
BLANK H 
Figure 2. El A scheme for anti-glucuronidase assay. Except column 3, columns 1 through 12 contain doubling dilutions of 
glucuronidase starting with 0.1 mg/ml In column 1 through 0.0000977 mg/ml In column 12. Column 3 contains BSA a 
negative control. Rows A, C, and H are blank. Row B contains anti-glutamate decarboxylase. Rows D (1:10,000), E 
(1:1,000), F (1:100), and G (1:10) contain dilutions of alkaline phosphatase conjugated antl-glucuronidase. 
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Figure 3. Anti-tryptoplianase and anti-glucuronidase native PAGE. Lanes A and K contain 
prestained molecular weight standards (Sigma, product number SDS-7B). Lanes B 
through E contain anti-tryptophanase purified by protein A, antigen-specific affinity 
chromatography, the gentle method, and the DEAE method, respectively. Lane F 
contains commercial rabbit immunoglobulin as a control. Lanes G through J 
contain anti-glucuronidase purified by protein A, antigen-specific affinity 
chromatography, the gentle method, and the DEAE methods, respectively. 
Approximate molecular masses are indicated along the left side. 

Figure 4. Anti-glutamate decarboxylase native PAGE. Lanes A and G contain prestained 
molecular weight standards (Sigma, product number SDS-7B). Lanes B through F 
contain anti-glutamate decarboxylase purified by protein A, antigen-specific affinity 
chromatography, the gentle method, the DEAE method, and protein A from a 
previous investigator, respectively. Lane H contains a low molecular weight 
standard (Sigma, product number SDS-7B). Lane I contains commercial rabbit 
immunoglobulin (Sigma, product number 15006) as a control. Lane J contains 
bovine serum albumin (Sigma, product number A7030) as a molecular weight 
marker. Approximate molecular masses are indicated along the left side. 
1 1 9  
6 2  
3 8  
Figure 5. Anti-tryptophanase denatured PAGE. Lane A contains normal rabbit serum. Lanes B 
and G contain prestained molecular weight standards (Sigma, product number SDS-
78). Lanes C through F contain anti-tryptophanase purified by protein A, antigen-
specific affinity chromatography, the DEAE method, and the gentle method, 
respectively. Lane H contains commercial rabbit immunoglobulin (Sigma, product 
number 15006) as a control. Lane I contains bovine serum albumin (Sigma, product 
number A7030) as a molecular weight marker. Approximate molecular masses are 
indicated along the left side. 

Figure 6. Anti-glucuronidase denatured PAGE. Lane A contains bovine serum albumin (Sigma, 
product number A7030) as a molecular weight marker. Lanes B and G contain 
prestained molecular weight standards (Sigma, product number SDS-7B). Lanes C 
through F contain anti-glucuronidase purified by protein A, antigen-specific affinity 
chromatography, the DEAE method, and the gentle method, respectively. Lane H 
contains commercial rabbit immunoglobulin (Sigma, product number 15006) as a 
control. Lane I contains normal rabbit serum. Approximate molecular masses are 
indicated along the left side. 

Figure 7. Anti-glutamate decarboxylase denatured PAGE. I_anes A and G contain prestained 
molecular weight standards (Sigma, product number SDS-7B). Lanes B through F 
contain anti-glutamate decarboxylase purified by protein A, antigen-specific affinity 
chromatography, the gentle method, the DEAE method, and previously protein A 
purified antibodies, respectively. Lane H contains commercial rabbit 
immunoglobulin (Sigma, product number 15006) as a control. Lane I contains 
bovine serum albumin (Sigma, product number A7030) as a molecular weight 
marker. Approximate molecular masses are indicated along the left side. 
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Figure 8. Anti-tryptophanase Ouchteriony. 
Figure B-A; Protein A purified anti-tryptophanase titers; 
WELL CONTENTS 
Center (E) 2.0 mg/ml tryptophanase 
1 1.0 mg/ml anti-tryptophanase 
2 0.5 mg/ml anti-tryptophanase 
3 0.25 mg/ml anti-tryptophanase 
4 0.125 mg/ml anti-tryptophanase 
5 0.0625 mg/ml anti-tryptophanase 
6 blank (buffer) 
Figure B-B; Protein A purified anti-tryptophanase cross-reactions; 
Not done. 
Figure B-C; Antigen-specific affinity chromatography purified anti-tryptophanase titers; 
WELL CONTENTS 
Center (E) 0.5 mg/ml tryptophanase 
1 1.0 mg/ml anti-tryptophanase 
2 0.5 mg/ml anti-tryptophanase 
3 0.25 mg/ml anti-tryptophanase 
4 0.125 mg/ml anti-tryptophanase 
5 0.0625 mg/ml anti-tryptophanase 
6 blank (buffer) 
Figure B-D; Antigen-specific affinity chromatography purified anti-tryptophanase cross-reactions; 
WELL CONTENTS 
Center (E) 1 mg/ml anti-tryptophanase 
-1 1 mg/ml glucuronidase 
2 1 mg/ml tryptophanase 
3 1 mg/ml glutamate decarboxylase 
4 1 mg/ml glucuronidase 
5 blank (buffer) 
6 1 mg/ml tryptophanase 
A B 
Figure 9. Anti-glutamate decarboxylase Ouchteriony. 
Figure 9-A; Protein A purified anti-glutamate decarboxylase titers; 
VVELL CONTENTS 
Center (E) 1.0 mg/ml glutamate decarboxylase 
1 1.0 mg/ml anti-glutamate decarboxylase 
2 0.5 mg/ml anti-glutamate decarboxylase 
3 0.25 mg/ml anti-glutamate decarboxylase 
4 0.125 mg/ml anti-glutamate decarboxylase 
5 0.0625 mg/ml anti-glutamate decarboxylase 
6 1.0 mg/ml anti-tryptophanase 
Figure 9-B; Protein A purified anti-glutamate decarboxylase cross-reactions; 
WELL CONTENTS 
Center (E) 1 mg/ml glucuronidase 
1 1 mg/ml anti-glucuronidase 
2 1 mg/ml anti-glutamate decarboxylase (AgSAC)® 
3 1 mg/ml anti-glucuronidase 
4 1 mg/ml anti-glutamate decarboxylase (proA)" 
5 1 mg/ml anti-glutamate decarboxylase (Kaspar) 
6 1 mg/ml anti-glutamate decarboxylase (DEAE) 
Figure 9-C: AgSAC purified anti-glutamate decarboxylase titers; 
WELL CONTENTS 
Center (E) 1.0 mg/ml glutamate decarboxylase 
1 1.0 mg/ml anti-glutamate decarboxylase 
2 0.5 mg/ml anti-glutamate decarboxylase 
3 0.25 mg/ml anti-glutamate decarboxylase 
4 0.125 mg/ml anti-glutamate decarboxylase 
5 0.0625 mg/ml anti-glutamate decarboxylase 
6 1.0 mg/ml anti-tryptophanase 
Figure 9-D; AgSAC purified anti-glutamate decarboxylase cross-reactions; 
WELL CONTENTS 
Center (E) 25 mg/ml tryptophanase 
1 1 mg/ml anti-tryptophanase 
2 1 mg/ml anti-glutamate decarboxylase (AgSAC) 
3 1 mg/ml anti-tryptophanase 
4 1 mg/ml anti-glutamate decarboxylase (proA) 
5 1 mg/ml anti-tryptophanase 
6 1 mg/ml anti-glutamate decarboxylase (DEAE) 
^AgSAC=antigen-specific affinity chromatography purification 
''proA=protein A purification 
A B 
Figure 10. Anti-glucuronidase Ouchterlony. 
Figure lO-A; Protein A purified anti-glucuronidase titers; 
WELL CONTENTS 
Center (E) 1.0 mg/ml glucuronidase 
1 1.0 mg/ml anti-glucuronidase 
2 0.5 mg/ml anti-glucuronidase 
3 0.25 mg/ml anti-glucuronidase 
4 0.125 mg/ml anti-glucuronidase 
5 0.0625 mg/ml anti-glucuronidase 
6 0.03125 mg/ml anti-glucuronidase 
Figure 10-B; Protein A purified anti-glucuronidase cross-reactions; 
WELL CONTENTS 
Center (E) 1.0 mg/ml anti-glucuronidase 
1 2.0 mg/ml tryptophanase 
2 1.0 mg/ml glucuronidase 
3 0.5 mg/ml glucuronidase 
4 1.0 mg/ml glucuronidase 
5 1.0 mg/ml glutamate decarboxylase 
6 1.0 mg/ml glucuronidase 
Figure 10-C; Antigen-specific affinity cliromatography purified anti-glucuronidase titers; 
WELL CONTENTS 
Center (E) 1.0 mg/ml glucuronidase 
1 1.0 mg/ml anti-glucuronidase 
2 0.5 mg/ml anti-glucuronidase 
3 0.25 mg/ml anti-glucuronidase 
4 0.125 mg/ml anti-glucuronidase 
5 0.065 mg/ml anti-glucuronidase 
6 0.03125 mg/ml anti-glucuronidase 
Figure 10-D; Antigen-specific affinity cliromatography purified anti-glucuronidase cross-reactions; 
WELL CONTENTS 
Center (E) 1 mg/ml anti-glucuronidase 
1 1 mg/ml tryptophanase 
2 1 mg/ml glucuronidase 
3 1 mg/ml glutamate decarboxylase 
4 1 mg/ml glucuronidase 
5 blank (buffer) 
6 1 mg/ml glucuronidase 
1  
Figure 11. Denatured enzyme PAGE. Lane A contains prestained moiecular weight standards 
(Sigma, product number SDS-7B). Lane B contains Clostridium perfringens 
glutamate decarboxylase (Sigma, product number G2251) as a control. Lane C 
contains £ coli C-galactosidase (Sigma, product number G5635) as a control. Lane 
D contains tryptophanase. Lane E contains glucuronidase. Lane F contains 
glutamate decarboxylase. Approximate molecular masses are indicated along the 
left side. 
A B C D E F 
Figure 13. Anti-glutamate decarboxylase Western blot. Lane A contains glutamate 
decarboxylase. Lane B contains glucuronidase. Lane C contains tryptophanase. 
Lane D contains £ coli 6-galactosidase (Sigma, product number G5635) as a 
control. Lane E contains Clostridium perfringens glutamate decarboxylase (Sigma, 
product number G2251) as a control. Lane F contains prestained molecular weight 
standards (Sigma, product number S0S-7B; visualization of these bands is due to 
the prestaining and not reactivity w/ith the primary antibody). Approximate molecular 
masses are indicated along the right side. 
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62 
38 
Figure 14. Anti-glucuronidase Western blot. Lane A contains glutamate decarboxylase. Lane B 
contains glucuronidase. Lane C contains tryptophanase. Lane D contains £ coli 
6-galactosidase (Sigma, product number G5635) as a control. Lane E contains 
Helix pomatia (snail) glucuronidase (Sigma, product number G1512) as a control. 
Lane F contains prestained molecular weight standards (Sigma, product number 
SDS-7B: visualization of these bands is due to the prestaining and not reactivity with 
the primary antibody). Approximate molecular masses are indicated along the right 
side. 
A B O D E  F  
Figure 15. Western blot using absorbed anti-glutamate decarboxylase. Lane A contains 
glutamate decarboxylase. Lane B contains glucuronidase. Lane C contains 
tryptophanase. Lane D contains E. coli 6-galactosidase (Sigma, product number 
G5635) as a control. Lane E contains Helix pomatia (snail) glucuronidase (Sigma, 
product number G1512) as a control. Lane F contains prestained molecular weight 
standards (Sigma, product number SDS-7B: visualization of these bands is due to 
the prestaining and not reactivity with the primary antibody). Approximate molecular 
masses are indicated along the right side. 
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Figure 16. Western blot with bovine serum albumin. Lane A contains tryptophanase. Lane B 
contains glucuronidase. Lane C contains glutamate decarboxylase. Lanes marked 
X contain bovine serum albumin. An approximate molecular mass is indicated along 
the left side. Appropriate antigen specific affinity chromatography anti-enzyme 
antibodies were allowed to react with each blot. 
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Figure 17. Anti-glutamate decarboxylase EIA. Except column 3, columns 1 through 12 contain doubling dilutions of glutamate 
decarboxylase starting with 0.1 mg/ml in column 1 through 0.0000977 mg/ml In column 12. Column 3 contains BSA a 
negative control. Rows A and H are blank. Rows B (1:10,000), C (1:5,000), D (1:1,000), E (1:500), F (1:100), and G 
(1:10) contain dilutions of alkaline phosphatase conjugated anti-glutamate decarboxylase. Conjugated antl-glutamate 
decarboxylase antibodies exhibited reactivity at a 1:10,000 dilution with approximately 0.4 fig glutamate decarboxylase. 
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Figure 18. Anti-glucuronidase EIA. Except column 3, columns 1 through 12 contain doubling dilutions of glucuronidase starting with 
0.1 mg/ml in column 1 through 0.0000977 mg/ml in column 12. Column 3 contains BSA a negative control. Rows A, C. 
and H are blank. Row 8 contains 1:1000 dilution of conjugated anti-glutamate decarboxylase. Rows D (1:10,000), E 
(1:1,000), F (1:100), and G (1:10) contain dilutions of alkaline phosphatase conjugated anti-glucuronidase. Conjugated 
anti-glucuronidase at a 1:10 dilution reacted with as little as 97 ng of commercial enzyme preparation. A 1:100 dilution of 
conjugated anti-glucuronidase, however, detected only 6.25 to 12.5 /xg of commercial enzyme preparation. The 
conjugated anti-glucuronidase did cross-react with 50 ng of commercial glucuronidase preparation. 
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PART 3. LATEX PREPARATION FOR SENSITIZATION WITH IMMUNOGLOBULINS 
AND ADSORPTION OF IMMUNOGLOBULINS 
142 
INTRODUCTION 
Development of latex agglutination assays require that antibodies be functionally adsorbed 
to latex particles. Several protocols for the adsorption of immunoglobulins to latex were examined, 
but the assays failed to function satisfactorily because of nonspecific agglutination. An investigation 
into the causes of the nonspecific agglutination was begun, especially as it pertains to the 
adsorption of immunoglobulins on the latex. Adsorption of protein on the latex was measured 
under several different conditions of buffer, protein concentration, and brand of latex. In addition, 
the effects of anti-enzyme and other immunoglobulins on sensitized latex were studied in attempts 
to determine the conditions under which the sensitized latex started to undergo nonspecific 
agglutination. 
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MATERIALS AND METHODS 
Common Procedures Used in this Project 
Cleaning Latex for Use 
Latex particles were cleaned before protein coating by either centrifugatlon washing or 
dialysis. For centrifugatlon washing, enough latex needed for each experiment was added to 1.5 or 
2.0 ml microcentrifuge tube. Enough 1 M KCI was added to bring the total volume to either 1.25 or 
1.8 ml, depending on the microcentrifuge tube being used. The latex suspension was mixed 
several times by inversion before being sedimented by centrifugatlon for 5 to 15 min at 13,000 rpm 
(approximately 11,300 x g) In a microcentrifuge. Liquid was aspirated from the microcentrifuge 
tube without disturbing the latex pellet. An appropriate volume of sterile filtered buffer was added 
to each tube and the latex was suspended by either vortex mixing or by ultrasonlcation. Each 
washing with buffer was performed three times before the latex was suspended at a known latex 
concentration In buffer. 
For dialysis cleaning, enough latex needed for each experiment plus 10 mg was diluted to 
2%, put into a 15 X 1.6 cm dialysis bag (molecular weight cutoff 12-14,000; SpectraPor, product 
number 08-667B, Fisher Scientific, Pittsburgh, PA) and placed in approximately one liter of 1 M KCI. 
After dialysis overnight at approximately 4°C without agitation, the KCI was replaced with Tris/azlde 
buffer (0.03 M Tris, pH 7.4, 0.05% sodium azide) and dialysis was continued for another 24 h. The 
Tris/azlde buffer was replaced with fresh buffer and the dialysis continued for another 24 h before 
the latex was used. 
Latex Bound Protein Detmninations 
The amount of protein bound to the latex particles was determined by the method 
suggested by Seradyn Inc. (Indianapolis, IN). Bicinchonic acid (BCA) reagent (20, 21; Pierce, 
catalog number 23225) was mixed according to the manufacturer's instructions. A seven-point 
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Standard curve was prepared from horse IgG (Pierce, catalog number 23211G) diluted from 1.2 to 
0.1 mg/ml. Six controls were included to monitor test performance: these consisted of a gamma 
globulin protein standard (Bio-Rad Laboratories, product number 500-0001) in two-fold dilutions 
from an initial concentration of 1.44 mg/ml. A 0.25-ml portion of each protein standard, control, 
four blanks, and latex samples (normally at 1%, or 0.25 mg of latex) was added to 12 x 75 mm test 
tubes. BCA reagent (2.5 ml) was added to each tube, mixed, and incubated at 60°C for 30 min in a 
water bath with gentle agitation. After incubation, the tubes were cooled to room temperature in 
chilled water. Solutions of standards, controls, and blanks were transferred to disposable cuvettes. 
Then the latex suspensions were aspirated into a 3-ml disposable syringe and passed through a 
filter (Millex-GS, 0.22-/im, catalog #SLGS0250S, Millipore Corp., Bedford, MA) into the disposable 
spectrophotometer cuvettes. The absorbance was read at 562 nm, using a reagent blank, on a 
Uvikon 930 spectrophotometer (Tegimenta, Switzerland). Readings were completed within 45 min 
after incubation to prevent continued reagent drift. A standard curve was constructed; 
determinations of unknown values were calculated from the standard curve using geometric and 
linear regression determinations. Calculation of ng protein per mg latex was then used to 
standardize values. The BCA reaction gives a nonlinear standard curve, so dilutions of latex 
suspensions were sometimes used to insure that absorbance values were within standard curve 
limits. 
Performance of Agglutination Assays 
Agglutination assays were performed by separately depositing 15 /xl of a 1% latex 
suspension and 15 /zi of antigen-containing solution on a glass slide circumscribed with a raised 
ring. The latex suspension and antigen solution were mixed until homogeneous by using a 
disposable plastic applicator (Despenstirs, catalog #8728-10, Becton-Dickinson, Cockysville, MD). 
The glass slide was incubated at room temperature on a rotator (Junior Orbital Shaker, model 
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3520/3522, Lab Line Instruments, Melrose Park, IL) rotating at approximately 100 rpm. A cover was 
used on the shaker to reduce evaporation. 
Reactions were read both macroscopicaily and with the aid of an illuminated magnifying 
lens. A positive reaction was graded on a scale of ± to + + + + on the basis of degree of 
agglutination present. A ± reaction appears negative macroscopicaily but some agglutinated 
particles were observed when the preparation is examined with a magnifying lens. A + reaction 
has a grainy appearance macroscopicaily on the basis of only a few particles participating in an 
agglutination reaction. A + + reaction has discernible agglutinated clumps on a field of individual 
or slightly agglutinated particles. A + + + reaction has several agglutinated particles of a moderate 
size with a relatively clear background. A + + + + reaction has one or more agglutinated particle 
clumps with no macroscopicaily free particles. 
Effects of Saline on Unsensitized Latex 
Eight glycine buffered saline solutions (7.3 g/L glycine, pH 8.2) were prepared with sodium 
chloride concentrations ranging from 10 g/L to 0.078 g/L Ten milligrams of blue dyed 0.81-/<m 
latex (Bangs Laboratories Inc., Indianapolis IN) were cleaned by centrifugatlon washing before final 
suspension. The latex suspensions were observed at 10 and 30 min and 1,2,3, and approximately 
18 h for flocculation of the latex suspension. 
Sensitization of Latex to Determine of the Effects of Different Brands of Latex and Different 
Buffers on Protein Adsorption 
in general, 0.5 ml of 1% sensitized latex was prepared in each of four separate 
experiments. In each experiment, a different 0.8/im diameter latex from IDC (Interfaciai Dynamics 
Corporation, Portland, OR), Seradyn (Seradyn inc., Indianapolis, IN), Polysclences (Polysciences, 
Warrington, PA), or Bangs (Bangs Laboratories, Indianapolis IN) was used. Antibody sensitization 
of the latex was performed at antibody concentrations of 0.36, 0.18, 0.09, and 0.045 mg/ml. 
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Buffers used consisted of Tris/azide (0.03 M Tris, pH 7.4, 0.05% sodium azide), borate (0.34 M 
boric acid, pH 8.0, with 0.1% BSA and 0.05% sodium azide), HEPES (0.02 M, pH 7.5), glycine 
buffered saline (7.3 g/L glycine, 10 g/L NaCI, pH8.2), and phosphate buffered saline (0.01 M 
NaHgPO^eHgO, 0.155 M NaCI, pH 7.2). The latex particles for these studies were cleaned by 
centrifugation washing. One miliitliter of different concentrations of antigen specific affinity 
chromatography purified anti-glucuronidase antibody solution was added to each appropriately 
labeled 2.0-ml centrifuge tube. Ten milligrams of washed latex were added to each tube and the 
volume was brought to 1.5 ml (total volume) with buffer. The tubes were mixed by inversion 
several times and then the latex/antibody suspensions were incubated at room temperature 
(approximately 27°C) overnight on a platform rocker (Thermolyne Speci-Mix, model M26125). After 
incubation, the latex was pelleted by centrifugation and washed once in an appropriate buffer 
solution before suspending it to 0.5 ml (1% (w/v) latex) with appropriate buffer. Latex bound 
proteins were determined on a sample of the latex suspension (see Latex Bound Protein 
Determinations). One ml of 1 mg/ml bovine serum albumin in the appropriate buffer was added. 
The latex suspensions were again incubated at room temperature (approximately 27°C) for 
approximately 4 h on a platform rocker (Thermolyne Speci-Mix, model M26125). After the second 
incubation, the latex suspensions were pelleted by centrifugation, washed twice in the appropriate 
buffer, and suspended to a volume of 0.5 ml with the appropriate buffer containing 1 mg/ml BSA 
and 0.1% thimerosal. The antibody sensitized latex was stored at 4°C. 
Sensitization of Latex to Determine Maximal Protein Binding 
In three separate experiments, 0.5 ml of 1% sensitized latex was prepared. Enough yellow 
dyed polystyrene latex of 0.8-/im diameter (Bangs Laboratories) was cleaned by centrifugation 
washing. The latex was sensitized by using antibody concentrations of 6, 3,2, 1, and 0.5 mg/ml In 
Tris/azide buffer (0.03 M Tris, 0.05% sodium azide, pH 7.4). One ml of protein A purified anti-
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glucuronidase antibody solution was added to an appropriately labeled 2.0-ml centrifuge tube. Ten 
milligrams of washed latex were added, the volume was increased to 1.5 ml total volume with 
buffer, and the tubes were mixed by inversion several times. The latex/antibody suspensions were 
incubated at 37°C overnight on a platform rocl<er (Thermolyne Speci-Mix, model M26125), pelleted 
by centrifugation, washed once with Tris/azide buffer and suspended to a volume of 0.5 ml with 
buffer. Latex bound proteins were determined on a sample of the latex suspension (see Latex 
Bound Protein Determinations). One ml of 1 mg/ml bovine serum albumin in buffer was added to 
block unreacted sites on the latex and the latex suspensions were incubated at room temperature 
(approximately 2TC) overnight on a platform rocker. After the second incubation, the latex 
suspensions were again pelleted by centrifugation, washed twice in buffer, and suspended to a 
volume of 0.5 ml (1% (w/v) latex) with buffer containing 1 mg/ml BSA and 0.1% thimerosal. The 
sensitized latex was stored at 4°C. 
Differences in Non-specific Agglutination of Sensitized Latex Resulting from Immunoglobulins 
SensitizaO'on of latex to detemine the effects of antibody purification metfiods on nonspecific 
agglutination 
The effects of antibody purification methods on the enzyme-latex agglutination assay were 
examined. Antigen-specific affinity chromatography purified, DEAE column purified, protein A 
purified, and, in the case of anti-glutamate decarboxylase, gentle purified antibodies were used to 
sensitize the latex. Blue and red dyed polystyrene latex particles, 0.8 /xm diameter (Bangs 
Laboratories) were cleaned by centrifugation washing as previously described. Ten milligrams of 
latex (blue dyed latex for anti-glutamate decarboxylase and red dyed latex for anti-tryptophanase) 
were added to antibody solutions and the suspensions incubated at 37°C for 2 h. In addition, the 
latex was coated with BSA (0.047) and carried through the sensitization as a negative control. After 
sedimentation of the latex by centrifugation at 13,000 rpm (approximately 11,300 x g) in a 
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microcentrifuge, the antibody solutions were removed and filtered through a 0.22- or 0.45-^m 
syringe filter. The recovered antibody protein concentration was estimated by a spectrophotometric 
method, using Aggo values and an extinction coefficient of 1.4 (3, 6). Two milliliters of buffer 
containing 0.1% BSA and 0.05% polyvinylpyrrolidone (molecular weight 40,000; Sigma, product 
number PVP-40) were added and the suspension was allowed to incubate at room temperature 
overnight before use. 
The latex was tested against 0.1, 0.01, and 0.001 mg/ml of appropriate enzyme solution. 
(Appropriate refers to using an enzyme as an antigen to which the latex was sensitized with anti-
enzyme antibody preparations). In addition, controls consisting of distilled water, 1 M KHgPO^ 
buffer, 0.1 mg/ml glucuronidase (Sigma, product number G7896), 0.1 mg/ml glutamate 
decarboxylase (Sigma, product number G3757), and 0.1 mg/ml apotryptophanase (Sigma, product 
number A6007) were used. 
Sensitization of latex to detemiine nonspecific agglutination of commercial anti-glucuronidase 
Anti-glucuronidase solutions containing 0.04, 0.05, 0.06, and 0.07 mg/ml of protein were 
prepared from four different sources: antigen-specific affinity chromatography purified, protein A 
purified, IVIolecular Probes (IVIolecular Probes, Inc., product number A-5790), and 5'3' 
(5Prime~ 3Prime Inc., product number 5307-246468). Protein estimates were performed by using 
Ajgo values and an extinction coefficient of 1.4 (3, 6). Ten milligrams of washed 0.81-/xm yellow 
dyed polystyrene (Bangs Laboratories) were added to 1.75 ml of each antibody containing solution 
(total volume 2 ml) and mixed by inversion. The latex suspensions were incubated for 1 h at 37°C 
with Intermittent mixing by inversion followed by 1 h stationary. Tris/azide buffer (0.25 ml) 
containing 4 mg/ml BSA was added and allowed to incubate with the latex suspension stationary, 
overnight, at 4°C. The latex suspension was washed three times before 200 /xl of 0.8% latex was 
suspended in assay buffer. The assay buffers consisted of glycine buffer (0.03 M, pH 8.2, with 0.1% 
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BSA and 0.05% sodium azide), phosphate buffer (0.1 M NaHgPO^-HgO, 0.155 M NaCI, pH 6.6, with 
0.1% BSA and 0.05% sodium azide), borate buffer (0.34 M boric acid, pH 8.0, with 0.1% BSA and 
0.05% sodium azide), and Tris/azide buffer (0.03 M, pH 7.4, with 0.1% BSA and 0.05% sodium 
azide). Saline was prepared with concentrations ranging from 0.43, 0.26, 0.17, 0.09, 0.04, and 
0.02 M. 
Sensitization of latex with inelevant immunoglobulins to detennine immunoglobulin-induced 
nonspecific agglutination 
Anti-glucuronidase from Molecular Probes (Molecular Probes, Inc., product number A-
5790), horse IgG (Pierce, catalog number 31126G), mouse IgG (Pierce, catalog number 31204G), or 
rabbit IgG (Sigma, product number 15006) solutions containing 1 and 0.01 mg/ml of protein were 
prepared. Protein A purified anti-glucuronidase and normal rabbit serum (1:1) solutions containing 
1 and 0.1 mg/ml of protein were prepared. Protein estimates were performed by using Aggo values 
and an extinction coefficient of 1.4 (3, 6). Ten milligrams of washed 0.81-^m polystyrene latex 
(Seradyn) were added to 1.75 ml of each antibody containing solution (total volume 2 ml) and 
mixed by inversion. The latex suspensions were incubated for 2 h at STC on a platform roci<er 
(Thermoiyne Speci-Mix, model M26125). The latex suspensions were pelleted by centrifugation, 
washed once with Tris/azide buffer and suspended to a volume of 0.5 ml with buffer. Latex bound 
proteins were determined on a sample of the latex suspension (see Latex Bound Protein 
Determinations). One ml of 10 mg/ml bovine serum albumin in buffer was added to block 
unreacted sites on the latex and the latex suspensions were incubated at 37°C overnight on a 
platform rocker. After the second incuisation, the latex suspensions were again pelleted by 
centrifugation, washed twice in Tris/azide buffer, and suspended to a volume of 0.5 ml (1% (w/v) 
latex) with TPG buffer (7.8 g/L NaH2P04'2H20, 1 g/L NaCI, 2 g/L gelatin, pH 6.6). The sensitized 
latex was stored at 4°C. 
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RESULTS AND DISCUSSION 
Effects of Saline on Unsensitized Latex 
During the work with immunoglobulin adsorption to latex, it was noticed that in some 
buffers the latex would settle out of suspension. Originally, this was thought a resuit of the 
adsorption of immunoglobulins to the latex. Later, it was reexamined to determine if there was a 
correlation between the degree of settling and the degree of nonspecific agglutination obtained with 
sensitized latex. (There was a positive correlation; data not shown). Studies of unsensitized latex 
in saline solutions also were completed. 
Suspensions of latex were all evenly dispersed after 10 min (Table 1). After 30 min, 
however, floccuiation could be observed at the greatest saline concentration (10 g/L) and 
flocculation increased over the next 2 h. In the 5 g/L concentration of saline, floccuiation started 
after about 2 h and increased to 1 + by 3 h. In the 2.5 g/L concentration of saline, a slight 
floccuiation developed only after incubation overnight. Concentrations of saline less than 2.5 g/L 
did not cause flocculation of the latex over the period of observation. 
The results demonstrated that the flocculation of latex in suspension was caused, in part, 
by the concentration of saline in the suspending buffer. Saline evidently decreases the zeta 
potential (the innate charges that surround particulate solid-phases; 14, 25) that keeps the latex 
particles repelled from each other and at saline concentrations above about 2.5 g/L, floccuiation 
starts to occur. The significance of this observation was that many buffers recommended for use in 
protein coating of latex contains concentrations of saline that are greater than 2.5 g/L (NaCi at 9 to 
10 g/L is normal in these buffers). This could be detrimental to efficient protein absorption on 
latex. If latex particles start flocculating before maximum quantities of protein are absorbed to the 
particles, the protein could cross-link the particles and cause tightly bound latex aggregates. 
The results of this study suggested that a change from glycine buffered saline to Tris/azide 
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buffer (no saline) would be beneficial. In addition, the results of several other studies demonstrated 
that Tris/azide was a suitable buffer system for protein adsorption. The latex bound protein studies 
(data follow later) suggested that Tris/azide performed well for adsorption of immunoglobulins, 
Tris/azide resulted In less background color in the latex bound protein determinations, and 
subjective observations of flocculation during immunoglobulin adsorption with Tris/azide buffer 
indicated that spontaneous flocculation of the latex particle was significantly less. With this 
information, Tris/azide became the most commonly used adsorption buffer for immunoglobulin 
adsorption to the latex particles. 
Protein Adsorption to Latex 
Comparison of latex brands 
To insure that immunoglobulins were adsorbing to the latex particle, a series of experiments 
was accomplished specifically looking at immunoglobulin adsorption. With the use of BCA reagent, 
the quantity of protein adsorbed to the latex could be directly measured rather than calculated from 
an analysis of residual protein in the adsorption solutions. 
Figure 1 shows a comparison of protein binding by four brands of latex particles (all 0.8 /im 
diameter polystyrene). Two of the four brands of latex bound more protein than was bound by the 
other two brands of latex. In one instance (Polysciences), the results exceeded the standard error 
of the means for two other latexes (Bangs and Seradyn; error bars not shown for the difference in 
the four replicates). In the other instance (IDC), although not statistically significant (the error bars 
overlapped), the same trend was noted. Thus, there were differences among the brands of latex in 
their ability to bind rabbit immunoglobulins. The results of the studies on latex brands established 
that Polysciences latex, the original brand used, was not the best latex for adsorption of 
immunoglobulins. On the basis of these results, sensitization of latex particles for the latex 
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agglutination assay was subsequently restricted to particles from either Seradyn or Bangs 
Laboratories. 
Analysis of the results corroborates Finkelstein and Yang's (5) demonstration of differences 
in brands of latex. This work was different from Finkelstein and Yang's, however, because the data 
were quantitatively based on the amount of protein bound to the latex rather than on the subjective 
evaluation of the sensitivity of the assay. The study did not involve evaluating different lots of latex 
from the same manufacturer. A more thorough study of differences in immunoglobulin binding to 
several lots of latex from each manufacturer might have added additional information. Although an 
attempt was made to use one lot number of latexes for the entire project, when the original 
samples of latex had been consumed, other lot numbers of latex were used without further testing 
of the adsorption characteristics. Redoing the protein adsorption studies should have been 
accomplished to insure that the new latex lots performed as well as the original material. 
Although the purpose of these studies was to confirm that immunoglobulins adsorbed to 
the latex particles, changes in the total volume, percent solids, temperatures of adsorption, 
mechanical agitation, and other parameters, could influence protein adsorption. Further studies on 
the effects of these parameters could have been accomplished to insure that the optimal conditions 
were obtained. After insuring that adequate immunoglobulin adsorption occurred in this study, 
however, a decision was made to proceed with other areas of investigation so that the project was 
not side tracked into studies of protein adsorption to latexes. Such studies would have been 
performed if satisfactory latex agglutination assays had been developed to optimize the assays. 
Comparison of binding buffers 
As part of the investigation of immunoglobulin adsorption to different brands of latex, the 
effect of buffers on immunoglobulin adsorption also was tested. Protocols on protein adsorption to 
latex from different sources included the use of different buffers. Although information exists on the 
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effects of different buffers on protein adsorption (7, 23), tfie findings were substantiated for 
application in this project. 
Figure 2 shows the quantities of protein bound by different brands of latexes sensitized in 
the presence of different buffers. In general, neither the buffer type nor the pH significantly affected 
the amount of immunoglobulins adsorbed to the latex. This Is consistent with previously published 
work (7, 23) that suggest that protein adsorption Is Independent of pH. 
Although a definitive buffer was not identified as superior for the adsorption of 
immunoglobulins, the information gained In the study of different buffers was useful. By knowing 
that there were no differences in the effects of buffers or pH on the adsorption of Immunoglobulins 
to latex, unconstrained substitution of adsorption buffers could be made. This was done when 
Tris/azide was substituted for glycine buffered saline after the effects of saline on unsensitlzed latex 
became known. 
Determination of Maximum Protein Binding 
After the determination of immunoglobulin adsorption, differences among brands of latex 
adsorbed on the latex particle was determined. Until this time, the amount of immunoglobulin used 
had been estimated by extrapolation of protein-adsorption results on other types of polystyrene by 
other Investigators (2). 
Figure 3 shows the relationship between the quantity of protein used and the quantity 
bound to latex. The results approximate a curve with maximal protein binding at approximately 
1 mg/ml of protein applied. The curve follows the formula: 
y^ (4.1624 + 366.18%) 
(1 + 3.43%) 
The results, illustrating a saturation curve for protein binding, are consistent with other investigators' 
work (4, 10, 17,18, 22). This knowledge was useful in deciding how much protein should be used 
154 
to saturate latex preparations for other experiments. Some sources (2,16) suggested that less than 
saturation of the latex with antibodies Is desirable because of prozone effects. (The prozone Is a 
phenomenon exhibited In which agglutination occurs within a range of equivalence of antibodies 
and antigens; outside which, optimal agglutination Is hindered by a reactant excess). The results 
from studies on Immunoglobulin-sensitlzed latex suggested that nonspecific agglutination might be 
directly influenced by the amount of Immunoglobulin bound to the latex (data follow). By woridng 
within the parameters of the saturation curve, a better sensitized latex reagent should be achieved. 
Extrapolation of the other polystyrene results to latex provided an incorrect estimate for the 
adsorption of immunoglobulins on latex, and the data in this study were more consistent with 
subsequent information (17). The adsorption data were used throughout the remainder of the 
project to determine the degree of immunoglobulin saturation on the latex. 
Differences in Non-specific Agglutination of Sensitized I^tex Resulting from Immunoglobulins 
Effects of antibody purification mettiods on nonspecific agglutination 
Because Kaspar (8) had used polyclonal antibodies made In-house that evidently performed 
well in his assays, an original consideration when the present latex agglutination tests were not 
performing as expected, was to lool< at the antibody purification method. Kaspar had used protein 
A purified antibodies for coaggiutination and enzyme-capture assays (8). in the present study, 
antigen-specific affinity chromatography purified antibody preparations were being used (Part 1). It 
Is known that the harsh conditions of antibody eiution from antigen-specific affinity chromatography 
columns (pH 2.8) can cause some physical changes in immunoglobulin structure (11). Because of 
differences in purification methods, it was reasoned that a change in the purification method could 
result in antibodies not as prone to nonspecific agglutination. Changes to protein A, DEAE, and 
gentle antibody purification methods (see part 1 of this dissertation) were examined to determine 
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which method (s) might yield antibody preparations not prone to nonspecific reactions when used to 
sensitize latex. 
Antibodies purified by protein A, antigen-specific affinity chromatography, DEAE, and gentle 
elution from protein A, were all predisposed to nonspecific agglutination (Table 2). It was noted In 
this set of experiments, however, that nonspecific agglutination appeared only when 
immunoglobulins were adsorbed to the latex; BSA-coated latexes were nonreactive in all the test 
solutions. 
Although there were slight differences in the reactivities of antibodies prepared by different 
methods, the differences were not considered significant. On the basis of the potential for reduced 
cross-reactivity of the antibodies, antigen-specific affinity chromatography purified antibodies 
continued to be used most often for further studies. Owing to the low yields and the time required 
for antigen-specific affinity chromatography purification of the immunoglobulins, however, protein A 
purified antibodies were used in some work. Because DEAE and gentle antibodies demonstrated 
no significant improvement on nonspecific agglutination, they were not used in further studies. 
Nonspecific agglutination of commercial anti-glucuronidase 
When commercial anti-glucuronidases were located, samples of those antibodies were tried 
in the latex agglutination assay. It was reasoned that, besides differences in antibody purification, 
antibody production methods might have an influence on nonspecific agglutination. Using 
commercial antibodies in the latex agglutination test, it was believed, might make a satisfactory 
assay and would provide Information on the cause(s) of nonspecific agglutinations. 
Anti-glucuronidase preparations from Molecular Probes, 5'3', antigen-specific affinity 
purification, and protein A purification were compared by using different latexes and by using 
moderate concentrations for adsorption to the latex. All four antibody preparations yielded 
nonspecific agglutinations (Table 3). The anti-glucuronidase from Molecular Probes and protein A 
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purified antibody preparations were more reactive than the anti glucuronidase from 5'3'. Antigen-
specific affinity chromatography purified antibody preparations were slightly more reactive than 
comparably adsorbed antibody preparations from the commercial sources or from the protein A 
purified antibody preparations. 
All four antibody preparations displayed results that suggested a prozone effect. All the 
strongly positive reactions centered at approximately 7.8 /xg/ml glucuronidase, with reactions 
weal<ening or becoming negative as the enzyme concentration was increased or decreased. 
Positive results were detected at enzyme concentrations as little as 3.8 ng/ml (not shown in Table 
3; the results remained essentially unchanged in the degree of agglutination from the results shown 
for 0.31 /ig/ml). Positive results at the extreme dilutions were considered non-specific agglutination 
because latex agglutination tests are theoretically able to detect only about 10 ng/ml under ideal 
conditions (1). When more immunoglobulin was used to sensitize the latex, stronger reactions and 
more nonspecific agglutination were noticed. 
While it was possible to obtain acceptable results with this batch of sensitized latex using 
glucuronidase in GBS-BSA buffer as samples, the latex preparation did not provide definitive results 
when cell lysates were examined (data not shown). The use of cell lysates continued to result in 
nonspecific reactions. Changes in cell lysis buffers did nothing to alleviate the nonspecific 
agglutination (discussed in part 3 of this dissertation). 
Whereas it was expected that antigen-specific affinity chromatography purified antibody 
preparations would have displayed more reactivity when less antibody was used to sensitize the 
latex. But, this was not observed. Antigen-specific affinity chromatography purified antibody 
preparations should contain more functionally reactive immunoglobulins per unit measure than an 
equivalent concentration of an antibody preparation purified by using another method. 
The reactivities of the commercial anti-glucuronidase preparations were, for the most part. 
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equal to those detected with the in-house antibody preparations. In addition, all four antibody 
preparations exhibited similar nonspecific agglutination reactions. Because of time and resource 
constraints, the commercial sources of anti glucuronidase were not evaluated for cross-reactivities 
such as was completed for the antibody preparations made in-house. In discussion with the 
manufacturers, they revealed that the preparations were protein A purified from rabbits immunized 
with enzymes from Sigma. While the full characterization of these antibodies would have been 
informative, the time and costs involved would have been excessive, considering what useful 
information might have been gleaned. In conclusion, there were no substantial differences in the 
use of the commercial antibody preparations that warranted their continued use. 
General immunoglobulin induced nonspecific agglutination 
An investigation into the adsorption of nonenzyme antibody preparations on latex was 
completed because of the continual presence of nonspecific agglutination in the latex assays. If the 
nonspecific agglutination problems were related to the anti-enzyme preparations, then switching 
immunoglobulins to unrelated preparations should resolve the problem. Commercial antibodies 
that had no relation to the project (horse IgG, mouse IgG, and rabbit IgG) were used to determine 
if the immunoglobulins themselves caused nonspecific agglutination. 
The results revealed that immunoglobulins, despite the type or source, can cause 
nonspecific agglutination (Table 4). Although there were slight differences in the degree of 
agglutination with the commercial immunoglobulins, all caused a degree of nonspecific 
agglutination. When protein A purified anti-glucuronidase mixed with normal rabbit serum was used 
to sensitize the latex, nonspecific agglutination was practically eliminated: reactions with 
glucuronidase, however, were not present (data not shown). This information reinforced the idea 
that the immunoglobulin itself, despite the source, contributes directly to nonspecific agglutination. 
It was concluded that methods for reducing nonspecific agglutination of immunoglobulin sensitized 
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latex required modification of other parameters, inciuding better blocking of the latex and better 
assay buffer systems. 
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SUMMARY AND CONCLUSIONS 
In attempts to eliminate nonspecific agglutination, adsorption of the antibodies to the latex 
was studied. Kaspar (8) had used staphylococci as the solid-phase indicator system in a 
coagglutination assay. The use of latex was a new approach to the anti-enzyme assays. The 
change from a biological solid-phase to the latex solid-phase was suspected of being part of the 
cause for false-positive reactions. By determining if immunoglobulins were being adsorbed to the 
latex, and in what amounts, and by evaluating some immunoglobulin-adsorption parameters that 
resulted in nonspecific agglutination, it was hoped that the causes of nonspecific agglutination 
could be elucidated. 
Different latex brands and different adsorption buffers were investigated. Differences in the 
adsorption of immunoglobulins to different brands of latex were found. Differences in adsorption 
buffers and pH, however, were not found. With the information from the immunoglobulin saturation 
curve, parameters for the adsorption of immunoglobulins became known. From this information, 
other studies were attempted to try to resolve the problems with nonspecific agglutination. 
The effects of antibody purification resulted in no significant differences on the problem of 
nonspecific agglutination of the latex. The antibodies, despite the method of purification, continued 
to contribute to nonspecific agglutination. Commercial anti-glucuronidase was tried to further 
insure that the nonspecific agglutination was not a result of either the production or the methods of 
purification of the antibodies. Because earlier worl< with BSA adsorbed on latex displayed no 
nonspecific reactivity (Part 1), investigation into the effects of irrelevant immunoglobulins on latex 
was tried in attempts to understand the cause of nonspecific agglutination reactions. These studies 
revealed that, under the conditions of the assay, even unrelated immunoglobulins resulted in a 
degree of nonspecific agglutination. 
Continual manifestation of nonspecific agglutination is most likely a result of ionic 
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interactions among individual sensitized latex particles in the suspension. Latex particles are known 
to have native surface charges that make them interact and agglutinate (2, 13,14, 15, 25). 
Nonspecific agglutinations occurred when latex was sensitized with immunoglobulins but not BSA 
(Table 2). From the other studies presented (Tables 3 and 4), the phenomenon was not limited to 
Immunoglobulins made In-house, but also occurred when other Immunoglobulins were used to 
sensitize the latex. When less Immunoglobulin was used, nonspecific agglutination was reduced 
proportionally, but so was the sensitivity of the assay. 
Information on sensitization of latex contends that after a certain adsorption level, additional 
protein stabilizes latex flocculation (9,12, 19). The addition of protein normally neutralizes charge 
interactions and stabilizes the latex suspension (13, 16, 24). This obviously did not occur during 
the development of the present assays. After sensitizing latex with immunoglobulins, saturating 
quantities of irrelevant proteins (e.g. BSA) should have imparted stability on the latex suspensions. 
Because stabilization of the latex was not observed, further explanations for the nonspecific 
agglutination phenomena were sought, including the study of the assay conditions and the effects 
of blocking agents, and are presented In the next part. 
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TABLE 1. Effects of buffered sodium chloride on unsensitized latex 
Observation times 
NaCI in GBS" (g/L) 10 min 30 min 1 h 2 h 3h -18 h 
10 0'' ± 1 + 2+ 2+ 2 + 
5 0 0 0 ± 1 + 1 + 
2.5 0 0 0 0 0 ± 
1.25 0 0 0 0 0 0 
0.625 0 0 0 0 0 0 
0.313 0 0 0 0 0 0 
0.156 0 0 0 0 0 0 
0.078 0 0 0 0 0 0 
°GBS - glycine buffered saline. 
*^0 represents a negative or no change in condition, ± represents a visible but weat< 
reaction, 1 + represents partial fiocculation, 2+ represents complete fiocculation in that no 
iatex is left in suspension. 
TABLE 2. Effects of antibody purification on nonspecific agglutination 
Protein Appropriate enzyme"^ 1M 
Commercial enzyme preparations 
Latex Preparation coating (mg/ml) dHjO (mg/ml) 
(mg/ml) 0.1 0.01 0.001 KHjPO^ 0.1 GUD 0.1 GAD 0.1 Tryp 
Anti-glutamate 0.047^ + + 0 0 0 0 4- 4- 4- 4-
decarboxylase 0.047 + 4- + 4- + 0 0 0 0 4- 4- 4- 4-
affinity purified antibody 0.047 0 : 4- 4- 4- 4-4-4-
Anti-glutamate 0.141 + + + + + + 4- 4- 4- 4- + 4-4- 4-4-4- 4-4-4-
decarboxylase DEAE 0.094 + + + + + + 4- 4- 4- 4- 4- -t- 4-4-4- 4-4-4-
purified antibody 0.047 + + + + 0 0 ± 4- 4-4-4- 4- 4-
Anti-glutamate 0.0738 + + + + + 4- + 0 0 ± 4-4-4- 4-4-4-
decarboxylase protein A 0.0369 -H- -H + 4- + 0 ± 4-4-4-purified ± 0 4- 4-
O) 
Anti-glutamate 0.094 4- 4- 4-4-4- 4-4-4- 4-4-4-
decarboxylase gentle 0.047 4- 4- 4- 4- 4- 4-purification 4-
These results are from three separate batches of sensitized latex. The other results are from multiple coatings done during the same batch preparation. 
'^Key to reactions: 0 reaction contains no agglutinated particles; ± reaction appears negative macroscopically but has a degree of agglutinated particles on 
magnified examination; + reaction has a grainy appearance macroscopically on the basis of a few agglutinates formed; + + reaction has discernible 
agglutinated clumps on a field of individual or slightly agglutinated particles; + + + reaction has several agglutinated particles of a moderate size with a 
relatively clear background; + + + + reaction has one or more agglutinated particle clumps with no macroscopically free particles. 
•^Appropriate refers to using as an antigen the enzyme with the same anti-enzyme sensitized latex. 
"^GUD - glucuronidase; GAD - glutamate decarboxylase; Tryp - tryptophanase. 
TABLE 2. Continued 
i_atex Preparation 
Protein 
coating 
(mg/ml) 
Appropriate enzyme® 
(mg/ml) dHgO 
0.1 0.01 0.001 
1M 
KHjPO, 
Commercial enzyme preparations 
(mg/ml)": 
0.1 GUD 0.1 GAD 0.1 Tryp 
Anti-tryptophanase affinity 0.047® + + + + + 0 0 0 0 + + + + 
purified antibody 0.047 + + + 0 0 0 0 ± + + 
0.047 + + + + + 0 0 0 0 0 + 
0.141 + + + + + + + + + ± + + + + + + 
Anti-tryptophanase DEAE 0.094 + + + + + + + ± ± + + + + + + purified antibody 
0.047 ± 0 0 0 0 0 0 + 
Anti-tryptophanase protein 0.0738 + + + + + + 0 ± 0 ± + + + 
A purified 0.0369 + + + + + + 0 0 0 ± + 
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BSA coated blue dyed latex 0.047 0 0 0 0 0 0 0 0 
BSA coated red dyed latex 0.047 0 0 0 0 0 0 0 0 
TABLE 3. Degree of agglutination in the presence of glucuronidase wfien three brands of latex were each sensitized with three 
concentrations of four different anti-glucuronidase preparations 
Latex 
brand 
Antibody 
source® 
Protein 
coating • 
(mg/ml) 
Glucuronidase enzyme in GBS-BSA'^  buffer (/ig/ml) GBS-
BSA 
buffer 1000 500 250 125 62.5 31.3 15.6 7.81 3.91 1.95 0.98 0.49 0.24 0.12 0.06 0.03 
Seradyn Mol. 0.08 + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 0 
Probe 0.06 0 0 0 ± ± + + ± + + ± + + ± ± ± 0 
0.04 0 0 0 0 ± + + ± ± ± ± + ± ± ± 0 0 
5'3' 0.08 ± ± + ± ± ± ± ± ± ± ± ± ± ± + ± 0 
0.06 ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 0 
0.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
protein A 0.08 + ± ± + + + + + + + + + + + + + + + + ± ± ± 0 
0.06 0 0 0 + ± + + + + + + + + ± ± 0 0 0 0 
0.04 0 0 0 0 0 0 0 0 ± ± ± 0 0 0 0 0 0 
affinity 0.04 ± ± ± + + + + + + + + + ± ± ± ± 0 i 
0.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ' 
0.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
®Mol. Probe - Molecular Probes; 5'3r - 5Prime->3Prime; protein A - protein A purified antibodies; affinity - antigen-specific affinity chromatography purified 
antibodies. 
''Key to reactions: 0 reaction contains no agglutinated particles; ± reaction appears negative macroscopically but has a degree of agglutinated particles on 
magnified examination; + reaction has a grainy appearance macroscopically on the basis of a few agglutinates formed; + + reaction has discernible 
agglutinated clumps on a field of individual or slightly agglutinated particles; + + + reaction has several agglutinated particles of a moderate size with a 
relatively clear background; + + + + reaction has one or more agglutinated particle clumps with no macroscopically free particles. 
"^GBS-BSA - glycine buffered saline with bovine serum albumin. 
TABLE 3. Continued 
l_atex Antibodv Glucuronidase enzyme in GBS-BSA buffer (/xg/ml) GBS-
y coating BSA 
brand source (^ng/ml) ^000 500 250 125 62.5 31.3 15.6 7.81 3.91 1.95 0.98 0.49 0.24 0.12 0.06 0.03 buffer 
Bangs Mol. 0.08 + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
Probe 0.06 0 ± ± + + + + + + + + + + + + + + + + + + + ± ± 0 
0.04 0 0 0 0 ± ± ± + + + + + + + ± ± 0 
5'3' 0.08 + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
0.06 + + + + + + + + + + + + + + + + 0 
0.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
protein A 0.08 ± + + + + + + + + +  + +  +  + + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + + 
0.06 0 0 + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  ± 0 
0.04 0 0 0 0 0 0 0 + + +  +  +  ± ± 0 0 0 
affinity 0.04 0 0 0 ± +  +  +  +  +  +  +  +  +  +  +  +  ± ± ± 0 
0.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
O) 
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TABLE 4. General immunoglobulin induced nonspecific agglutination 
Immunoglobulins^ Protein coating (mg/ml) Lysis buffer" TPG buffer GBS-BSA 
Protein A Purified 1.0 0' 0 ± 
Anti-glucuronidase 0.1 0 0 0 
Molecular Probes 1.0 + + + + ND'^  
Anti-glucuronidase 0.1 + + + 0 ND 
Horse IgG 1.0 + + + + + + 
0.1 + + + 0 
Mouse IgG 1.0 + + + + + 
0.1 + + + 
Rabbit IgG 1.0 + + + + + + + 
0.1 + + + + + + 
®Horse, mouse, and rabbit IgG were commercial preparations of general immunoglobulins 
that were not related to detection of E. coll enzymes: they may or may not contain any anti-
enzyme activity. 
"Lysis buffer - a phosphate buffered saline system containing EDTA, lysozyme, sucrose, and 
Triton X-100: TPG - a phosphate saline buffer with gelatin; GBS-BSA - glycine buffered saline 
with bovine serum albumin. 
^Key to reactions: 0 reaction contains no agglutinated particles: ± reaction appears negative 
macroscopically but has a degree of agglutinated particles on magnified examination: + 
reaction has a grainy appearance macroscopically on the basis of a few agglutinates 
formed: + + reaction has discernible agglutinated clumps on a field of individual or slightly 
agglutinated particles: + + + reaction has several agglutinated particles of a moderate size 
with a relatively clear background: + + + + reaction has one or more agglutinated particle 
clumps with no macroscopically free particles. 
"^ND = not done 
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Figure 1. Comparison of protein binding by four brands of latex particles using antigen 
specific affinity cfiromatograpfiy purified anti-glucuronidase as the protein. 
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Figure 2. Points represent the average quantities of protein bound for each adsorption buffer 
used for antibody sensitization of four brands of latex with antigen specific affinity 
chromatography purified anti-giucuronidase. The experiments were represent the 
averages of twelve determinations per buffer. Maximum and minimum values are 
shown, as well as the average and ± 2 standard deviations (95% limits). 
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Figure 3. Relationsliip between quantity o f  protein used and quantity bound to latex. Data 
shown are the average values of a minimum of three determinations per point using 
protein A purified anti-glucuronidase as the protein. 
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PART 4. EFFECTS OF BUFFERS AND BLOCKING AGENTS ON SENSITIZED LATEX 
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INTRODUCTION 
Results from the initial work on the development of the latex agglutination tests revealed 
serious nonspecific agglutination reactions that limited the specificity of the assays. Investigation 
into adsorption of immunoglobulins revealed that, the latex particles adsorbed Immunoglobulins 
under a variety of conditions. The adsorbed immunoglobulins, however, significantly contributed to 
nonspecific agglutination under the conditions of assay performance. The causes of nonspecific 
agglutination, resulting from Immunoglobulin adsorption to latex particles, could be a result of either 
the ionic conditions of the assay system or incomplete blocking of the latex particles with irrelevant 
proteins. One recommended procedure for optlmizaton of a latex assay (47) Is adjustment of the 
assay buffer pH and ionic strength. 
Another area for examination concerns the blocking of reactive sites on the latex particles. 
A possible explanation for the cause(s) of nonspecific agglutination Is that blocking is incomplete 
and leaves open, unreacted sites on the latex available for charge-Induced reactions. Two causes 
for incomplete blocking of the remaining reactive sites could be proposed: either steric hindrance by 
complete saturation with immunoglobulins failed to allow the blocking agents to adsorb on the latex 
surface or blocking agents, such as BSA, failed to completely cover open areas on the latex surface. 
If the original hypothesis was correct, then less immunoglobulins on the latex should allow saturation 
of the latex with blocking protein without significant steric hinderance from the Immunoglobulins. 
Results previously presented (Part 2, Table 4), however, showed that this is not true. The latter 
hypothesis, that globular proteins failed to completely cover open areas, was suggested from reports 
from work on other solid-phase assay systems (10, 19, 45, 46). 
In attempts to optimize the latex agglutination assay and eliminate nonspecific reactions, 
many different procedures were tried. These are described In this introduction, but no data are 
presented because the results showed that all these methods were ineffective. They are mentioned 
here, however, to provide a basis for the experiments that are described in more detail in this part of 
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the dissertation. Washing latex in alcohol before adsorption of the antibodies was accomplished as 
suggested by Kakabakos et al. (27, 28) without any obvious difference in protein binding or 
agglutination assay results. Tween 20 (37, 47, 56), normal rabbit serum, and polyvinylpyrrolidone 
(24; molecular weight 40,000; Sigma, product number PVP-40) were tried as blocking agents for 
sites without adsorbed antibody. Results from using these agents in the assays did not warrant 
further work. Another detergent, GAFAC® RE-610 (Rhône-Poulenc, inc., Princeton, NJ) had been 
successfully used previously (13, 36), but it had no significant effects on assay performance in my 
tests. Protein A-coated latex (46) was used unsuccessfully to capture the anti-enzyme antibodies. 
Adsorption and covalent coupling of the antibody preparations to carboxyiate modified latex 
particles (3,12, 25, 47, 57) were also tried without the sought after reduction of nonspecific 
agglutination reactions. 
To continue investigations of the causes of nonspecific agglutination, the conditions for the 
performance of the latex tests were examined. In addition to those described in the previous 
paragraph, the effects of buffers and blocking agents to reduce or eliminate nonspecific 
agglutination were studied. The establishment of functional parameters for the latex agglutination 
assays were determined. 
175 
MATERIALS AND METHODS 
Common Procedures Used in this Project 
Stock Cultures and Media 
The bacterial cultures were obtained from either Dr. Paul A. Hartman or from the Department 
of Microbiology, Immunology, and Preventive Medicine stock culture collection, Iowa State 
University, Ames, lA. The cultures were grown on tryptlcase soy agar and identities were confirmed 
by using API-20E kits (bloMérieux, Hazelwood, MO, product number 886-010258). 
All media were products of Difco Laboratories (Detroit, Ml), unless otherwise noted. Enzyme 
induction broth (EIB) was made according to the formulation of Kaspar (29), as follows: 3.56 g lauryl 
tryptose broth (Difco); 0.015 g 4-methylumbelliferyl-B-D-glucuronide (MUG; Hach Company, Ames, 
I A, product number 21844-21); 0.05 g L-glutamic acid (Oxoid Limited, Basingstoke, Hampshire, 
England, product code L124); 100 ml distilled water; pH 6.8-7.0. 
Cell lysis 
To obtain immunologically reactive enzymes from the cultures, the method of Kaspar et al. 
(30) was used. First, cells were sedimented from 0.5 ml of a 24-h culture grown in EIB by 
centrifugation in a microcentrifuge (Fisons, England, model Microcentaur) for 5 min at approximately 
11,300 X g. The supernate was removed and the cell pellet was suspended to the original volume 
in lysis buffer (25 ml of 0.2 M NagHPO^, 25 ml of 0.2 M NaHgPO^, 8 g of sucrose, 0.93 g of EDTA, 
50 fÂ of Triton X-100, total volume to 50 ml with dHjO, pH 7.0). RNAse solution (0.5 ml; 20 mg/ml 
bovine pancreas ribonuclease A, 0.5 /d/ml Tween 20, and 30 mg/ml BSA in 0.01 M phosphate 
buffered saline [0.01 M NaHgPO^-HgO, 0.155 M NaCI], pH 7.0) and 15 /d of lysozyme solution (10 
mg/ml iysozyme in phosphate buffered saline [0.01 M NaHgPO^-HgO, 0.155 M NaCI], pH 7.0) were 
added. The pellet was suspended by mixing on a vortex mixer and incubated for 20 to 30 min at 
37°C. Cellular debris was pelleted by centrifugation and the supernatant was used for the test 
material. 
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Sensitization of Latex to Determine the Effects of 
Assay Conditions on Nonspecific Agglutination 
Sensitization of anti-glucumnidase latex for testing the effects of different a^ay buffers on 
nonspecific agglutination 
In three separate experiments, 0.5 ml of 1% sensitized latex was prepared. A sample of 
0.8-/xm diameter yellow dyed polystyrene latex (Bangs Laboratories, Indianapolis IN) was cleaned by 
centrifugation washing. The latex was sensitized by using antibody concentrations of 6, 3,2,1, and 
0.5 mg/ml in Tris/azide buffer (0.03 M Tris, 0.05% sodium azide, pH 7.4). One milliliter of protein A 
purified anti-glucuronidase antibody preparation was added to an appropriately labeled 2.0-ml 
centrifuge tube. Ten milligrams of washed latex were then added, the volume increased to 1.5 ml 
total volume with buffer, and the tubes mixed by inversion several times. The latex/antibody 
suspensions were incubated at 37°C overnight on a platform rocker (Thermolyne Speci-Mix, model 
M26125), pelleted by centrifugation, washed once with Tris/azide buffer and suspended to a volume 
of 0.5 ml with Tris/azide buffer. Latex-bound proteins were determined on a sample of the latex 
suspension (see Latex Bound Protein Determinations). One milliliter of 1 mg/ml bovine serum 
albumin in buffer was added to block unreacted sites on the latex and the latex suspensions were 
incubated at room temperature (approximately 27°C) overnight on a platform rocker. After the 
second incubation, the latex suspensions were again pelleted by centrifugation, washed twice in 
buffer, and suspended to a volume of 0.5 ml (1% [w/v] latex) with buffer containing 1 mg/ml BSA 
and 0.1% thimerosal. The sensitized latex was stored at 4°C. 
Buffers of several compositions and ionic strengths were then used as assay buffers. These 
buffers included TPG buffer (7.8 g/L NaH2P0 '^2H20, 1 g/L NaCI, 2 g/L gelatin, pH 6.6), glycine 
buffered saline (7.3 g/L glycine, 10 g/L NaCI, pH 8.2), Med calf's buffer (21 g/L borate, 22.37 g/L 
KCI, 1% BSA, 33.8 g/L polyethylene glycol, pH 8.0) and Tris/azide-BSA (0.03 M Tris, pH 7.4, with 
0.1% BSA and 0.05% sodium azide). The ionic strength of each buffer was adjusted by the addition 
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of NaCI if necessary, according to the formula: 
In which c = concentration and Z = valence. TPG buffer with ionic strengths of 0.4, 0.5, 0.6, 0.7, 
0.8,1.0,1.25,1.5,1.75, and 2.0, Medcalf's buffer with ionic strengths of 0.175, 0.35, 0.7, and 1.4, 
GBS with ionic strengths of 0.57 and 0.7 and Tris/azlde buffer with an ionic strength of 0.045 were 
used to wash and suspend a sample of latex. Portions of the sensitized latex preparations were 
washed in the assay buffer before being resuspended to 1% (w/v). The latex was then used to 
conduct agglutination assays with some of the following samples; cell lysates from £. coli B, £ coli 
K12, E. coli 222, £ coli 329, Enterobacter agglomerans, glucuronidase enzymes at 0.1 and 
0.01 mg/ml, lysis buffer, and lysis buffer without lysozyme. 
Sensitization of anti-giucumnidase latex for testing the ^ ects of saline on nonspecific agglutination 
Antibody preparations containing 0.04, 0.05, 0.06, and 0.07 mg/ml were prepared from four 
different anti-glucuronidases: antigen-specific affinity chromatography purified, protein A purified. 
Molecular Probes (Molecular Probes, Inc., Eugene, OR, product number A-5790), and 5'3' 
(5Prime~ 3Prime Inc., Boulder, CO, product number 5307-246468). Protein estimates were made by 
using Aggo values and an extinction coefficient of 1.4 (8, 22). Ten milligrams of 0.81-/xm diameter 
washed yellow dyed polystyrene latex (Bangs Laboratories) were added to 1.75 ml of each antibody 
preparation (total volume 2 ml) and mixed by inversion. The latex suspensions were incubated for 
1 h at 37°C with intermittent mixing by inversion followed by 1 h stationary. Tris/azide buffer 
(0.25 ml) with 4 mg/ml BSA was added and allowed to incubate with the latex suspension 
stationary, overnight at 4°C. The next day, the latex was sedimented by centrifugation until a latex 
pellet formed and the supernate was clear, using a Sorval model RT6000B centrifuge at 3400 RPM 
(2410 X g) and 10°C (Sorval Instruments, DuPont Co., Newton CT). All but 0.5 ml of the supernate 
was removed and the latex pellet was resuspended in the remaining supernate. Portions of the 
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sensitized latex suspensions (200 /il) were transferred to 2.0-ml microcentrifuge tubes and the 
volumes increased to approximately 1 ml with filtered buffer solution. Buffers used consisted of 
Tris/azide, borate (0.34 M boric acid, pH 8.0, with 0.1% BSA and 0.05% sodium azide), glycine 
buffered saline (7.3 g/L glycine, 10 g/L NaCI, pH8.2), and phosphate buffered saline (0.01 M 
NaHgPO^eHgO, 0.155 M NaCI, pH 6.6). The sensitized latex suspensions were washed three times 
by centrifugation washing in the appropriate buffer before use. The samples for testing consisted of 
0.43, 0.26, 0.17, 0.09, 0.04, and 0.02 M NaCI solutions without the presence of antigens (see 
"Performance of Agglutination Assays" previously described). 
Sensitization of anti-glutamate decaitaxylase latex for testing ttie ^ ects of 
saline on nonspecific agglutination 
Protein A purified anti-glutamate decarboxylase antibodies at concentrations of 0.1, 0.08, 
0.06, and 0.04 mg/ml were prepared in 12 x 75 mm test tubes in Tris/azide buffer (0.03 M Tris, 
pH 7.4, 0.1% BSA, 0.05% sodium azide). Ten milligrams of washed 0.8-/im diameter blue dyed 
polystyrene (Bangs Laboratories) was added to 1.75 ml of each antibody preparation (total volume 
2 ml) and mixed by inversion. The latex suspensions were incubated for 1 h at 37°C with 
intermittent mixing by inversion followed by 1 h stationary. Tris/azide buffer (0.25 ml) with 4 mg/ml 
BSA was added and allowed to incubate, with the latex suspension stationary, overnight at 4°C. The 
latex suspension was washed three times before the latex was suspended in assay buffer at 1% 
(w/v). Four different types of assay buffers were used; glycine buffer (0.03 M, pH 8.2, with 0.1% 
BSA and 0.05% sodium azide), phosphate buffer saline (0.1 M NaH^PO^-HgO, 0.155 M NaCI, pH 6.6, 
with 0.1% BSA and 0.05% sodium azide), borate buffer (0.34 M boric acid, pH 8.0, with 0.1% BSA 
and 0.05% sodium azide), and Tris buffer (0.03 M, pH 7.4, with 0.1% BSA). The sensitized latex 
suspensions were washed three times by centrifugation washing in the appropriate buffer before use. 
The samples for testing consisted of 0.43, 0.26, 0.17, 0.09, 0.04, and 0.02 M NaCI solutions without 
the presence of antigens (see "Performance of Agglutination Assays' previously described). 
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Preparation of Anti-glutamate Decarboxyiase l^tex witli Muitiple Bloclcing Agents 
Antigen-specific affinity chromatography purified anti-giutamate decarboxylase was adjusted 
to 0.5 and 2.25 mg/ml protein concentration using A^g^ values and an extinction coefficient of 1.4 (8, 
22). In addition, two preparations of antigen-specific affinity chromatography purified antl-glutamate 
decarboxylase was prepared containing B-casein (Sigma product number C-6905; 11, 26). The first 
preparation consisted of 0.5 mg/ml antibody and 0.02 mg/ml B-caseln. The second preparation 
consisted of 2.25 mg/ml antibody and 0.075 mg/ml B-casein. Two milliliters of anti-giutamate 
decarboxylase were added to six 12 x 75 mm test tubes. Two milliliters of anti-giutamate 
decarboxyiase-casein were added to two 12 x 75 mm test tubes. The tubes were prewarmed to 
37*0 and ten milligrams of either 0.8 /xm or 0.2 /im diameter dialysis cleaned blue dyed latex (Bangs 
Laboratories) were added to each tube. The tubes were covered with Parafilm (American National 
Can, Greenwich, CT), mixed by inversion several times, and incubated at 3TC for 2.5 h; they were 
mixed by inversion approximately every 15 min for the first hour. 
The six anti-giutamate decarboxylase sensitized latex preparations were sedimented by 
centrifugation, until a latex pellet formed and the supernate was cleared, using a Sorval model 
RT6000B centrifuge at 3400 RPM (2410 x g) and 10°C (Sorval Instruments, DuPont Co., Newton 
CT). The times of centrifugation varied from a few minutes, when using 0.8-/im diameter latex, to 
over three h, when using 0.2-/im diameter latex. Tris/azide buffer (1.25 mis) containing either 
B-casein (0.5% w/v) and thimerosal ([sodium ethylmercurithiosalicylate] 0.2% w/v; 31), B-casein 
(0.33 mg) and BSA (0.165 mg), or B-casein (5 mg/ml) and glycerol (5%; Fisher Scientific, product 
number G33-500) were used as blocking agents for the three anti-giutamate decarboxylase 
sensitized latex preparations. The anti-giutamate decarboxyiase-casein sensitized latex preparation 
had no additional blocking agents added. The suspensions were incubated overnight at 
approximately 4°C. 
All the sensitized latex preparations were sedimented by centrifugation, until a latex pellet 
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formed and the supernate was cleared, using a Sorvai model RT6000B centrifuge at 3400 RPM (2410 
X g) and 10°C (Sorvai Instruments). The latexes were then washed twice In buffer (0.03 M Tris, 5 
mg/ml BSA, 5% glycerol, 0.016 mg/ml B-casein, 0.05% sodium azide, pH 8.2) before suspending to 
1% (w/v) In the wash buffer. The latex suspensions were then tested against several sources of 
antigens and controls using the slide agglutination procedure discussed previously. 
Preparation of Sensitized Latex to Determine the Effects of 
Sodium Salicylate on Nonspecific Agglutination 
Antigen-specific affinity chromatography purified decarboxylase and anti-tryptophanase were 
adjusted to approximately 6 mg/mi protein concentration using Ajgo values and an extinction 
coefficient of 1.4 (8, 22). Two milliliters of 6, 3, 1.5 and 0.5 mg/ml antibody preparation were added 
to 12 X 75 mm test tubes. The tubes were prewarmed to 3TC and twenty milligrams of 0.2 /zm 
diameter dialysis cleaned dyed latex (Bangs Laboratories) were added to each tube. The test tubes 
were covered with Parafilm (American National Can, Greenwich, CT) and mixed by inversion several 
times. The latex suspensions were incubated at 3TC for 2 h; they were mixed by inversion 
approximately every 15 min for the first hour. 
A sample of each latex suspension (0.055 mi) was removed to determine latex-bound 
protein as previously described. The sensitized latex preparations were sedimented by 
centrifugation, until a latex pellet formed and the supernate was cleared, using a Sorvai model 
RT6000B centrifuge at 3400 RPIVI (2410 x g) and lO'C (Sorvai Instruments, DuPont Co., Newton 
CT). Tris/azide buffer (0.5 ml) containing 10 mg/ml B-casein and glycerol (5%; Fisher Scientific, 
product number G33-500) were used as blocking agents. The suspensions were incubated 
overnight at approximately 4°C. 
Sensitized latex preparations were sedimented by centrifugation, until a latex pellet formed 
and the supernate was cleared, using a Sorvai model RT6000B centrifuge at 3400 RPM (2410 x g) 
and 10°C (Sorvai Instruments). The latexes were then washed twice in buffer (0.03 M Tris, 5 mg/mi 
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BSA, 5% glycerol, 0.016 mg/ml casein, 0.05% sodium azide, pH 8.2) before suspending to 1% (w/v) 
in fresh buffer. The latex suspensions were then tested against several ceil lysates using the slide 
agglutination procedure discussed previously. 
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RESULTS AND DISCUSSION 
Effects of Assay Conditions on Nonspecific Agglutination 
Non )^ecific agglutination of anti-glucuronidase latex in different assay buffers 
Results from the sensitization of latex (Part 2) suggested that immunoglobulin sensitized 
latex undergoes nonspecific agglutination reactions. The cause of nonspecific agglutination could 
be a result of the conditions under which the sensitized latex is tested. To investigate the effects of 
the assay conditions on nonspecific agglutination of sensitized latex, different assay buffers, with 
different saline concentrations, were tried. 
Table 1 presents the effects of ionic strength on the agglutination reaction. When latex, 
sensitized with antibody preparations that covered the entire protein saturation curve (Part 1), was 
suspended in buffers of different ionic strengths, the agglutination reaction changed, depending on 
the electrolyte conditions. In general, the higher the ionic strength of the buffer, the greater the 
effect on the latex that had been sensitized with large amounts of antibody (3 and 6 mg/ml). The 
latex preparations that had the larger amounts of antibody tended to become less reactive and not 
display nonspecific agglutination. This is in direct contrast to the flocculation detected with 
unsensitized latex (Part 2). 
Sensitized latex in glycine buffered saline (a commonly used buffer for latex agglutination 
assays: 4, 5, 6, 9, 11, 34, 48, 51), exhibited nonspecific agglutination with all the samples without any 
significant differences resulting from the variation in ionic strengths. TPG is a phosphate buffer with 
gelatin described by Bangs (company monograph) for use in latex agglutination tests. When TPG 
was used as the assay buffer, the ionic strength influenced the nonspecific agglutination of the 
reaction more than with the other two buffers in this set of experiments. As the ionic strength of the 
buffer was increased, both nonspecific and specific agglutinations were neutralized on the latex 
sensitized with the greater immunoglobulin concentrations. Medcalf et al. (13, 36, 52) described a 
borate buffer that was used successfully in several studies. This buffer yielded results similar to 
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those obtained with glycine buffered saline. The overall conclusion derived from the results 
presented in Table 1, however, was that with these three buffers, changes in the ionic strength did 
little to eliminate nonspecific agglutination reactions. 
Singer and Plotz (49) reported that sodium chloride, near normality (0.31 to 1.25%), was 
necessary for optimal agglutination reactions. Kondo et al. (33), Price et al. (43), Medcalf et al. (36), 
and Dezelié et al. (15) ail stated that the ionic strength of the reaction buffer effected agglutination 
reactions. Whereas all the buffers had at least normal saline concentrations, buffers with different 
ionic strengths (on the basis of saline concentration) were used to discern if nonspecific 
agglutination could be eliminated. It was reasoned that if the nonspecific agglutination was related 
to the ionic influences of the buffers, changes in the buffer ionic strengths might affect nonspecific 
agglutination. In these tests, buffers with greater ionic strengths did not sufficiently eliminate 
nonspecific agglutination but did affect the overall strength of the agglutination reactions in the 
assays. 
Nmtspecific agglutination of anti-glucuronidase latex in saline 
Because the effect of different buffers and saline concentrations did not eliminate nonspecific 
agglutination reactions, the effects of saline on sensitized latex without antigens were examined. 
There was essentially no difference in nonspecific agglutination on the basis of antibody 
purification or source (Table 2). Within each buffer, ail four sources of antibody preparations reacted 
similarly with respect to nonspecific agglutination reactions. Glycine and borate buffers exhibited the 
least amount of nonspecific agglutination reactions. Tris/azide buffer yielded nonspecific 
agglutination reactions consistent with increasing sodium chloride and sensitizing protein 
concentrations. Phosphate buffer, with varying concentrations of sodium chloride, induced 
nonspecific agglutination in all the latex preparations. 
In general, nonspecific agglutination reactions were more evident as the pH of the buffer 
solutions decreased (Table 2). This is consistent with the recommendation (47) that the pH during 
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latex agglutination should not be at or near the isoelectric point of the antibody (rabbit IgG has an 
isoelectric pH of approximately 7.8: 40). In the studies presented here, however, those buffers with 
a pH below 7.8 were the most prone to induction of nonspecific agglutination reactions. 
Results of tests with the latex suspended in the glycine buffer against cell lysates from three 
organisms (£ coli B, E. coll 222, and Enterobacter sp.), were not acceptable (data not shown). In 
general, the reactivity with cell lysates was weak and not specific. The weak results might be 
attributed to the low concentration of immunoglobulins adsorbed to the latex particles. 
Nonspecific agglutination of anti-glutamate decartxixylase latex in saline 
These experiments were conducted to confirm that the results Just described on the effects 
of saline on latex sensitized with anti-glucuronidase were similar when a different antibody 
preparation was used. In this analysis, the effects of buffer pH and immunoglobulin concentration 
used for adsorption also were evaluated. 
Nonspecific agglutination reactions in these assays continued to be related to the pH of the 
assay buffer (Table 3). When glycine buffer was used, nonspecific agglutination increased when 
either ionic strength or immunoglobulin concentration on the latex particles were increased. The 
results of nonspecific agglutination using borate buffer were similar to the results obtained with anti-
glucuronidase preparations; nonspecific agglutination reactions were reduced in both severity and 
frequency. The Tris buffer at pH at 6.0, however, was generally less prone to nonspecific 
agglutination reactions than the Tris/azide buffer at pH 7.2 used in the previous anti-glucuronidase 
preparations. Phosphate buffer at pH 6.6 induced strong nonspecific agglutination reactions similar 
to those obtained in the previous anti-glucuronidase experiments. When the pH of the phosphate 
buffer was raised to 8.1, however, nonspecific agglutination reactions were eliminated (Table 3). 
Whereas the pH of the assay conditions appeared to affect nonspecific agglutination, simple 
procedures, such as buffer composition or salt content, did not appreciably eliminate nonspecific 
agglutinations. Applying a change of buffer pH to the actual cell lysis conditions for reduction of 
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nonspecific agglutination was difficult. The cell lysis procedure developed by Kaspar et al. (30) 
imparted another set of parameters affecting nonspecific agglutination reactions for which neither pH 
nor buffer composition alone could compensate (see Lysis Buffer discussed later in this part). 
The results of the effects of different buffer compositions and pHs applied to cell lysates also 
was consistent with the results from the previous anti-glucuronidase latex results (data not shown). 
Cell lysates continued to have nonspecific agglutination reactions in the glycine assay buffer being 
used. Insufficient latex remained to test the effects of the Tris or phosphate (pH 8.1) assay buffers 
with the cell lysates, but it would be expected that the nonspecific reactions also would be present 
in those assays. It had become evident that the assay buffers alone would not eliminate the 
nonspecific agglutination reactions and that other areas were more in need of further research. 
Anti-glutamate decarboxylase sensitized latex with multiple biccidng agents 
Results from sensitization of latex with immunoglobulins and from testing the sensitized latex 
revealed that sensitized latex was prone to nonspecific agglutination and that changes in the assay 
conditions alone would not eliminate the nonspecific agglutination. Introductory work on the 
development of these latex agglutination assays included some investigation of the effects of 
blocl<ing agents on nonspecific agglutination. Although the early work did not reveal any useful 
findings on the effects of the blocking agents, the choice of blocking agents kept recurring as a 
potential method to eliminate nonspecific agglutination. In addition, the effects of using smaller 
diameter particles that had less total surface area also were examined. 
The effects of using different blocking agents on 0.8- and 0.22-/Ltm diameter latex particles 
were evaluated over the course of several experiments. Casein coadsorbed with the antibody, a 
casein-thimerosal buffer, a casein-BSA buffer, and casein and glycerol as blocking agents, with a 
range of antibody concentrations, were all tried as methods to overcome nonspecific agglutination. 
Preliminary results with both commercial enzymes (data not shown) and cell lysates (Table 4) 
suggested that nonspecific agglutination could be significantly reduced with casein as a blocking 
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agent. The combination of B-casein and glycerol or BSA, used with the smaller 0.2-/xm diameter 
latex particles, appeared to give good results with minimal nonspecific agglutination. 
Kenna et al. (31) reported that casein with thimerosal was a better agent for blocking 
nonspecific reactions than Tween 20. In addition, Vogt et ai. (55) tested nine different proteins for 
their abilities to block nonspecific binding in a microtitration-plate EIA assay and concluded that 
casein and dry skim milk were the most effective proteins. Although Kenna et al. (31) and Vogt et al. 
(55) reported that casein was a better blocking agent than BSA, others (44) have reached the 
opposite conclusion. Hechemy et al. (23) also observed that nonspecific agglutination, in their latex 
agglutination assay for £ coli antigens, was eliminated by using fatty acid-free BSA. In addition, 
detergents, such as Tween 20 and Triton X-100, are often used to reduce nonspecific agglutination 
(18, 31, 37, 47, 56). Neither the use Tween 20 during latex preparation (data not shown) nor the 
presence of Triton X-100 or Tween 20 in the lysis buffers, however, appeared to reduce nonspecific 
agglutination in the present study. 
The use of the smaller 0.2-nm diameter latex particles and the B-casein and glycerol 
blocking agents were used to develop the other anti-enzyme agglutination assays. Overall, the other 
anti-enzyme latex agglutination tests yielded similar results. Although sporadic nonspecific 
agglutination still occurred, the assays were generally able to distinguish the appropriate reactions 
from cell lysates of control organisms. Further investigations using these approaches were made. 
Determination of the Effects of Sodium Salicylate on Nonspecific Agglutination 
Because of the continued sporadic presence of nonspecific agglutination with the 0.2-/:m 
diameter latex particles and the B-casein and glycerol blocking agents, sodium salicylate was 
evaluated for use in the assay. It was recommended in a discussion with Dr. Bruce Shull (Seradyn, 
Indianapolis IN; personal communication) that sodium salicylate be tried, although none of the 
literature reviewed had mentioned the used of sodium salicylate in latex agglutination tests. The 
action of sodium salicylate on nonspecific agglutination is not known, but it has been used as a 
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protein blocking agent in other immunoassays (1, 21, 42). Although chaotropic agents (14, 47, 50) 
had been investigated earlier (data not shown), their use had not been encouraging. It had been 
found that low concentrations of agents did not reduce nonspecific agglutination reactions and that 
greater concentrations of the agents reduced or eliminated the desired agglutination reaction. 
Sodium salicylate had not been included in the early work on chaotropic agents. Because of the 
difference in mode of action, it was tested to determine if it would reduce nonspecific agglutination 
reactions. 
The effects of sodium salicylate on nonspecific agglutination reactions were varied (Table 5). 
Anti-tryptophanase latex responded well to the presence of sodium salicylate at 100 mM and 
nonspecific agglutinations were significantly reduced. The specific agglutination reactions, however, 
also were retarded, but a distinction between positive verses negative reactions was possible. With 
anti-glutamate decarboxylase latex, however, the effects of 100 mM sodium salicylate were not as 
pronounced; the anti-glutamate decarboxylase latex showed a general decrease in both specific and 
nonspecific agglutination reactions. Although a lysis buffer control was not included, the nonspecific 
agglutination reactions of lysis buffer without cellular material would not be expected to exceed the 
results observed with the cell lysate from the Proteus sp.; there was only minimal growth of Proteus 
in the enzyme induction broth. 
The results demonstrated that sodium salicylate could be added to the latex agglutination 
reactions to control nonspecific agglutination reactions without eliminating the specific agglutination 
reactions. When combined with the smaller latex and the casein-glycerol blocking agents, it 
appeared that a suitable latex agglutination assay was near at hand. 
Lysis buffers 
Because some latexes were produced that appeared to work when commercial enzymes in 
buffers were used, but had nonspecific agglutination reactions when cell lysates were used, the lysis 
buffer was considered a part of the problem. Several other lysis procedures were tried to determine 
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if tfiey would reduce nonspecific agglutination reactions with the sensitized latex reagents. Takei et 
al. (51) also detected nonspecific agglutination in the absence of antigen when they used 
chromatographically purified IgG fractions of polyclonal rabbit antibodies. To eliminate nonspecific 
agglutination, they studied fifteen antigen extraction reagents. Although none of the lysis procedures 
of Takei et al. (51) were tested (this work preceeded publication of their research), a number of other 
lysis procedures were examined with the goal of eliminating nonspecific agglutination. 
To study the effects of lysis buffers on nonspecific agglutination reactions, the buffering 
agents in the lysis buffer were changed from those used by Kaspar (29). Lysis systems with the 
buffering agents changed to HEPES, glycine, or borate were tried; other components of the lysis 
buffer (lysozyme, EDTA, etc.) were not changed. None of the different buffering agents significantly 
affected nonspecific agglutination reactions (data not shown). 
Other cell lysis procedures were also tested. A polymyxin B ceil lysis buffer, previously used 
in a latex agglutination assay (20), was evaluated. In addition, a cell lysis procedure that uses 
dithiothreitol (35), and a second lysozyme method using Tris/EDTA/NaCI buffer and sodium dodecyl 
sulfate (2), also were examined. No significant improvement in reduction of nonspecific 
agglutination reactions was noted with any of the cell lysis procedures (data not shown). 
To obtain maximum immunologically reactive enzymes from bacterial cells, Kaspar (29) also 
tried several different extraction protocols and concluded that his lysozyme method was the most 
suitable. It has been established, however, that lysozyme will bind immunoglobulins and cause 
cross-linking (17, 39). Although lysozyme in the lysis buffer did have some affect on the general 
strength of the agglutination reaction (Table 1), lysozyme was not itself responsible for nonspecific 
agglutination reactions in this study. 
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SUMMARY AND CONCLUSIONS 
Attempts to eliminate nonspecific agglutination through adjustment of the assay conditions 
were only partially successful. Although the effects of saline and pH on the latex assays provided 
some very useful Information, they were not able to reduce nonspecific agglutination reactions to a 
level that made the assay sensitive and specific. Acceptable reduction of the nonspecific 
agglutination reactions was achieved with 0.2-/im diameter latex particles and the B-casein and 
glycerol blocking agents. Whereas casein has been used as an effective blocking agent in other 
immunoassays, this is the first known use of casein to block a latex agglutination assay. (Dr. Bruce 
Shull [Seradyn, Indianapolis IN; personal communication] did not recommend use of casein for 
blocking). The effectiveness of fi-casein and glycerol as blocking agents support the hypothesis that 
BSA was not effectively blocking reactive sites on the latex, leaving exposed latex open for reactions 
with the immunoglobulins. 
Another way that reactive sites might become available on the latex would be from the 
desorption of proteins from the latex surface. Desorption of passively bound protein has been 
reported a cause of problems in EIA (41, 54) and latex agglutination assays (7). Up to 68% of 
protein adsorbed to latex can later desorb (53), leaving reactive spaces on the solid-phase that can 
contribute to nonspecific agglutination. To try to compensate for the effects of desorption, inert 
protein (e.g. BSA) was used in both the assay and the lysis buffer. Any protein that desorbed during 
the performance of the assay would be readily replaced with protein that was present in excess in 
the assay and lysis solutions. 
Although some nonspecific agglutination reactions were still occuring, the latex assays were 
thought suitable for more extensive evaluation. A more complete evaluation of the sensitivities and 
specificities of the latex reagents was deemed necessary. From the extensive evaluation of the latex 
reagents, further work might be planned. 
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TABLE 1. Agglutination reactions with cell lysates, glucuronidase, and lysis buffers when three assay buffers of various ionic strengths 
were used with latex coated at six concentrations with protein A purified anti-glucuronidase 
Buffer Ionic 
strength 
Protein 
coating 
(mg/ml) 
Cell lysates" Glucuronidase (mg/ml) Lysis Lysis buffer 
w/o 
lysozyme E. coli B r 1/4 o E. coli #222 Enterobacter 
and #329 sp. 0.1 0.01 
buffer 
Glycine 0.57 6 + + + + + + + 
buffered 3 + + + + + + + + + 
saline 1.5 + + + + + + + + 
0.75 + + + + + + + + 
0.38 + + + + + + + + + + + + + 
0.18 + + + + + + + + + + + + + 
0.7 
0.8 
6 + ± ± + + + + + + ± ± 
3 + + + + + + + + + + + + + 
1.5 + + + + + + + + + + + + + + + + + 
0.75 + + + + + + + + + + + + + + + + + + + 
0.38 + + + + + + + + + + + + + + + + + + + + + 
0.18 + + + + + + + + + + + + + + + + + + 
6 + + + + + + + + + + + 
3 + + + + + + + + + + + 
1.5 + + + + + + + + + + + + + + + + 
0.75 + + + + + + + + + + + + 
0.38 + + + + + + + + + + + + + + + 
0.18 + + + + + + + + + + 
(O 
oi 
®Key to reactions: 0 reaction contains no agglutinated particles; ± reaction appears negative macroscopically but has 
some agglutinated particles on magnified examination; + reaction has a grainy appearance macroscopically on the 
basis of a few agglutinates formed; + + reaction has discernible agglutinated clumps on a field of individual or slightly 
agglutinated particles; + + + reaction has several agglutinated particles of a moderate size with a relatively clear 
background; + + + + reaction has one or more agglutinated particle clumps with no macroscopically free particles. 
''Numbers and letters refer to strain used (for reference only). 
TABLE 1. (continued) 
Buffer 
TPG 
Ionic Protein 
coating 
(mg/ml) 
Cell lysates Glucuronidase (mg/mi) Lysis 
strength E. coli B 
^an?#Sf Enterobacter sp. 0.1 0.01 buffer 
0.4 6 + + + + 4-4-4- 4-
3 + + + + + + + + 4-4-4- 4-4-
1.5 + + + + + + + + 4-4-4- 4- 4-
0.75 + + + + + + + + + 4-4-4- 4-4-
0.38 + + + + + + + + 4-4-4- 4- 4-
0.18 + + + + + 4-4-4- 4-4-4- 4- 4-
Lysis buffer 
w/o 
lysozyme 
0.5 + + 
+ + 
+ + + 
6 
3 
1.5 
0.75 + + 
0.38 + + 
0.18 + + 
+ 
+ 
+ + 
+ + 
+ + 
+ + 
+ + + 
+ + + 
+ + 
+ + 
+ + 
+ + + 
+ + + 
+ + + 
+ + + 
+ 
+ 
+ 
+ + 
+ + 
+ + 
CO 0> 
0.6 ± 
+ + 
+ + + 
+ + + 
+ + + 
+ 
+ 
+ + + 
+ + + 
+ 
+ + 
0 
+ 
+ + + 
+ + + 
+ + 
+ 
0 
+ 
+ + 
+ + 
+ 
+ 
6 4- 4- + ± 4-4-4- 4-4-4-4- 0 ± 
3 4- ± ± 4- 4- 4- 4- ± ± 
1.5 4-4-4- 4- + 4- 4-4-4- 4-4-4- 4- 4- 4- 4-
0.75 4-4-4- 4-4-4- 4- 4- 4-4-4- 4-4-4- 4- 4-
0.38 4-4-4- 4-4-4- 4-4-4- 4-4-4- 4- 4-4-4- 4-4-4-
0.18 4-4-4- 4- 4- 4-4-4- 4-4-4- 4- 4- 4-
TABLE 1. (continued) 
Buffer Ionic 
Protein 
coating 
(mg/ml) 
Cell lysates Glucuronidase (mg/ml) Lysis 
strengtfi E. coli B Enterobacter 
sp. 0.1 0.01 
buffer 
0.8 6 0 0 0 + + + 0 
3 + + + + + + + + ± 
1.5 + + + + + + + + + 
0.75 + + + + + + + + + + + + 
0.38 + + + + + + + + + + + + 
0.18 + + + + + + + + + + + + 
1.0 6 0 0 0 + + + 0 
3 + ± ± + + + + + 0 
1.5 + + + + + + + + + + 
0.75 + + + + + + + + + + + + + + + + 
0.38 + + + + + + + + + + + + 
0.18 + + + + + + + + + + + + + + + + + 
1.5 6 0 0 0 ± ± 0 
3 0 0 0 ± + 0 
1.5 0 0 0 + + + 0 
0.75 + + + + + + + 
0.38 + + + + + + + + + + + + 
0.18 + + + + + + + + + + + 
2.0 6 0 0 0 ± + + 0 
3 0 0 0 + + + 0 
1.5 ± ± + + + + + + ± 
0.75 + ± + + + + ± 
0.38 + + + + + + + + + + + + 
0.18 + + + ± + + + 
Lysis buffer 
w/o 
lysozyme 
TPG 
Î3 
TABLE 1. (continued) 
Ionic Protein coating 
(mg/ml) 
Cell lysates Glucuronidase (mg/ml) Lysis Lysis buffer 
w/o 
lysozyme strength E. coli B Enterobacter 
sp. 0.1 0.01 
buffer 
0.18 6 + + + + + + + + + + + 
3 + + + + + + + + + + + + + 
1.5 + + + + + + + + + + + 
0.75 + + + + + + 
0.38 + + + + + + 
0.18 + + + + + + 
0.35 6 + + + + + + + + + 
3 + + + + + + + + + + 
1.5 + + + + + + + + + + 
0.75 + + + + + + + + + 
0.38 + + + + + + + + + 1
98 
0.18 + + + + + + + + + 
19
8 
0.7 6 + + + + + + + + + + + + 
3 + + + + + + + + + + + + 
1.5 + + + + + + + + + + + + + + + + 
0.75 + + + + + + + + + + + + + + + + + 
0.38 + + + + + + + + + + + + + + + + + + 
0.18 + + + + + + + + + + + + + + + + + + 
1.4 6 + + + + + + + + + + + 
3 + + + + + + + 
1.5 + + + + + + 
0.75 + + + + + + 
0.38 + + + + + + + + 
0.18 + + + + + + + + 
Buffer 
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TABLE 2. Effects of buffer types and saline concentrations on 
nonspecific agglutination of latex sensitized with four levels of each of 
four different antl-glucuronidase antibody preparations 
Saline Molecular Probes 
Buffer Concentration (mg/ml protein applied) 
(M) 0.07 0.06 0.05 0.04 
Glycine buffer 0.43 0^ 0 0 0 
(pH 8.2) 0.26 0 0 0 0 
0.17 0 0 0 0 
0.09 0 0 0 0 
0.04 ± 0 0 0 
0.02 0 0 0 0 
Borate buffer 
(pH 8.0) 
0.43 ± 
0.26 ± 
0.17 ± 
0.09 ± 
0.04 ± 
0.02 ± 
± 0 0 
± 0 0 
± 0 0 
± 0 0 
+ 0 0 
± 0 0 
Trls/azide buffer 
(pH 7.2) 
Phosphate buffer 
(pH 6.6) 
0.43 ± ± ± ± 
0.26 ± ± ± 0 
0.17 ± ± 0 0 
0.09 ± 0 0 0 
0.04 ± 0 0 0 
0.02 ± 0 0 0 
0.43 ± ± ± ± 
0.26 ± ± ± ± 
0.17 ± ± ± ± 
0.09 ± ± ± ± 
0.04 ± ± ± ± 
0.02 ± ± ± ± 
®Key to reactions: 0 reaction contains no agglutinated particles; ± reaction appears 
negative macroscopicaliy but has some agglutinated particles on magnified 
examination; + reaction has a grainy appearance macroscopicaliy on the basis of a 
few agglutinates formed. 
200 
TABLE 2. (continued) 
5'3' 
Sampie Concentration (mg/mi protein applied) 
0.07 0.06 0.05 0.04 
Glycine buffer 0.43 0 0 0 0 
(pH 8.2) 0.26 0 0 0 0 
0.17 0 0 0 0 
0.09 0 0 0 0 
0.04 0 0 0 0 
0.02 0 0 0 0 
Borate buffer 0.43 ± ± 0 0 
(pH 8.0) 0.26 ± ± 0 0 
0.17 ± ± 0 0 
0.09 ± ± 0 0 
0.04 ± ± 0 0 
0.02 ± ± 0 0 
Tris/azide buffer 0.43 0 ± ± 0 
(pH 7.2) 0.26 0 ± 0 0 
0.17 0 ± 0 0 
0.09 0 0 0 0 
0.04 0 0 0 0 
0.02 0 0 0 0 
Phosphate buffer 0.43 ± + ± ± 
(pH 6.6) 0.26 ± + ± ± 
0.17 ± + ± ± 
0.09 ± + ± ± 
0.04 ± + ± ± 
0.02 ± + ± ± 
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TABLE 2. (continued) 
Protein A 
Sample Concentration (mg/ml protein applied) 
0.07 0.06 0.05 0.04 
Glycine buffer 0.43 ± ± ± 0 
(pH 8.2) 0.26 ± ± 0 0 
0.17 0 0 0 0 
0.09 0 ± ± 0 
0.04 0 0 0 0 
0.02 0 0 0 0 
Borate buffer 0.43 0 0 0 0 
(pH 8.0) 0.26 0 0 0 0 
0.17 0 0 0 0 
0.09 0 0 0 0 
0.04 0 0 0 0 
0.02 0 0 0 0 
Tris/azide buffer 0.43 ± ± ± 0 
(pH 7.2) 0.26 ± ± ± ± 
0.17 ± ± ± ± 
0.09 ± ± 0 0 
0.04 ± 0 0 0 
0.02 ± 0 0 0 
Phosphate buffer 0.43 ± + ± ± 
(pH 6.6) 0.26 ± + ± ± 
0.17 ± + ± ± 
0.09 ± + ± ± 
0.04 ± + ± ± 
0.02 ± 4- ± ± 
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TABLE 2. (continued) 
Sample Concentration 
Antigen-specific affinity 
cliromatograpliy (mg/ml 
protein applied) 
0.07 0.06 0.05 0.04 
Glycine buffer 0.43 ± ± ± 0 
(pH 8.2) 0.26 ± ± ± 0 
0.17 0 0 0 0 
0.09 0 0 0 0 
0.04 ± ± 0 0 
0.02 0 0 0 0 
Borate buffer 0.43 0 0 ± 0 
(pH 8.0) 0.26 0 0 ± 0 
0.17 0 0 ± 0 
0.09 0 0 ± 0 
0.04 0 0 ± 0 
0.02 0 0 ± 0 
Tris/azide buffer 0.43 ± ± ± ± 
(pH 7.2) 0.26 ± ± ± ± 
0.17 ± ± ± ± 
0.09 ± ± ± 0 
0.04 ± ± ± 0 
0.02 ± ± 0 0 
Pfiosphate buffer 0.43 ± + ± + 
(pH 6.6) 0.26 ± + ± + 
0.17 ± + ± + 
0.09 ± + ± + 
0.04 ± + ± + 
0.02 ± + ± + 
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TABLE 3. Effects buffer type and saline concentrations on nonspecific agglutination of latex 
sensitized with four different levels of protein A purified anti-glutamate decarboxylase antibody 
Buffer NaCI Concentration 
Anti-glutamate decarboxylase latex 
(mg/ml protein applied) yivi/ 0.1 0.08 0.06 0.04 
Glycine buffer 0.43" + " ± ± 0 
(pH 8.2) 0.26 4" ± 0 0 
0.17 ± 0 0 0 
0.086 ± 0 0 0 
0.043 0 0 0 0 
0.025 0 0 0 0 
0 0 0 0 0 
Borate buffer 0.43 ± 0 0 0 
(pH 8.0) 0.26 ± 0 0 0 
0.17 ± 0 0 0 
0.086 0 0 0 0 
0.043 0 0 0 0 
0.025 0 0 0 0 
0 0 0 0 0 
Tris buffer 0.43 ± 0 0 0 
(pH 6.0) 0.26 ± 0 0 0 
0.17 ± 0 0 0 
0.086 ± 0 0 0 
0.043 ± 0 0 0 
0.025 ± 0 0 0 
0 ± 0 0 0 
Phosphate buffer 0.43 + + ± ± 0 
(pH 6.6) 0.26 + + ± ± 0 
0.17 + + ± ± 0 
0.086 + + ± ± 0 
0.043 + + ± ± 0 
0.025 + + ± ± 0 
0 + + ± ± 0 
Phosphate buffer 0.43 0 0 0 0 
(pH 8.1) 0.26 0 0 0 0 
0.17 0 0 0 0 
0.086 0 0 0 0 
0.043 0 0 0 0 
0.025 0 0 0 0 
0 0 0 0 0 
'Key to reactions: 0 reaction contains no agglutinated particles; ± reaction appears negative macroscopically but 
has some agglutinated particles on magnified examination; + reaction has a grainy appearance macroscopically 
on the basis of a few agglutinates formed; + + reaction has discernible agglutinated clumps on a field of 
individual or slightly agglutinated particles. 
TABLE 4. Latex agglutination reactions obtained when four different blocking agents were tested with 0.8 and 0.2 /xm diameter 
latex sensitized with anti-glutamate decarboxylase 
Latex Blocking treatment® 
Cell lysates 
£. coli 
C 
£. coli 
B E. coli NOS 
E. coli 
329 
£. coli 
222 
Klebsiella 
sp. 
Enterobacter 
sp. 
Lysis 
buffer 
Anti-glutamate co-blocked + + + + 
decarboxylase casein- + + + + 
- 0.8 fim latex thimerosal 
casein-BSA + + + + + 
casein- + + + + + 
glycerol 
+ + 
+ + 
+ 
+ + + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + + 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Anti-glutamate 
decarboxylase 
- 0.2 fim latex 
coblocked 
casein-
thimerosal 
casein-BSA 
casein-
glycerol 
+ 
+ + 
+ + + 
+ + + 
+ 
+ + 
+ + + + 
+ + + 
+ 
+ 
+ + 
+ + 
0 
+ 
+ 
+ 
+ + 
+ + + 
+ + + + 
+ + + 
0 
0 
0 
0 
0 
± 
0 
0 
0 
0 
0 
0 
fO 
o 
^Coblocked = for 0.2 fim latex - 2.25 mg/ml antibody + 0.075 mg/ml casein and for 0.8 ^xm latex - 0.5 mg/ml antibody + 0.02 
mg/ml casein; casein-thimerosal = included 0.02% (w/v) thimerosal; casein-BSA = 0.33 mg/ml casein + 0.165 mg/ml bovine 
serum albumin; casein-glycerol = 5 mg/ml casein + 5% glycerol. 
"Numbers and letters refer to strain used (for reference only). Cultures were not all at the same growth stage; cultures were 
grown only for 24 h and differences among the species and strains were not adjusted for. . 
®Key to reactions: 0 reaction contains no agglutinated particles; ± reaction appears negative macroscopically but has some 
agglutinated particles on magnified examination; + reaction has a grainy appearance macroscopically on the basis of a few 
agglutinates formed; + + reaction has discernible agglutinated clumps on a field of individual or slightly agglutinated particles; 
+ + + reaction has several agglutinated particles of a moderate size with a relatively clear background; + + + + reaction has one 
or more agglutinated particle clumps with no macroscopically free particles. 
TABLE 5. Effects of sodium salicylate on agglutination results obtained with 0.2 /xm latex sensitized with four different concentrations 
of anti-tryptophanase or anti-glutamate decarboxylase. 
Sodium Antibody Cell lysates 
Latex salicylate 
concentration 
concentration 
(mg/ml) E. coli B* 
E. coli 
C 
E. coli 
222 
E. coli 
329 
Enterobacter 
sp. 
Klebsiella 
sp. 
Citrobacter 
sp. 
Proteus 
sp. 
Anti-
tryptophanase 
0 6 
3 
+ +b 
+ + + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + 
+ + 
+ + + 
+ + + 
0.2 nm 1.5 + + + + + + + + + + + + + + 0 
0.5 0 0 + 0 0 0 0 0 
Anti-
tryptophanase 
0.2 /im 
100 mM 6 
3 
1.5 
+ 
+ 
0 
+ 
± 
0 
+ + 
+ + + 
+ + 
+ 
+ 
0 
0 
0 
0 
+ 
0 
0 
± 
0 
0 
0 
0 
0 
0.5 0 0 + 0 0 0 0 0 
Anti-glutamate 
decarboxylase 
0 6 
3 
+ + + 
+ + + 
+ + + 
+ + 
+ + + 
-H + + 
+ + + 
+ + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + 
M 0 01 
0.2 fim 1.5 + + + + + + + + + + + + + + + + + + + + + + 4-
0.5 + + + + + + + + + + + + + + 0 
Anti-glutamate 
decarboxylase 
100 mM 6 
3 
+ + 
+ + 
+ + 
+ + -t-
+ + 
+ + + 
+ + 
+ + 
+ + 
+ + 
4- + 
+ + 
+ + 
+ + 
0 
0 
0.2 /im 1.5 + + + + + + + + + + + + + + + + + + + 0 
0.5 + + + + + + + + 0 0 + 0 
^Numbers and letters refer to strain used (for reference only). Cultures were not all at the same growth stage; cultures were 
grown only for 24 h and differences among the species and strains were not adjusted for. 
^Key to reactions; 0 reaction contains no agglutinated particles; ± reaction appears negative macroscopically but has some 
agglutinated particles on magnified examination; + reaction has a grainy appearance macroscopically on the basis of a few 
agglutinates formed; + + reaction has discernible agglutinated clumps on a field of individual or slightly agglutinated particles; 
+ + + reaction has several agglutinated particles of a moderate size with a relatively clear background; + + + + reaction has one 
or more agglutinated particle clumps with no macroscopically free particles. 
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LATEX AGGLUTINATION TESTS WITH CELL CULTURE LYSATES AND 
COMMERCIAL ENZYMES 
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INTRODUCTION 
Results obtained when 0.2-nm diameter sensitized latex particles were blocked with 
13-casein and glycerol (Part 3 of this dissertation) indicated that the assays had the potential to 
distinguish among positive and negative control organisms. To further evaluate the assays, the full 
sensitivity and specificity of the reagents needed to be determined. Results reported in Part 1 (of 
this dissertation) demonstrated that antibodies elicited to one E. coll enzyme might cross-react with 
antibodies elicited to a different £ coll enzyme. Therefore, in a practical situation the latex 
agglutination tests might not fully distinguish among strains of E. coll that were negative for a 
specific trait (tryptophanase, glutamate decarboxylase, or glucuronidase). A moderate amount of 
nonspecific agglutination also was still present, but it was not known if it was sufficient to cause 
substantial Interference. Only by testing of the latex preparations with actual cell culture lysates 
could valid conclusions about the usefulness of the latex agglutination assays be made. 
The original project idea was to develop a latex agglutination assay that could detect the 
presence of three distinct bacterial enzymes on the basis of colored latex particles separating as a 
result of one or more agglutination reactions. Results of previous tests, however, did not indicate 
that the assay was sufficiently developed for combined testing. Results from the use of sodium 
salicylate established that different parameters were necessary for each individual assay. Each 
assay was therefore tested on the basis of individually optimized reaction conditions. The 
optimized conditions were determined by testing cell lysates of six control organisms (three positive 
and three negative) and adjusting reaction parameters accordingly. The optimum reaction 
conditions were then applied to this larger study of known cultures to determine specificity and 
sensitivity. 
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MATERIALS AND METHODS 
Preparation of Sensitized Latex 
Three separate batches of sensitized anti-enzyme latex were made. From a pooled batch 
of antigen-specific affinity chromatography purified antibody preparations, a portion of each 
antibody preparation was adjusted to approximately 1 and 0.5 mg/mi protein by using Aggo values 
and an extinction coefficient of 1.4 (1, 3). Two milliliters of each antibody preparation, were added 
to three 12 x 75 mm test tubes and prewarmed to 3TC. Ten milligrams of dialysis cleaned dyed 
0.22 /xm diameter latex were added to each test tube. Blue dyed latex was used for anti-glutamate 
decarboxylase, red dyed latex was used for anti-tryptophanase, and yellow dyed latex was used for 
anti-glucuronidase. The tubes were covered with Parafilm (American National Can, Greenwich, CT) 
and mixed by inversion several times. The latex suspensions were incubated at 37°C for a 
minimum of 2 h. During the 2 h incubation, they were mixed by Inversion approximately every 
15 min for the first hour and left stationary the second hour. After incubation, 0.25 mg of latex was 
removed to determine the quantity of latex bound protein (see Latex Bound Protein 
Determinations). One milliliter of blocking solution (10 mg/ml 6-casein [Sigma, product number 
C-6905], 10% glycerol [Fisher Scientific, product number G33-500], in Tris/azide buffer [0.03 M, 
0.1% BSA, 0.05% sodium azide, pH 7.4]) was added and the latex suspensions were incubated 
overnight at 4''C. The following day, using a Sorval model RT6000B centrifuge (Sorval Instruments, 
DuPont Co., Newton CT), the latex was sedimented at 3400 RPM (2410 x g) until a latex pellet 
formed and the supernate was clear. This was accomplished in approximately 3 h. All except 
approximately 0.5 ml, the supernate was removed. The latex pellets were each resuspended in the 
remaining supernates and the latex suspensions were transferred to 2.0 ml microcentrifuge tubes. 
The volume of each tube was increased to approximately 1.5 ml with filtered blocking solution. The 
latex was washed three times by centrifugation washing using assay buffer (0.03 M Tris, 5 mg/ml 
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BSA, 0.02 mg/ml B-casein, 5% glycerol, and 0.05% sodium azide, pH 7.4) as the wash buffer. The 
latex was resuspended to a concentration of 1% (w/v) latex in assay buffer and stored at 4°C. 
Each batch of latex was tested against cell lysates to determine reactivity. Three 
phenotypically negative (non-E. coli) and three phenotypically positive (£ coll) organisms were 
used to prepare the cell lysates. The cell lysates were used to determine the optimal level of 
sodium salicylate that should be added, depending on the enzyme that was to be detected (data 
not shown). The optimum sodium salicylate concentration was the concentration at which non-
E. coll cell lysates did not result in agglutination whereas the E. coll cell lysates did produce 
agglutination reactions. Later, pooled batches of latex were tested by using the revised assay 
parameters. 
Testing of the Latex Reagents 
The latex suspensions were tested by using enzyme preparations and cell lysates. Cell 
lysates, from known cultures grown in EIB for 24 h, were prepared as previously described. When 
commercial enzyme preparations were used, they were prepared in 1 ml (total volume) of cell lysis 
buffer (see Cell Lysis previously described) and further diluted in the lysis buffer to the appropriate 
concentrations. In addition, preparations of tryptophanase and glutamate decarboxylase, from Dr. 
David Metzler, were diluted 0.1 to 0.000001 mg of enzyme per ml of lysis buffer. 
An unanticipated problem arose during these studies. When the RNAse reagent used in the 
lysis procedure was exhausted and replaced with fresh reagent, the pattern of nonspecific 
agglutination reactions suddenly changed. Because of these differences in the RNAse reagent, 
further adjustments in the concentrations of sodium salicylate (or polyethylene glycol) had to be 
made to achieve the appropriate agglutination reactions for the control organisms. 
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Calculation of Sensitivity, Specificity, and Efficiency of the Latex Agglutination Assays 
Sensitivity and specificity were calculated on the basis of the results of cell lysate tests. 
The formulas for the calculation of sensitivity and specificity (2, 5) are: 
SENSITIVITY = TRUE POSITIVES % 100% 
TRUE POSITIVES + FALSE NEGATIVES 
SPECIFICITY = TRUE NEGATIVES ^ 100% 
TRUE NEGATIVES + FALSE POSITIVES 
Determinations of true and false reactions were made by comparing the phenotypic traits found by 
conventional methods with the results of the latex agglutination tests. If a culture was 
phenotypically positive and agglutination did not occur for that enzyme, this was considered a 
false-negative reaction. Conversely, if a culture was phenotypically negative but agglutination 
occurred in the presence of the cell lysate, this was considered a false-positive reaction. 
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RESULTS AND DISCUSSION 
Culture Lysate Results 
Table 1 summarizes the results obtained when different batches of sensitized latex were 
prepared on different days by using the same protocol and antigen-specific affinity purified 
antibodies from the same purification pool. The results obtained with different batches of latex 
differed. Because of this, different batches of sensitized latex were mixed for some tests. The 
results of using mixed latex reagents to test culture cell lysates are summarized in Table 2. Mixing 
the latex batches provided sufficient quantities of uniform preparations of sensitized latex for more 
extensive cell-lysate testing. 
The sensitivities and specificities of the assays were determined from the results 
summarized in Tables 1 and 2. The average sensitivity of anti-tryptophanase was 77% with a 
specificity of 61%; these were insufficient to be a useful assay procedure. Anti-glutamate 
decarboxylase sensitized latex had a sensitivity of 83% and a specificity of 57%. Anti-glucuronidase 
sensitized latex had a sensitivity of 70% and a specificity of 82%. Some negative reactions 
occurred with E. coli strains, but these were generally consistent with the phenotypic 
characterizations. Most of the positive reactions with non-E. coli were inconsistent with the 
phenotypic characterizations. 
There are two general explanations for the inadequate performance of these assays. First, 
nonspecific agglutination reactions were not sufficiently eliminated from the assays. Second, cross-
reactions (positive agglutination) were obtained with species other than E. coli. The initial problem 
encountered in the development of the assay was nonspecific agglutination (Part 2 of this 
dissertation). Although these nonspecific agglutination problems were reduced (Part 3 of this 
dissertation), they were not completely eliminated (Tables 1 and 2). Furthermore, tests on cell 
lysates showed that an altogether higher degree of non-specificity existed in agglutination reactions 
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obtained when non E coli Enterobacteriaceae were tested. 
Results With Commercial Enzymes 
To test the latex preparations for specificity and cross-reactivity, with commercial enzymes 
themselves, enzyme preparations in lysis buffer were used as antigen sources. The approximate 
sensitivities of the latex suspensions (Table 3) were: 10 jug/ml (0.01 mg/ml) for anti-tryptophanase, 
0.1 ffg/ml (0.0001 mg/ml) for anti-glutamate decarboxylase, and 1 (0.001 mg/ml) for anti-
glucuronidase. These results demonstrate that the sensitized latex preparations ranged from 
sensitive (anti-tryptophanase) to highly sensitive (glutamate decarboxylase). 
Anti-glucuronidase sensitized latex reacted with as little as 1 fig/ml of glucuronidase (Table 
3). Considering that this latex failed to readily react with cell lysates leads to the belief that cell 
lysates yielded insufficient free glucuronidase for a readily detectable latex agglutination reaction. 
This occurred despite the positive reactions seen when the cultures were grown in EIB-MUG 
medium. Kaspar (4) encountered a similar problem in his coagglutination assay for glucuronidase. 
Kaspar found that his coagglutination anti-glucuronidase assay required a minimum of 31 /xg/ml of 
glucuronidase for detection; 500 ftg/ml was optimal. According to Kaspar (4), the anti-
glucuronidase coagglutination assay was the least sensitive and most difficult of all the 
coagglutination reactions to visualize. Although these studies disclosed the sensitivity of the anti-
glucuronidase latex agglutination assay to be about 1 /xg/ml (Table 3), this was insufficient for 
adequate detection of the enzyme in cell lysates. A procedural difference, however, between 
Kaspar's coagglutination assay and the latex agglutination assay described here should be 
mentioned. The coagglutination reaction was observed with the aid of magnification. In the latex 
agglutination reaction, differentiation at this level was often not conclusive. The ± reactions (those 
observed only with the aid of magnification) were sometimes background level because of 
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nonspecific agglutination. Tfierefore, stronger, macroscopic agglutination, was the goal of these 
latex agglutination assays. 
The sensitivities of the other latex agglutination assays also were compared to the 
sensitivities of the anti-enzyme coagglutination assay developed by Kaspar (4). Kaspar's anti-
tryptophanase coagglutination assay (4) could detect 2-3 /ig/ml of commercial enzyme preparation 
but was unable to detect any enzyme in cell lysates. Although the latex assay was evidently unable 
to achieve the sensitivity Kaspar claimed for his coagglutination assay, it did detect positive 
reactions with cell lysates. Because of cross-reactions with other commercial enzymes (reported 
later), despite antigen-specific affinity chromatography purification of the antibody preparations, 
determinations of which substances were acting as the antigens can only be speculated. The latex 
assay for glutamate decarboxylase was about an order of magnitude more sensitive than Kaspar's 
coagglutination assay (4); 0.1 Mg/ml for the latex assay versus 2-3 ^g/ml for the coagglutination 
assay. 
Cross-reactivities among commercial enzyme preparations and latex suspensions are 
shown in Table 4. All latex suspensions cross-reacted with 100 /xg/ml (0.1 mg/ml) of the other 
enzymes, and sometimes cross-reactivity developed at even lower enzyme concentrations. All latex 
preparations reacted readily with 1 mg/ml of enzyme preparation (data not shown). Only at 
0.1 mg/ml were differences in reactivities evident. 
Anti-tryptophanase sensitized latex gave a very strong agglutination reaction with the 
commercial glutamate decarboxylase enzyme preparation; the agglutination reaction with 10 /zg of 
glutamate decarboxylase per ml was as strong or stronger than with 10 /^g of tryptophanase per ml. 
The anti-tryptophanase sensitized latex also reacted with 0.1 mg/ml of glucuronidase. As expected, 
this was consistent with the reactivities of the anti-tryptophanase in the Western blot studies (Part 1 
of this dissertation). The Ouchterlony immunodiffusion results (Part 1 of this dissertation), however, 
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did not suggest that antigen-specific affinity chromatography purified antibody preparations would 
cross-react with the other enzyme preparations. 
Anti-glutamate decarboxytase-sensitized latex also had cross-reactions to the other 
enzymes (Table 4). Cross reactivity with both tryptophanase and glucuronidase resulted at 
concentrations of 0.1 mg enzyme per ml of lysis buffer. Again, as expected, the results were 
consistent with the Western blot studies (Part 1 of this dissertation). The results (Table 4) were 
consistent with some of the Ouchterlony immunodiffusion results (Part 1 of this dissertation). 
Antigen-specific affinity chromatography purified antibody preparations indicated that cross-
reactivity occurred with tryptophanase. Anti-glucuronidase cross-reactivity, however, was not 
detected. 
Anti-glucuronidase sensitized latex exhibited the most severe cross-reactivities with the 
other enzymes (Table 4). As stated before, the anti-glucuronidase-sensitized latex preparation did 
not consistently detect glucuronidase activity in cell lysates, but latex preparation could detect 
approximately 1 /ug of glucuronidase per ml of lysis buffer tryptophanase (Table 3). 
The use of different tryptophanase and glutamate decarboxylase preparations (from Dr. 
David Metzler) did not significantly change the cross-reactivity patterns detected (data not shown). 
Significant cross-reactivities were still present when the different glutamate decarboxylase and 
tryptophanase preparations were used as antigens. The cross-reactivities were probably a result of 
the heterogeneous polyclonal antibody preparations used to sensitize the latex. 
There are three possible explanations for the cross-reactivity of the assays; the presence of 
enzymes in species not normally considered having the enzymes, cross-reactivity with similar 
structural proteins, or nonspecific antibody preparations. Based on the present studies and the 
biochemical phenotypes of the bacterial cultures used, the latter explanation is most likely. 
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SUMMARY AND CONCLUSIONS 
Cell lysates of members of the Enterobacteriaceae were used for preliminary evaluations 
of the anti-enzyme latex agglutination preparations. These tests were conducted to determine if the 
assays would be satisfactory for use by industrial and governmental food and water analysts. 
Evaluations of the assays in circumstances under which they would be employed (Tables 1 and 2) 
were necessary to decide if the assays were specific and sensitive enough to replace or 
supplement current methods. Although the assays were sensitive (Table 3), they were not 
sufficiently specific (Tables 1, 2, and 4). It has been noted previously (2) that as the sensitivity of 
immunoassays increase, there is often a decrease in specificity. Tests on cell lysates from 
additional cultures could have been made. Results of the tests were not good enough, however, to 
warrant further work with the current assays. 
The anti-enzyme latex agglutination assays suffered from heterologous antibody 
preparations which caused nonspecific agglutination reactions. The full extent of the problems with 
the antibody preparations, however, was not realized until the assays were used in the evaluation of 
the ceil lysates. Although there were early indications that cross-reactions might pose an obstacle 
to the assay (Part 1 of this dissertation), problems with nonspecific agglutination reactions were 
dealt with first (Parts 2 and 3 of this dissertation). Nevertheless, anti-enzyme agglutination tests do 
appear feasible. Latex agglutination assays are easier to interpret than coagglutination assays, and 
multiple indicators (tests for different enzymes) could be combined in a multianalyte assay. Lii<e 
coagglutination assays, latex assays are rapid and simple to use. It is clear that additional work is 
required to obtain better antibody preparations. Whether or not different antibody preparations 
would solve all of the problems encountered in this study, however, remains unresolved. 
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TABLE 1. Number of positive latex agglutination tests using cell lysates 
Number Latex agglutination test'"' 
Species of strains 
tested 
Anti-Tryp® 
(8/92) 
Antl-Tryp 
(9/92) 
Anti-GAD 
(8/92) 
Anti-GAD 
(9/92) 
Anti-GUD 
(8/92) 
Anti-GUD 
(9/92) 
£ coli 22 22 21 18 16 22 16 
Citrobacter spp. 2 0 0 0 1 0 0 
Klebsiella spp. 2 1 1 0 1 1 0 
Enterobacter spp. 1 0 0 0 0 0 0 
Hafnia spp. 1 0 0 0 0 0 0 
Proteus spp. 3 2 0 . 0 0 0 0 
Shigella spp. 2 2 1 0 0 1 1 
Salmonella spp. 2 1 1 0 0 2 1 
®Tryp = tryptophanase; GUD = glucuronidase: GAD = glutamate decarboxylase. 
''Numbers refer to date of latex batch preparation; for reference only. 
'^ Sodium salicylate (50 mM) was added to latex buffer to control nonspecific agglutination. 
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TABLE 2. Number of positive latex agglutination results using cell lysates with a different batch 
of sensitized latex 
Species 
Number 
of 
Latex agglutination test 
strains 
tested «
 
Anti-Tryp Antl-GAD 
250 mM 200 mM 
Antl-GAD 
250 mM 
Anti-GUD 
200 mM 
Anti-GUD 
50 mM 
E. coli 8 7 5 7 6 0 0 
Cltrobacter spp. 2 1 0 0 0 0 0 
Klebsiella spp. 4 3 2 1 0 0 0 
Enterobacter spp. 4 3 1 2 0 0 0 
®Tryp = tryptophanase; GUD = glucuronidase: GAD = glutamate decarboxylase. 
"^The concentration of sodium salicylate included in the assay buffer. 
TABLE 3. Sensitivity of latex with commercial enzyme preparations 
Appropriate*^ enzyme preparations in lysis buffer (mg/ml) 
Latex conditions® 0.1 0.01 0.001 0.0001 0.00001 0.000001 
Anti-tryptophanase 100 mM SS + + + + ± 0 0 0 0 
Anti-glutamate 
decarboxylase 
225 mlVI SS + + + + + + + + ± 0 0 
Anti-glucuronidase 4% PEG + + + + + + + ± 0 0 0 
®The amount of sodium salicylate (SS) or polyethylene glycol (PEG) used to stabilize the sensitized latex. 
^Appropriate enzyme refers to using the enzyme against which the latex was sensitized with the anti-enzyme antibodies 
(tryptophanase, glutamate decarboxylase, or glucuronidase). 
TABLE 4. Cross-reactivity of latex with commercial enzyme preparations 
Enzyme Concentration of enzyme preparations in lysis buffer (mg/ml) 
Latex conditions® preparation 
used'' 0.1 0.01 0.001 0.0001 0.00001 0.000001 
Anti-T ryptophanase 0 mM SS Tryp + + + + ± 0 0 0 0 
GAD + + + + 0 0 0 0 
GUD + 0 0 0 0 0 
Anti-glutamate 200 mM SS Tryp + ± 0 0 0 0 
decarboxylase GAD + + + + + + + ± 0 0 
GUD + 0 0 0 0 0 
Anti-glucuronidase 4% PEG Tryp + + + + + + + + + + + + + 
GAD + + + + + + + + + + + + 
GUD + + + + + + + + + 0 0 0 
®The amount of sodium salicylate (SS) or polyethylene glycol (PEG) used to stabilize the sensitized latex. 
''Tryp = tryptophanase; GAD = glutamate decarboxylase: GUD = glucuronidase. 
^Key to reactions; 0 reaction contains no agglutinated particles: ± reaction appears negative macroscopically but has 
some agglutinated particles under magnification; + reaction has a grainy appearance macroscopically on the basis of a 
few agglutinates formed; + + reaction has discernible agglutinated clumps on a field of individual or slightly agglutinated 
particles: + + + reaction has several agglutinated particles of a moderate size with a relatively clear background: + + + + 
reaction has one or more agglutinated particle clumps with no macroscopically free particles. 
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GENERAL SUMMARY AND CONCLUSIONS 
The development of rapid and sensitive methods to detect E coll in food and water, after a 
brief period of enrichment, would tremendously enhance the safety of perishable foods and potable 
water and would further protect consumers from the potential of food and waterborne illnesses. 
The original intent of the project was to develop a rapid, 10-minute assay that could eliminate the 
need for time-consuming cultural confirmation of initially presumptive cultures to establish the 
presence of E. coli. 
Antibody preparations were developed against three selected E. coli enzymes: glutamate 
decarboxylase, glucuronidase, and tryptophanase. These enzymes were chosen because, taken 
together, they would provide a highly sensitive and specific indication of the presence of any 
E. coll, including verotoxin-producing strains. 
Sensitivity and specificity are the most important parameters of immunoassays (1,6, 11). 
Although antibodies were prepared by using procedures that were apparently successful in 
previous studies (8,10), the antibody preparations were too heterogeneous to be used in latex 
agglutination assays. They reacted with proteins in the antigen preparations and cell lysates that 
were not the intended target antigens. Although this problem was recognized, its severity was not 
fully realized until late in the study, otherwise, more specific antibody preparations would have been 
prepared from more highly purified enzyme preparations or monoclonal antibodies could have been 
attempted. The concurrent presence of other problems with the assays directed attention to other 
studies in the belief that many of the problems with autoagglutination and cross-reactions might be 
resolved by appropriate conditions for latex preparation and use. 
Evaluation of immunoglobulin binding to the latex particles provided a starting point for the 
investigation of causes of nonspecific agglutination reactions. Nonspecific agglutination reactions 
were reduced but not completely eliminated by the selection of several methods used for 
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contending with them. These included latex particle size, sensitization procedures, alternative 
blocking agents, type and pH of buffer and changes in the ionic conditions of the assay. Two 
methods were discovered that substantially reduced the number and intensity of the nonspecific 
agglutination reactions: the use of 0.22/^m diameter latex particles and use of a mixture of G-casein 
and glycerol as the blocking reagents. Reductions in nonspecific agglutination reactions permitted 
better evaluation of the assays developed. 
The latex agglutination assays, when tested against ceil lysates from known cultures, failed 
to achieve useful levels of sensitivity and specificity. Sensitivity and specificity of the assays 
suffered from cross-reactions among the antibody preparations and the Intended target antigens, it 
was concluded that the cross reactivities were probably the result of the heterogeneity of the 
antibody preparations. 
As stated previously, nonspecific agglutination of sensitized latex was a major problem in 
development of the £ coli enzyme latex agglutination tests. The greatest problem, however, was 
contending with cross-reactions. The results suggest that more highly purified enzyme preparations 
need to be used for immunization to produce polyclonal antibodies of suitable homogeneity for use 
in latex agglutination tests. Even more specific antibodies than polyclonals may be required, 
however, for the assay to become practical. The development of monoclonal antibodies to 
tryptophanase, glutamate decarboxylase, and/or glucuronidase (or other enzymes unique to 
E. coli) might be necessary to completely eliminate cross-reactions and achieve a satisfactory 
degree of specificity for these assays. Once the problems of specificity and cross-reactivity are 
solved, the assays should be sensitive enough to detect 10® to 10® E. coli per milliliter or per gram 
of sample. 
In conclusion, the present work establishes the groundwork for the development of an anti-
enzyme latex agglutination assay to detect E. coli. This is the first time that an anti-enzyme latex 
223 
agglutination test has been described. Some of the methods necessary for development of this 
assay are presented. More specific antibody preparations, however, are needed. 
Several alternative formats that might utilize specific antibodies to selected E. coli enzymes 
also are possible. Rapid filter-based particle assays, latex chromatography, or magnetic particles 
are several of the methods that could be exploited to aid in the rapid confirmation of E. coli from 
presumptive cultures. 
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